Silvernanowires and their potential applications in 3D scaffolds for biomedical applications by De Mori, Arianna
  
Silvernanowires and their potential applications 
in 3D scaffolds for biomedical applications 
 
 
 
 
 
 
 
 
The thesis is submitted in partial fulfilment of the requirements for the 
award of the degree of Doctor of Philosophy of the University of Portsmouth 
 
 
 
 
 
 
 
 
 
 
Arianna De Mori 
 
 
October, 2018 
2 
 
Preface 
 
The three years project was supervised by Dr. Marta Roldo, Dr. Gianluca Tozzi and Dr. Eugen 
Barbu. 
Experiments were conducted at the School of Pharmacy and Biomedical Sciences, the 
School of Engineering, the School of Biological Sciences, the School of Geography and the 
School of Geology of the University of Portsmouth. 
 
 
Arianna De Mori 
3 
 
Abstract 
 
The aim of this work was to design, prepare and characterize novel composite materials 
with inherent antibacterial properties to be used in bone repair and bone regeneration 
applications. The project was developed in three stages, looking at novel filler materials 
initially and then investigating their use in two different types of scaffolds, namely soft 
hydrogels and hard cements. 
The first part of the project dealt with the in vitro elucidation of the antibacterial activity 
and cytocompatibility of silver nanowires (AgNWs). These silver nanoparticles have been 
attracting increasing attention in comparison to other silver nanospecies due to their high 
aspect ratio that influences their thermal and electrical properties for use in flexible 
transparent conductive films (TCFs). Nevertheless, a limited number of papers have explored 
AgNWs antibacterial activity and eukaryotic toxicity. In this work, a polyol method, in 
presence or absence of carbon nanotubes (CNTs) has been used to guide the silver nanowires 
formation. Initially, the synthesised nanomaterials were fully characterized in terms of their 
physicochemical properties. Then, their toxicity, reactive oxygen species (ROS) formation 
and release of cytoplasmic proteins was studied against four different bacterial species and 
against three different mammalian cell types, to simulate different infection types and routes 
of exposure, respectively. Results showed that AgNWs, with similar characteristics, can be 
synthetized using either of the two synthetic methods, with no advantages imparted by the 
inclusion of CNTs in the synthetic process. Moreover, AgNWs were proven to be affective 
antibacterial agents acting via ROS formation and cellular membrane damage. Finally, we 
showed that AgNWs presented dose-dependent and time-dependent cytotoxicity following 
ROS formation in all the studied mammalian cell lines. 
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The second part of the project looked at applications of silver nanowires addressing the 
occurrence of infections as a complication following bone implant surgery. These infections 
can lead to destruction of the bone and consequently to an increased rate of treatment 
failure and delayed osseous-union. A chitosan-based hydrogel incorporating hydroxyapatite 
and AgNWs with potential bioactive, biocompatible properties and antibacterial properties 
was formulated. Physicochemical characterization, Ca/P deposition, silver release, 
antibacterial and cytocompatibility studies were carried out, and results suggested that the 
hydrogels herein developed present good bioactivity and biocompatible properties. 
The third part focused on trying to solve some of the drawbacks related to the use of 
polymethyl methacrylate (PMMA) cements in vertebroplasty and total joint replacement: 
stiffness mismatch between the bone and the cement, high exothermic reaction 
temperature, leakage of toxic monomer and lack of antibacterial properties. In this part, we 
encapsulated AgNWs in PMMA bone cements with different concentrations of chitosan or 
methacryloyl-chitosan, to ensure a long lasting and increased release of Ag+ over time. 
Cytocompatibility, antibacterial and mechanical properties of the novel composite cements 
were investigated. This study suggested that the inclusion of CS/CSMCC (between 10 and 
20%) and AgNWs (1%) in the existing commercial materials could provide bone cements with 
good results in terms of cytocompatibility combined with appropriate thermal, mechanical, 
and antibacterial properties. However, no advantages were shown by the inclusion of CSMCC 
over CS. 
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deposits in hydrogels for bone regeneration. 
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Chapter 1: Silver nanowires and their suitability for biomedical 
applications 
 
 
Antibacterial resistance is currently one of the most serious health problems for medicine. 
Indeed, a recent review has estimated that, by 2050, 10 million people a year will die as a 
result antimicrobial resistance [1]. Unfortunately, as bacteria have a short doubling time and 
can acquire resistance genes from other strains via horizontal gene transfer (transformation, 
conjugation and transduction), they can both accumulate mutations faster than humans and 
increase the risk of spread of antibiotic resistance from species to species [2]. Moreover, in 
the case of implant-surgeries, the presence of infections can cause longer length of hospital 
stay, pain, implant failure, amputations and ultimately death [3]. In this context, there is a 
huge demand for novel antibiotics in order to prevent a health disaster. Nanotechnology has 
an important part to play in the fight against antimicrobial resistance, in fact nanoparticles 
(NPs) (particles having at least one dimension in the size range 1- 100 nm [4]) seem to exert 
their antimicrobial activity via multiple mechanisms rendering the development of 
simultaneous defence mechanisms very unlikely. Therefore, attention has been focused on 
novel NPs with antibacterial activity, such as silver nanoparticles. 
 
 
1.1 Silver 
 
Silver is the metallic element with atomic number 47, atomic mass 107.89 and symbol Ag 
(from Latin argentum, derived from Greek ὰργὀς, literally "shiny" or "white"). Ag possesses 
unique chemical and physical properties such as the highest electrical and thermal 
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conductivities of all metals, catalytic and optical properties, chemical stability and 
malleability [5]. Moreover, silver has been used in engineering technologies (e.g. sensors) 
because of its superior plasmonics and surface-enhanced Raman scattering (SERS). Finally, 
silver is widely used in medicine for its antimicrobial activity. 
 
 
1.1.1 Silver as an antimicrobial material 
 
 
Silver is known for its antimicrobial properties against a wide range of microorganisms since 
times immemorial, even though its use was based on simple empirical observations. One of 
the first documented uses of silver has been reported by Herodotus (V century B.C.) to keep 
fresh and pure the water for long periods of time. In the XIX century isolated attempts were 
made to use silver, until 1880s, when Doctor Carl Siegmund Franz Crede, a German 
obstetrician, formulated 1 % silver nitrate eye drops to prevent ophtalimia in new-born 
infants and later used colloidal silver for the treatment of septic wounds. Through the 20th 
century, silver fell into disuse as the medical world concentrated on antibiotics for the control 
of infections, as they presented less toxicity to the host and they were more effective for 
systemic use. In the 60s, the rise of bacterial resistance brought the attention of silver back 
to research because of its effective antimicrobial activity against a wide spectrum of 
unicellular organisms [6]. Nowadays, silver is used into sanitary devices, such as catheters 
and plasters for preventing urinary tract and wound infections, respectively [7]. When in the 
1980s the first findings on unique properties of nanoparticles (NPs) were published [8], new 
doors opened up to tailor the chemical and physical properties of materials for various 
applications. 
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In this perspective, several studies have focused on the synthesis and development of 
different shapes and sizes of silver nanoparticles (AgNPs) for a wide variety of engineering 
and biomedical applications. 
 
 
 
1.2 Metallic Nanoparticles and Silver Nanoparticles 
 
Engineered nanomaterials have unique properties that make them suitable for uses in 
various industrial applications, such as agriculture [9], chemistry, electronics, food [10], 
medicine, automotive telecommunication, energy, textiles, etc. 
The main motivation to perform research on NPs is based on the so-called quantum size 
effect of nano-scale materials [8]. As their size reduces from macro to nano, materials not 
only acquire a larger surface area per unit mass, but also a higher surface energy, due to the 
high friction of atoms/molecules on the particle surface. Surface energy increases in 
magnitude with a decreasing particle size, generating unique physical, chemical and 
biological properties [11]. The large fractions of surface atoms and surface energy seem to 
influence the optical, thermal and magnetic properties of nanomaterials. Consequently, 
tailoring the size and shape of nanomaterials, it is possible to obtain defined properties and 
characteristics. Furthermore, NPs possess surface atoms which have a smaller coordination 
number (number of atoms, ions or molecules bonded to an atom in crystal) than bulk atoms 
and thus, highly polarized surfaces (a dielectric surface is said ‘polarized’ when its molecules 
acquire an electric dipole moment, in response to an applied external field) [12]. 
Consequently, NPs can adsorb and bind to biological materials non-specifically through their 
need for steric and electrostatic stabilization [13, 14]. 
In comparison to other types of nanomaterials, metal nanoparticles show the advantages 
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of a high heat resistance, excellent antimicrobial properties, low cost preparation and less 
chances to induce microbial resistance in comparison to conventional antibiotics. Metal NPs 
include Ag, silver oxide (AgO), titanium dioxide (TiO2), alluminiun oxide (Al2O), silicon, copper 
oxide (CuO), zinc oxide (ZnO), Au, calcium oxide (CaO) and magnesium oxide (MgO). All these 
nanomaterials seem to exert their antibacterial effects by the release of free ions from 
dissolution of metals and oxidative stress via the generation of reactive oxygen species (ROS) 
on the surfaces of the nanoparticles [15]. 
Among the other types of metallic NPs, silver nanoparticles (AgNPs) are the most studied 
due to their outstanding antimicrobial properties. Indeed, studies have shown that AgNPs 
are effective against a broad range of Gram positive and Gram negative bacteria, 
mycobacteria and fungi [16]. Few researches have also indicated that AgNPs act as potent 
antiviral agents against various virus species including hepatitis, herpes simplex virus, 
monkeypox virus and even human immunodeficiency virus (HIV-1). AgNPs possess 
therapeutic advantage over conventional and narrow targeting antibiotics, due to a rare 
chance of microbes to develop resistance against them [17]. 
Finally, AgNPs have been synthetized in many shapes and sizes, such as spherical, 
triangular, square, cubic, rods, rectangular disks, oval and wires [18]. Depending on their 
dimensions, they can also be classified into zero-dimensional (0D), one-dimensional (1D), 
two-dimensional (2D) and three dimensional (3D) [19]. 
 
 
1.3 Silver nanowires (AgNWs) 
 
Among other types of silver NPs, AgNWs (Fig. 1.1) have been attracting more and more 
attention due to their high aspect ratio and electrical and thermal properties. AgNWs are 
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one dimensional silver nanostructures with diameters in the range 10-200 nm and length in 
a range of 5-100 µm with an aspect ratio higher than 10. 
So far, AgNWs have been mainly used to fabricate flexible transparent electrodes (FTEs) 
which can be applied to many optoelectronic devices such as portable solar cells and touch 
screens. When applied on a substrate, they form a highly conductive network that enables 
an interplay between the user and the system [20]. More recently, the antibacterial 
properties of AgNWs have also emerged as potential alternative to traditional antimicrobial 
agents in a wide range of applications, such as wearable or medical devices. 
Due to the economic importance of AgNWs, many researchers have focused on the 
investigation of synthetic methods to obtain of high-yield and low costs AgNWs with 
different length and diameter. In general, AgNWs can be synthetized using different methods 
that can be broadly classified as hard- and soft-template methods, even though other 
techniques can be used, such as hydrothermal method, ultraviolet irradiation technique and 
electrochemical processes. 
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Figure 1.1 Silver nanowires obtained by a polyol method imaged by field emission scanning electron 
microscope (FESEM). Reproduced from [21]. 
 
 
 
 
 
1.3.1 Hard-template synthesis of AgNWs 
 
The hard-template method (or template-directed method) is based on the use of rigid 
materials as a mould, whose firm structure guides the formation of crystals on the surface, 
determining their size and morphology [22]. In this method, water and alcohols are used as 
solvents, whereas sodium borohydride, citrate, ascorbic acid, etc. are used as reductant [23]. 
At the end of the process, the metal wires can be removed from the template. 
In the template-directed method, the metal is deposited chemically or electrochemically 
within the mould. Different hard templates are available to build-up materials with this 
method: membranes, such as anodic aluminium oxide (AAO), carbon nanotubes, carbon 
fibers, plastic foams, nanoporous silica and alumina membranes, zeolites and track-etched 
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polycarbonate [24] [25]. 
 
The advantage of this technique is that the NWs produced in this way are perfectly 
customized and they are homogeneous. Finally, the process can be highly reproducible. 
However, this process presents several drawbacks, such as: high cost, difficulty to scale-up 
and the separation of the wires from the template can require a harsh process, causing 
damage to the wires [24, 26]. 
 
 
1.3.2 Soft-template synthesis of AgNWs 
 
To overcome the limitations associated with the hard-template method, the soft-template 
(or template-free methods) were developed [24]. In these synthetic methods, no fixed rigid 
structures are needed, but various types of surfactants, micelles, and many other polymers 
are used as soft-template [23, 27, 28]. 
 
 
1.3.2.1 Polyol process  
 
Among the other soft-template methods, the polyol method is the most popular [29], as it 
is a faster process compared to the hard-template methods, and it produces a greater yield 
of AgNWs, with controllable diameters and size [30]. Moreover, the use of polyols offers 
different relevant advantages in the synthesis of metallic NPs. Firstly, metal salts can be 
solubilized in hydrophilic polyols, reducing the production of toxic waste products (such as 
carbonyl metals or advanced organometallic compounds). Secondly, the polyols work both 
as stabilizing and reductive agents, allowing the formation of NWs in a one-pot reaction 
synthesis [28]. Finally, polyols can be highly-boiling solvents (this is advantageous when high 
temperature of synthesis are necessary to synthetize the desired NPs). 
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Typically, in the synthesis of AgNWs, ethylene glycol (EG) or glycerol, poly(vinyl pyrrolidone) 
(PVP), and AgNO3 are used as polyol, capping agent (to prevent agglomeration of the colloidal 
particles), and salt precursor, respectively. In this synthetic process, the polyol that is the 
reducing agent, promotes the reduction of ionic silver (Ag+) into metallic silver (Ag°), forming 
multiply-twinned nanoparticles (MTPs). The MTPs tend to have a decahedron configuration 
with ten {111} facets and (111) planes, as shown in Fig. 1.2 A. The multiply- twinned NPs 
serve as seeds for of subsequent formation of AgNWs. In particular, bigger NPs can form, 
through a process called Ostwald ripening. PVP, adsorbing on (100) planes, leaves 
(111) planes active for anisotropic growth in the <110> direction, forming at first nanorods 
and then nanowires. 
As also reported by Jones et al. [31], the formation of AgNWs of different sizes and 
diameters is controlled by several factors (e.g. small amount of salts, stirring rate, 
temperature and presence of oxygen) and different strategies can be adopted, making the 
polyol method very flexible and adaptable for the production of AgNWs for different 
applications. 
30 
 
 
 
Figure 1.2 Schematic growth mechanism of AgNWs. (A) At the beginning, multiply-twinned nanoparticles 
(MTPs) of silver are formed after reduction of Ag+ -> Ag°. {111} facets are highlighted in red and {111} planes in 
violet. Then, PVP passivates on (100) planes, blocking the access of Ag° to Ag seeds. (B) Schematic model 
illustrating the diffusion of silver atoms towards the two ends of a nanorod, with the side surfaces completely 
passivated by PVP. This drawing shows a projection perpendicular to one of the five side facets of a nanorod, 
and the arrows represent the diffusion fluxes of silver atoms. Reproduced from [32]. 
 
 
 
1.4 Gram-positive vs Gram-negative bacteria 
 
Bacteria are prokaryotic organisms, whose size ranges between 0.1 to 10 μm. These 
microorganisms reproduce themselves through binary fission and they exist in a variety of 
morphologies, such as bacilli, cocci and others (spirilla, vibrios and spirochaetes). Most of the 
bacteria can be primarily grouped into Gram-negative and Gram-positive (Fig. 1.3) strains 
based on their ability to retain or not Gram stain. 
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Figure 1.3 Schematic representation of differences between the cell walls of Gram-positive and Gram-negative 
bacteria. Reproduced from [33]. 
Gram-positive bacteria are those that retain crystal violet-iodine complex in their cell walls, 
due to their thicker and less porous peptidoglycan cell wall than Gram-negative [34, 35]. 
Moreover, Gram-positive bacterial cell wall is characterized by the presence of teichoic acid 
that is a negatively charged glycoprotein which is not present in Gram-negative bacteria. 
Gram-negative bacteria present a plasma membrane located outside of the cell wall, known 
as the outer membrane (OM) and, composed of lipids, proteins and lipopolysaccharide (LPS). 
This extra layer makes Gram-negative bacteria more resistant to antibiotics than Gram- 
positive. Furthermore, LPS plays an important role in the pathogenesis of many Gram- 
negative bacterial infections, inducing the release of proinflammatory cytokines and the 
activation of the complement, leading to endotoxin shock. 
There are essentially two pathways that antibiotics can take through the outer membrane: 
a lipid-mediated pathway for hydrophobic antibiotics, and general diffusion through porins 
for hydrophilic antibiotics [36]. 
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Finally, on the inner side of the cell wall there is a cell membrane, known as ‘inner’ in Gram 
negatives or ‘cytoplasmic’ in Gram-positives, composed of a phospholipid bilayer and 
proteins and, it performs multiple functions, such as active transport, respiratory chain 
components and energy-transducing systems. The membrane also contains components of 
protein export systems that enable proteins to exit the cell and it is the anchoring site for 
DNA, too [34, 37]. 
 
 
1.5 Mechanisms of action of AgNPs in bacteria 
 
To date very little is known about the exact mechanism of action of AgNPs, Ag ions or other 
silver nano species. Various theories on how AgNPs effect their microbicidal action have been 
proposed [38], with a combined action of both Ag+ and integral AgNPs being the most 
plausible explanation [39]. As little is known about AgNWs mechanism of action, here we 
propose the main hypotheses of AgNPs bacterial toxicity (Fig. 1.4 A-B) [40]: 
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Figure 1.4 A comparison of the silver ions (A) and silver nanoparticles’ (B) mode of action to Gram negative 
and Gram-positive bacteria. (1) Pore formation; metabolites and ions leakage (shown as plus and minus in the 
figure above) (2) Denaturation of structural and cytoplasmic proteins; enzymes inactivation. (3) Inactivation of 
respiratory chain enzymes. (4) Increase of intracellular reactive oxygen species (ROS) concentration. (5) 
Interaction with ribosome. (6) Interaction with nucleic acids. (7) Inhibition if signal transduction. Reproduced 
from [41, 42]. 
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(1) Adhesion of NPs to the bacterial surface, altering membrane properties. 
 
 
 
This phenomenon depends on the electrical interaction/repulsion between bacteria and 
materials’ surface charge. El Badawy et al. found that surface charge is the most important 
factor for nanosilver-bacteria interaction [43]. Indeed, on one hand, bacterial cells have a 
negative charge on their cell wall, mainly due to the presence of negatively charged teichoic 
acid in Gram positive and phospholipids and lipopolysaccharides in Gram negative bacteria 
[44]. On the other hand, AgNPs can be positively-, negatively- and neutrally- charged and 
their attachment and bactericidal activity is different. Abbaszadegan et al. demonstrated 
that positively- charged AgNPs presented the highest bactericidal activity against both Gram 
+ and Gram – bacteria while neutral or negative charged NPs provided the intermediate and 
lowest bactericidal activity [45] . Interestingly, negatively charged NPs coming closer to the 
bacteria can overcome the repulsive forces and somehow interact with cells or they can 
interact with sulphur-binding proteins within the cell membrane [46]. As a consequence, it 
has been suggested that NPs can cause local membrane damage, with consequent 
cytoplasmic materials leakage. 
 
 
(2) DNA damage. 
 
Lee et al. demonstrated that AgNPs can induce cell death in E.coli as an apoptosis-like 
response that includes the following: accumulation of reactive oxygen species (ROS), 
increased intracellular calcium levels, phosphatidylserine exposure in the outer membrane, 
disruption of membrane potential, activation of a bacterial caspase-like protein and DNA 
degradation [47]. DNA fragmentation was also shown in H. pylori, Proteus sp. and Klebsiella 
sp. [48]. 
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(3) Ag+ released from AgNPs can interact with sulphur and nitrogen-containing 
 
compounds 
 
 
 
Metallic silver present in AgNPs can be oxidized to form Ag+. Usually, the oxidation of AgNPs 
can be due to either reaction with oxygen or with hydrogen peroxide in acidic medium [24]. 
Ag ions, once inside the cells, interact with thiol (-SH) and amine (-NHx, x=1,2,3) groups of 
proteins, nucleic acids and enzymes. [42] Consequently, a cascade of damages happens to 
bacterial cell wall, cytoplasmic structures and genomic components [49, 50]. For instance, 
Jung et al. proved that the accumulation of Ag+ in the bacterial envelope was followed by the 
separation of the cytoplasmic membrane from the cell wall in both Gram-positive and Gram- 
negative bacteria [51]. A further major target in bacterial cells are S2 proteins in ribosomes 
that result in denaturation of the ribosome native structure and inhibition of protein 
biosynthesis [52]. Finally, damage can be due to the interaction of Ag+ with transport pumps 
leading to proton leakage and a decrease in proton motive force; or with inhibition of 
phosphate uptake causing cytoplasmic shrinkage and detachment of the cell membrane [53]. 
 
 
(4) Generation of reactive oxygen species (ROS). 
 
 
Many studies provide evidence for the production of ROS by AgNPs. ROS can be generated 
outside the cell, in medium, or inside the cell, also as a consequence of cell 
damage/disruption. Exposure to a concentration of ROS, such as hydrogen peroxide (H2O2), 
superoxide anion (O2-•) and hydroxyl radical (OH•), over the level of tolerance of antioxidant 
defence systems or inhibiting scavenging enzymes (e.g. superoxide dismutase), causes 
oxidative stress, protein damage, DNA breakage, inhibition of respiratory chain enzymes and 
consequently cell death [24, 54] [55]. 
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(5) Disruption of proton electrochemical gradient. 
 
 
 
Cao et al. reported that AgNPs could attach to cells creating proton depleted regions, thus 
interfering with ATP production in the intermembrane space: the disruption of the 
transmembrane proton electrochemical gradient may inactivate ATP synthesis, ion 
transport, and metabolite sequestration, leading to cell death [56]. 
 
 
 
1.5.1 Ag+ and AgNPs uptake in bacteria 
 
Little is known about the mechanisms of uptake of both Ag+ and AgNPs in bacteria. 
 
The mechanism of Gram-negative cells uptake of ionic Ag has been explored more than 
that of Gram positive bacteria. Most likely, to reach the plasma membrane of Gram-negative 
bacteria, Ag ions should first pass outer membrane via major outer membrane proteins 
(OMPs), especially OmpF and its homolog OmpC [51, 57], whose bacterial porin family is 
usually responsible for the efflux of specific toxic metals out of the cells [58]. 
On the other hand, it seems that the majority of the works suggest that bacteria are unable 
to uptake NPs, due to the lack of uptake mechanisms [59]. 
 
 
1.5.2 Studies on antibacterial properties of AgNWs 
 
Similarly to the more studied spherical AgNPs, the mechanism of action of AgNWs is still to 
be elucidated; some researchers suggest that the reason for AgNWs toxicity is due to only to 
Ag+ release, while others claim a shape and size effect [60, 61]. 
Visnapuu et al. compared toxicity of AgNWs (600 x 6100 nm) and Ag nanospheres (83 nm) 
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against E. coli to test the effect of shape and size. The surface charge of both nanostructures 
was negative and Ag+ was dissolved at similar rates in the aqueous suspensions. They found 
that AgNWs and spheres presented inhibition of bacterial growth at concentrations of 0.42 
± 0.06 and 0.68 ± 0.01 mg/L, respectively. Moreover, they found that the toxic effects of 
AgNWs, Ag spheres and AgNO3 were driven by dissolved Ag+ ions and that the toxicity was 
not dictated by nanoparticle shape [60]. 
Other studies seem to show that the shape and size of the metallic nanoparticles play an 
important role in toxicity. Hong et al., for instance, compared the antibacterial activity of Ag 
nanocubes (55 ± 10 nm), spheres (60 ± 15 nm) and wires (60  ± 10 nm in diameter and 2-4 
μm in length) against E. coli. They showed that spheres were more efficient than nanocubes 
and nanowires in inhibiting E. coli growth, presenting MIC values (for cell density if 1 x 10 4 
CFU/ml) of 37.5 ± 5.3, 75 ± 2.6 and 100 ± 5.3 μg/mL, respectively. According to TEM 
observation, it was concluded that nanocubes and nanospheres, presenting a larger specific 
surface area than NWs could attach to the cell membranes more closely, causing more cell 
membrane damage and stronger antibacterial performance than AgNWs [62]. 
The most complete study on AgNWs mechanism of action against bacteria has been carried 
out by Cui et Liu. They found that AgNWs were able to inhibit the growth of both E. coli and 
S. aureus at the concentrations of 28 and 35 µg/ml, respectively. Furthermore, they found 
out that exposure of E. coli to concentrations as low as 10 µg/ml were sufficient to cause 
leakage of proteins and DNA/RNA from bacteria walls and generation of ROS [63]. 
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1.6 Mechanisms of action of AgNPs in mammalian cells 
 
 
As already reported for bacteria, even for mammalian cells little is known about the precise 
mechanisms of action of AgNWs. Thus, here we report the possible mechanism of 
cytotoxicity of AgNPs in mammalian cells: 
 
 
1) Generation of ROS 
 
 
 
High levels of ROS, in mammalian cells, can cause DNA damage, alteration of gene 
expression, chromosomal aberrations, lipid peroxidation and reduction of glutathione (GSH), 
often accompanied by proliferation arrest. Several studies have demonstrated that AgNPs 
can induce ROS generation within different cell lines, by 1) directly interfering with 
organelles, such as mitochondria, 2) binding transition metals or 3) leading to ROS formation, 
due to their surface chemistry [64]. For instance, Gurunathan et al. demonstrated that AgNPs 
(ca. 20 nm in diameter) increased ROS formation in a dose-dependent manner in both human 
lung (L-132) and lung carcinoma cells (A549) (Fig. 1.5) [65], whereas Kim et al. found dose-
dependent ROS generation in human hepatoma cells (HepG2) by AgNPs (ca. 5-10 nm in 
diameter) [66]. 
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Figure 1.5 AgNPs induce generation of ROS in AgNP-treated A549 cells. Fluorescence (given by, 2’-7’- 
Dichlorofluorescin, DCF) images of A549 cells without silver nanoparticles (AgNPs) (0) and cells treated with 
AgNPs 30 μg/mL and incubated at different time points. Reproduced and adapted from [65]. 
 
 
2) Interaction with and damage to cellular proteins 
 
 
 
Both Ag+ and AgNPs can interact with aminoacids and proteins (such as serum albumin, 
haemoglobin, cytoskeletal proteins and antioxidant molecules), altering their functionality 
[67]. For instance, Paula et al. found that AgNPs (5-45 nm range in diameter) inhibited 
creatine kinase from the rat brain and skeletal muscle cells [68]. Asharani et al. found that 
AgNPs (6-20 nm) can bind to cytosolic proteins forming a protein-starch coating able to 
control cellular responses[69]. 
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3) Mitochondrial damage 
 
 
 
AgNP-induced apoptosis can also be achieved by the mitochondrial pathway. 
Mitochondrial-mediated apoptosis involves two phenomena: the alteration in the 
permeability of the outer mitochondrial membrane (due to the formation of mitochondrial 
membrane pores) and the loss of the electro chemical gradient. As a consequence, an event 
cascade occurs, leading to ROS production [70], reduced ATP production, increased 
mitochondrial calcium sequestration and release of cytochrome c [70]. For instance, 
Gurunathan et al. showed that after exposure of A549 cells to AgNPs (20 nm) the 
transmembrane potential decreased in comparison to the control [65]. Hsin et al. 
determined that nanosilver was able to cause mitochondrial damage, releasing cytochrome 
c into the cytosol in mouse fibroblasts [71]. Nair et al. also determined that AgNPs (6-20 nm) 
could induce a time-dependent drop in ATP synthesis in human lung fibroblast cells (IMR-90) 
and human glioblastoma cells (U251), which in turn caused DNA damage [72]. 
 
 
4) Induction of apoptosis 
 
 
 
AgNPs exposure can also induce cell death. It is not well known if this effect is due to the 
direct action of AgNPs and/or Ag+ or it is a consequence of other toxic mechanism induced 
by AgNPs in the cells. Kawata et al. found that non-cytotoxic doses of AgNPs (7-10 nm) 
induced the expression of genes associated with cell proliferation and apoptosis in human 
hepatoma cells (HepG2) [73]. 
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5) Cell membrane damage 
 
 
 
Studies found that AgNPs could cause cell membrane damage in different cell lines. For 
instance, Ghosh et al. evaluated AgNPs (20 nm)-induced morphological changes in human 
leukocytes of cetaceans, finding nuclear membrane rupture, after 4 hours of culture [74]. 
 
 
6) Genotoxicity 
 
 
 
Some studies have also reported that AgNPs induce genotoxicity in both cancer and normal 
cell lines [65]. For instance, Foldbjerg demonstrated a dose-dependent formation of DNA 
adducts in human alveolar cells (A519), after exposure to AgNPs (ca. 69 nm) for 24 hours 
[75]. 
 
 
1.6.1 Uptake of Ag+ and AgNPs in mammalian cells 
 
 
As for bacteria, very little is known about the systems involved in the uptake of Ag+ and 
AgNPs or AgNWs into mammalian cells. 
So far, studies suggest that silver may be transported inside the cells through the copper 
transporter 1 (Ctr1), which is a transmembrane protein [76]. 
On the other hand, theories suggest that AgNPs uptake by mammalian cells may happen 
though endocytosis or diffusion (Fig. 1.6). However, as yet, the exact mechanism of the 
endocytic pathways (clathrin- and caveolin-mediated endocytosis, phagocytosis or 
micropinocytosis)[77, 78] is not known. Further, the mechanism of NP uptake seems to be 
influenced by several factors such as their morphology, size, concentration and surface 
factors [64]. Asharani et al. showed that normal human IMR-90 lung fibroblasts and U251 
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glioblastoma cells treated with AgNPs (6-20 nm) presented endosomes with NPs in the 
cytosol, suggesting that nanoparticles were entering the cells mainly through endocytosis 
rather than diffusion [72]. According to Sabella et al., once inside the endosomes, NPs are 
uptaken by lysosomes whose acidic pH triggers an enhanced release of toxic ions [79]. 
 
 
 
 
 
Figure 1.6 Schematic illustration of AgNPs uptake, via endocytosis or diffusion, and possible mechanisms of 
cell toxicity. Reproduced from [79]. 
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1.6.2 Studies on cytotoxicity of AgNWs 
 
To date, studies on the interaction of AgNWs with mammalian cells are limited and seem 
to indicate that their reactivity depends on the specific tissue they come in contact with and 
the chemical composition of the extracellular liquid. 
One of the most relevant occupational risk of exposure to AgNWs is the respiratory route. 
For example, AgNWs suspensions are deposited onto substrates to make flexible and 
lightweight touchscreens via aerosolized droplets [20]. Pleural effects of AgNWs have been 
explored, for example, by Schinwald et al [80]. In particular, they have defined a threshold 
length (≥5 μm) at which AgNWs produce pathogenicity in the pleural space. They thoroughly 
demonstrated that the threshold length at which frustrated phagocytosis of AgNWs occurs in 
vivo (≥5 μm) is lower than that in vitro (≥14 μm) due to the abnormal experimental conditions 
inherent in the latter [80]. Silva et al. studied the biological responses of rats after intra-
tracheal (IT) administration of PVP-coated long and short AgNWs (S-AgNWs, 2 µm; L- AgNWs, 
20 μm) [81]. Both short and long AgNWs produced significant pulmonary toxicity 
(inflammation), and 21 days post exposure, silver was still present in the lungs. Shu Chen et 
al. characterized the mechanism of action of AgNWs against human alveolar epithelial cells 
type 1 (TT1). They determined that AgNWs (72 ± 36 nm in diameter and 1.5 ± 1.4 μm long) 
could rapidly access the cells, as they were found within endosome-like vesicles after a 1 h 
pulse and in the cytoplasm after 24 h. Moreover, they found Ag2S NPs formation around the 
AgNWs already after 1 h of exposure: Ag+ ions dissolved from AgNWs and rapidly precipitated 
as Ag2S nanoparticles. The precipitation of highly insoluble Ag2S became increasingly 
extensive over the 7 days post-exposure, finally coating all surface of AgNWs. Interestingly, 
in this study, they did not find evidence of ROS production after 1 h exposure and the overall 
cell viability was not significantly reduced by AgNWs up to 24 h. Overall, 
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these results suggested that AgNWs can be degraded within the cellular environment and 
transformed to Ag2S by sulfidation, limiting cell death from ROS production [82]. Theodorou 
et al. investigated 1.5 and 10.5 µm long AgNWs reactivity in human monocyte- derived 
macrophage cells (HMMs), as they are thought to phagocyte AgNPs to clear the lungs from 
these toxicants. They showed that 10 µm AgNWs were completely internalized by HMMs, 
whereas 1 µm were less phagocytized, with numerous lysosomal vesicles observed in close 
vicinity to the AgNWs. Even though AgNWs were close to the nuclei, they did not enter in 
them. Cell viability decreased in a dose dependent manner and it was higher for short AgNWs 
than for long AgNWs. Even in this study, they observed the formation of precipitates of Ag2S, 
as well as AgCl, maybe as a consequence of acidic degradation in lysosomes [83]. 
Another route of exposure that has been studied was the endovenous one. Kim et al. 
reported moderate toxicity of silver nanowires on red blood cells. In particular, they studied 
the toxicity of AgNWs (40 nm in diameter and 1-2 µm long) and Ag nanospheres (30 or 100 
nm in diameter) on human erythrocytes (RBC) rheology. They found that the haemolytic 
effect depended on the particle size: the smaller the particles, the more haemolysis 
occurred. In addition, AgNWs were safer than Ag nanospheres. Cellular deformity depended 
on nanomaterials concentration and incubation time: the small AgNPs (30 nm) caused the 
most significant reduction in RBC deformity by time in comparison to AgNPs (100 nm) and 
AgNWs. Finally, AgNWs more significantly reduced RBCs aggregation at lower concentration 
than Ag nanospheres [84]. 
Verma et al. compared the cytotoxicity of AgNWs (3-6 µm long) against various types of 
cells (lung epithelial cells, A549; umbilical vein endothelial cells, HUVEC; gastric epithelial 
cells, AGS; and phagocytic cells, THP-1), finding that the cytotoxic effect was dependent on 
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cell type, doses and incubations times [85]. All cell lines showed accumulation of AgNWs 
after 24 hours of exposure and no visual signs of cellular or nuclear abnormalities. 
Furthermore, all cell types treated with 5 µg/ml AgNWs showed significant decrease in cell 
viability. Finally, THP-1 cells, after 4 hours of exposure to 5 µg/ml of AgNWs, presented an 
increase in vescicle size, suggesting presence of autophagy. 
These studies demonstrate that a careful in vitro and in vivo study is needed in order to 
provide comprehensive datasets regarding the toxicity of these nanomaterials and their 
derivatives. 
 
1.7 Potential biomedical applications of AgNWs 
 
Due to the history of silver use in wound dressing there is interest in exploring ways of 
exploiting AgNWs in the design of textiles, wound dressing materials or surface coating for 
medical devices. 
Giesz et al. fabricated cotton and viscose fabrics using colloidal AgNWs and titanium dioxide 
(TiO2) to obtain a multifunctional material for the purification of air from nicotine. These 
materials were designed to have photocatalytic properties under UV and VIS light, as well as 
conductive and antibacterial properties. The application of AgNWs/TiO2 on fabric showed 3- 
4 times faster photocatalytic decomposition of nicotine in comparison to unmodified cotton 
fabric. Cotton fabric modified with AgNWs/TiO2 showed excellent bacteriostatic and 
bactericidal effect against S. aureus and K. pneumoniae [86]. Nateghi et al. also produced an 
electroconductive fabric made of AgNWs loaded into cotton by repeating iterations of 
submerging the cotton in alcohol suspensions of AgNWs and drying at room temperature. 
The results showed that the fabric caused 100% microbial death against Gram-positive and 
Gram-negative [31]. Another study focused on developing a film for wound dressing or skin 
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grafting Shahzadi et al [45]. They prepared an AgNWs-chitosan film by solution casting. The 
resulting film presented improved tensile strength and Young modulus compared both to 
chitosan and chitosan-silver nanoparticles films. Antimicrobial activity was shown by CS- 
AgNWs films in comparison to bare CS films that had no areas of inhibition against either E. 
coli or S. subtilis [45]. All these studies showed that AgNWs have antibacterial properties 
against both Gram + and Gram -, even when included in complex 3D scaffolds. 
Other researchers have tried to combine both the electrical and antibacterial properties of 
AgNWs for decreasing bacterial attachment and/or improving mammalian cell growth on 
AgNWs-loaded scaffolds. Tan et al. developed, for instance, a membrane to efficiently purify 
water from bacterial infections through the release of Ag+ in presence or absence of an 
applied field. The nanofiber membrane was prepared using polyacrylonitrile (PAN) and 
thermoplastic polyurethane (TPU) via electrospinning, and then embedding AgNWs on the 
surface of the electrospun nanofibers through vacuum filtration deposition. AgNWs formed 
a highly conductive network that can generate an electric field for electrochemical 
disinfection. Indeed, electroporation causes damages to bacterial membranes, which can 
lead to ion leakage and escape of metabolites. With the application of an electrical field, E. 
coli and S. aureus (105 CFU/ml) were inactivated within 20-25 min at 1.5 V, compared to 6 h 
without electrical field application [87]. In another study, Wickham et al., developed an 
electroactive nanocomposite material made by compression of self-assembled collagen 
fibrils and silver nanowires (AgNWs) for neural and cardiac regeneration. The scaffolds with 
the lowest concentrations of AgNWs (0.1 mg/ml) showed good embryonic cardiac cell 
proliferation within 7 days, whereas higher concentrations (0.5 and 1 mg/ml) led to a 
reduced cell proliferation in the same period of time. Prevention of E. coli and S. epidermidis 
biofilm formation was found up to 72 h for all the samples containing AgNWs [69]. Lee et al. 
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developed, instead, a conductive polyethylene glycol (PEG)/hydrogel enriched with AgNWs 
as a micropattern to direct differentiation of neuronal stem cells (NSCs) and neurite 
outgrowth under the application of electrical stimuli. In order to successfully seed the 
neurospheres and to guide the neurite growth a micropattern with 200 µm width was 
chosen. In the system, neural progenitor cells could differentiate into mature neuronal cells 
and the cells could better grow when a voltage between 5 and 10 V was used rather than 
lower or higher voltages [88]. 
 
 
1.8 Research gaps 
 
Despite some studies on AgNWs, this brief review highlighted the large gaps in the existing 
knowledge of the these nanomaterials’ antibacterial/ cytotoxic behavior and mechanisms of 
action against different bacterial and mammalian cell lines. Nevertheless, AgNWs seem to 
exhibit a promising activity as antimicrobial agents, in a world where bacterial infections are 
still a major cause of morbidity and mortality. Indeed, current antibiotics show low success 
in contrasting biofilm-associated infectious diseases, which account for over 80 percent of 
microbial infections in human body. All such agents have difficulty in penetrating the 
extracellular polysaccharide layer covering the biofilm, promoting the development of 
antibiotic resistance [89]. More and more studies should be carried out in order to explore 
the potential of AgNWs in inhibiting bacterial proliferation on surfaces and medical devices. 
 
 
1.9 Aims and Hypothesis 
 
Therefore, the aim of this study has been: 
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• To screen the potential toxicity of AgNWs, obtained through soft-template method, 
in absence or presence of carbon nanotubes (CNTs) against four strains of bacteria 
(Escherichia coli, Staphylococcus aureus, Methicillin-resistant Staphylococcus 
aureus and Staphylococcus saprophyticus) and three types of cell lines (human 
foreskin fibroblasts (Hs27), human colon adenocarcinoma (Caco-2) and human 
osteoblasts (hFOB 1.19)). Furthermore, studies on ROS production, cell morphology 
and release of cytosolic components have been carried out. 
• To incorporate AgNWs into thermo-sensitive chitosan-based hydrogels to establish 
their potential in inhibiting biofilm formation, without significantly interfering with 
cell proliferation on the scaffold. 
• To investigate how different ratios of CS/CSMCC and AgNWs in a commercial bone 
cement could modify the thermal, mechanical, cytotoxic and antibacterial 
properties of the material. 
 
The hypothesis of the study is that the introduction of AgNWs within 3D scaffolds will 
provide antibacterial properties to both a soft and a hard material, without statistically 
affecting the cell viability on the scaffolds. Additionally, when CSMCC is included in the bone 
cement, lower polymerization temperature and lower cytotoxicity are expected following to 
crosslinking of methacrylic group of CSMCC with MMA. 
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Abstract 
 
In this work, we prepared silver nanowires via polyol method in presence or absence of single 
wall carbon nanotubes (CNTs), in order to test the physicochemical, antibacterial and 
cytotoxic properties of the two synthesis products. Results showed that the introduction of 
CNTs lead to the formation of AgNWs at lower temperature, but the final product 
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characteristics of AgNWs and AgNWs-CNT were not significantly different. AgNWs exhibited 
antibacterial properties against all the studied bacterial species via the formation of oxygen 
reactive species (ROS) and membrane damage. Furthermore, AgNWs exhibited a dose- 
dependent and time-dependent toxicity at concentrations ≥ 10 µg/ml. Fibroblasts appeared 
to be more resistant than Caco-2 and osteoblasts to the toxicity of AgNWs. The cytotoxicity 
of AgNWs was found to be related to the formation of ROS, but not to membrane damage. 
Overall, these results suggest that AgNWs are potential antibacterial agents against E. coli, 
S. aureus, MRSA and S. saprophyticus, but their dosage needs to be adjusted according to 
the route of administration. 
 
 
2.1 Introduction 
 
Silver has been known for its antimicrobial properties against a wide range of 
microorganism for centuries. When in the 1980s the first findings on the unique properties 
of nanoparticles (NPs) were published, researchers started to investigate novel applications 
for silver nanomaterials in electronic, optical and biomedical fields. In order to satisfy specific 
needs, several morphologies have been developed, including silver nanospheres, nanocubes, 
nanorods, nanotriangles and nanowires. 
Silver nanowires (AgNWs) are one-dimensional silver structures and are, for example, 
currently being used as alternative materials to indium tin oxide (ITO) for the production of 
conductive films in displays and touch panels, due to their excellent conductive properties 
[90]. Despite the fact that the antibacterial and cytotoxic properties of other silver 
nanoparticles have been widely explored and medical devices loaded with AgNPs have been 
developed, research on AgNWs antibacterial properties, mechanisms of action and possible 
51 
 
biomedical applications is still scarce [91]. So far we know that AgNWs are potential 
antibacterial agents against E. coli and S. aureus, but we know little about how they exert 
their action. Visnapuu et al., for instance, stated that the toxicity of AgNWs against E. coli 
was due to dissolved Ag+ ions rather than to a direct effect of the silver nanostructures [60]. 
Cui and Liu, instead, highlighted that E. coli is more sensitive than S. aureus to the action of 
AgNWs, determining their toxicity was a consequence of both AgNWs induced bacteria 
disruption and induction of ROS generation [63]. 
Moreover, AgNWs from commercial products can be released into the environment during 
manufacturing, use, or disposal, thus there is an impelling need to understand the short- and 
long-term toxicity of these materials in humans [20]. High-aspect ratio materials, such as 
asbestos or carbon nanotubes, have indeed been shown to be actively absorbed into 
eukaryotic cells, causing different types of damages [92]. As the respiratory route in one of 
the major possible risk of occupational exposure to AgNWs, the majority of studies focused 
on the possible damages through this route. Schinwald et al. found that AgNWs longer than 
≥14 μm or ≥ 5 μm were able to induce pleural inflammation, in vivo and in vitro respectively 
[80]. Further studies have also highlighted that AgNWs can enter and accumulate in epithelial 
cells, interstitial sites, airway smooth muscle cells, the vascular endothelium, the pleural 
membrane and macrophages. Stoehr et al. compared the cytotoxicity of AgNWs (length: 1.5-
25 µm; diameter 100-160 nm) and Ag nanospheres (30 nm) on human alveolar epithelial cells 
(A549), finding that whereas no effects were observed for the spherical particles, 
significantly reduced cell viability and increased LDH release were induced by AgNWs [93]. 
In light of this diverse evidence and in vitro studies on different routeS of administration, 
this study aims to investigate the in vitro antibacterial properties of AgNWs, obtained 
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through two synthetic methods (a soft template and a heterogeneous method) tested 
against E. coli, S. aureus, MRSA and S. saprophyticus. Moreover, the internalization, 
cytotoxicity and possible mechanisms of action of AgNWs, on human osteoblasts (hFOB 
1.19), human skin fibroblasts (Hs27) and human colon adenocarcinoma (Caco-2) were 
studied to investigate future potential applications such as inclusion in bone implants, and 
wound dressing for skin and mucosa. 
 
 
2.2 Materials and methods 
 
2.2.1 Materials 
 
2′,7′-Dichlorofluorescin diacetate (≥97%), acetone, agar, chitosan from shrimp shells low 
viscosity (degree of deacetylation ~85%, calculated by H1-NMR), dimethyl sulfoxide 
anhydrous, (≥99.9%), glutaraldehyde solution, hexamethyldisilazane (≥99%), sodium 
chloride, octaldehyde (99%), poly(vinylpyrrolidone) powder (55 kDa), phosphate buffered 
saline tablets, silver standard for AAS, sodium cacodylate trihydrate, trypsin-EDTA 0.25% 
solution, tryptone enzymatic digest from casein, Triton™ X-100 and yeast extract for 
microbiology were purchased from Sigma-Aldrich (Irvine, UK). Ethanol, glycerol (99%), 
hydrochloric acid (37%), isopropanol, L-(+)-lactic acid (90 %) and sodium borohydride were 
purchased from Acros Organics (Geel, Belgium). 3-(4, 5-dimetheylthiazol-2)-2, 5 diphenyl 
tetrazolium bromide (MTT), 4',6-Diamidino-2-Phenylindole dihydrochloride (DAPI), 
dimethylformamide, DMEM (high glucose, with GlutaMAXTM and pyruvate), foetal bovine 
serum (FBS), Hank's Balanced Salt Solution (HBSS), HPLC-grade water, methanol, nitric acid 
(70%), penicillin/streptomycin solution, phalloidin Dylight 550, Pierce ™ BCA Protein Assay 
and silver nitrate were purchased from Fisher (Loughborough, UK). Single-wall carbon 
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nanotubes-COOH OD 1-4 nm (SW-CNTs) were purchased from Cheaptubes.com (Grafton, 
VT). Corning DMEM/F12 (with L-glutamine and 15mM HEPES) was purchased from Scientific 
Laboratory Supplies (UK). 
 
 
2.2.2 Synthesis of AgNWs by soft template method 
 
 
AgNWs were synthesised via the polyol method, using silver nitrate (AgNO3) as the Ag 
source. PVP (3 g) was fully dissolved in glycerol (95 ml) by heating to 80 °C. The solution was 
cooled down and AgNO3 (0.79 g) was added under vigorous stirring (800 rpm) until the 
powder was fully dissolved. Subsequently, NaCl (5 mM in final solution) was mixed into 5 ml 
of glycerol and added to the PVP/glycerol solution. The reaction temperature of the mixture 
was raised to 210 °C. Once the temperature was reached, it was maintained for further 10 
min. Samples (1 ml) were taken at different temperatures, diluted with water and analysed 
by UV (300-900 nm, Thermo Scientific Nicolet Evolution 100 UV-Visible Spectrophotometer) 
to follow the formation of the AgNWs. Finally the reaction was cooled down to room 
temperature, diluted 1:1 with deionized water and centrifuged (2880 x g, 1 hour), the pellet 
was then washed twice with isopropanol (2880 x g, 30 min) and twice with deionized water 
(2880 x g, 10 min) (Thermo Electro Corporation, B4i Jouan Multifunction Centrifμge, UK). The 
product was stored in deoxygenated purified water at room temperature, protected from 
light. 
 
 
2.2.3 Synthesis of AgNWs in presence of CNTs (AgNWs-CNT) 
 
AgNWs were synthetized in presence of CNTs with a slightly modified method. After 
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complete dissolution of PVP in glycerol, 5.8 mg of carbon nanotubes were added and 
sonicated for 2 hours to favour dispersion. After sonication, silver nanowires were 
synthesized and washed as described above. 
 
 
2.2.4 Preparation of physical mixture of CNT and AgNWs (AgNWs-CNT mix) 
 
N-octyl-O-sulphate chitosan (NOSC) was synthetised as previously described [94]. NOSC (10 
mg) was dissolved in 10 ml of purified water, before the addition of 12.5 mg of CNTs. The 
sample was sonicated for 4 hours. Then, 40 ml of deoxygenated water and 2 g of PVP were 
added to the mixture. The mixture was then heated and maintained at 80 ̊C for 30 min. 
AgNWs in deoxygenated water (10 ml, 1.5mg/ml) were then added to the reaction mixture, 
this was stirred at 800 rpm for 6 hours in the dark. The sample was then centrifuged at 2880 
g for twenty min and the supernatant removed. This step was repeated twice. The solid pellet 
obtained was then washed and stored as described above. 
 
 
2.2.5 TEM characterization of AgNWs, AgNWs-CNT, AgNWs-CNT-mix and swCNTs 
 
Freeze dried products were suspended in chitosan solutions (1%, in lactic acid 0.1 M), to 
achieve different concentrations (0.5-1.5 mg/ml), by vortexing and sonicating for several 
min. Samples were then dropped onto TEM grids (Agar scientific square mesh TEM support 
grids-copper) and allowed to dry at room temperature and pressure. Dry grids were stored 
in sealed petri dishes in a desiccator until observation using a Jeol JEM 2100 Transmission 
Electron Microscope. 
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2.2.6 XRD characterization of AgNWs, AgNWs-CNT, AgNWs-CNT-mix and CNTs 
 
The crystal structure of nanoparticles was determined with a Bruker D2-Phaser 
diffractometer. Instrumental parameters were: CuKα radiation, 30kV, 10 mA, LynxEye PSD 
detector with an angular opening of 5°, 2θ range 6-84°, step size 0.020°, time per step 2 s, 
spinner 15 rpm. The alignment of the instrument was calibrated using an international 
standard (NIST 1976b). A low-background silicon crystal specimen holder (Bruker) was used. 
The analysis was performed at room temperature (25°C). The XRD pattern was evaluated 
using the software Bruker EVA 14.2 (DIFFRACplus Package) coupled with the database PDF- 
2 (ICDD). 
 
 
 
2.2.7 Total silver content and silver release by AAS 
 
For total silver content, freeze-dried NPs were digested in an equal volume of MilliQ water 
and 70% nitric acid. The volume of digested samples was brought up to 20 ml with MilliQ 
water. Finally the solutions were filtered 5 times by a glass microfiber filter (GF/D) to get rid 
of the CNTs. 
For silver cation release studies, freeze-dried NPs were transferred to a water bath 
maintained at 37°. At scheduled time points, the AgNWs suspensions were centrifuged at 
1440 x g for 3 min and 1 ml of supernatant was taken and substituted with 1 ml of fresh 
water. The determinations of Ag content of both experiments were carried out by a furnace 
absorption spectro-photometer (Varian SpectrAA 220FS) at a wavelength and spectral 
bandwidth of 328.1 and 0.2 nm, respectively. The experiments were carried out in triplicate. 
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2.2.8 Autofluorescence detection 
 
In order to determine whether either AgNWs or CNTs possessed any autofluorescence, 
freeze-dried NPs were suspended in deionized water and sonicated to provide a 
homogeneous suspension. Samples were excited at different wavelengths (390, 488, 550, 
570, 633 and 670 nm) and the respective emission spectra were recorded. Images of the 
suspensions were then acquired by fluorescence microscopy (Zeiss Axio Imager Z1). 
 
 
2.2.9 Zeta potential determination 
 
Surface zeta potentials were measured using Malvern Zetasizer (Nano ZS, UK). 
Nanoparticles were suspended by sonication in deionized water. An average of twelve 
measurements per samples were carried out. The selected refractive index for silver 
nanoparticles was 1.333. 
 
 
2.2.10 Bacterial cultures preparation 
 
 
The antibacterial activity of AgNWs was examined by a suspension assay against gram 
 
negative E.coli (ATCC 25922) and gram positive S. aureus (ATCC 25923), Methicillin-resistant 
 
S. aureus  (ATCC 12403) and S. saprophyticus  (ATCC  15305). The bacteria were transferred 
 
from -80°C (30 % glycerol) into 5 ml of fresh sterile LB by a sterile toothpick and incubated 
(at 37°C and 200 rpm) until the bacterial suspension was cloudy (1 day for E.coli and S. 
aureus, 2 days for MRSA and 3 days for S. saprophyticus) (MaxQ™ 8000, Thermo Scientific). 
Then, 50 µl of the bacterial suspension were transferred into 5 ml of fresh sterile LB and the 
bacteria were further incubated at 37°C until the suspension was newly cloudy (1 day for E. 
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coli, S. aureus and MRSA and 2 days for S. saprophyticus). 
 
 
 
2.2.11 Determination of minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) 
 
Bacterial suspensions were prepared as described above. Serial dilutions of NPs and silver 
nitrate were tested (10, 100, 200, 500, 750, 1000, 1500, 2000 and 3000 µg/ml) against 
bacterial suspensions (1 x 10^7 CFU/ml) to a final volume of 150 µl in 96 well plates. Batch 
suspensions (10 mg/ml) of NPs were prepared in deionized water and then, diluted in LB. 
Instead, AgNO3 was dissolved in water in order to have an initial concentration of 10 mg/ml 
of cationic silver. Medium with just bacteria served as negative control. The plates were 
incubated at 37°C for 24 hours with gentle shaking (60 rpm). The absorbance was read at 
600 nm using nanoparticles suspensions as blanks. MIC was determined as the lowest 
concentration visibly inhibiting growth. MBC was determined by transferring 25 µl samples 
from clear wells into nutrient agar plates. After overnight incubation, the MBC was 
determined as the concentration at which there was no microbial growth. All experiments 
were performed in duplicate and results were reported as mean ± SD. 
 
 
2.2.12 SEM imaging of bacteria with nanoparticles 
 
Bacterial suspensions were prepared as described above. Then, bacteria were diluted to an 
OD600 of 0.01 and they were treated with different concentrations of nanoparticles (50 and 
800 µg/ml) and incubated for 8 hours. The experiment was carried out in 96 well plates (150 
µl). The samples were then aseptically removed and centrifuged at 5000 x g for 10 min, the 
medium was removed and 800 µl of 0.2 M cacodylate was added to suspend the pellet. Then, 
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50 µl of cell suspension was added to a sterile silicon wafer (shiny side up) (Agar Scientific) 
and it was allowed to settle for 40 min. Glutaraldehyde (0.5 ml, 2%) in 0.2 M cacodylate was 
gently added to each silicon wafer, making sure the specimens were completely immersed. 
The samples were fixed for 1 hour, at 4°C. Then, the samples were washed once with buffer 
and were dehydrated through a series of ethanol solutions (30, 50, 70, 90, 95 and 100%) for 
5 min each at room temperature. Finally, samples were covered with acetone (until 
evaporation) and in 100% hexamethyldisilazane (HMSD) before being allowed to air-dry 
overnight. Images were taken by a scanning electron microscope (Zeiss EVO MA10), after 
having sputter coated the samples with gold and palladium (Polaron e500, Quoram 
Technologies, UK). 
 
 
 
2.2.13 Protein leakage from bacteria 
 
Bacteria were grown as described above. Then, bacteria suspensions were centrifuged 
(13000 x g for 5 min) and the pellets were suspended in sterile PBS to a final concentration 
of 0.6 CFU/ml in presence of two concentrations of NPs: 12.5 and 100 µg/ml. Bacteria were 
incubated at 37 ̊C and 200 rpm. After 1 hour and 24 hours of incubation, 1 ml of sample was 
taken from each test tube and centrifuged at 13000 g for 5 min. The supernatant was then 
stored at -20°C until further analysis. The bicinchoninic assay (Pierce ™ BCA Protein Assay) 
was carried out according to the manufacturer’s instructions. Briefly, 25 μl of samples were 
mixed with 200 μl of working solution. Samples absorbance was read at 562 nm after two 
hours of incubation at 37 ̊C. The experiment was carried out in duplicate. 
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2.2.14 ROS production in the extracellular medium 
 
To determine levels of ROS generated, a DCFH-DA probe was used. 2, 7- dichlorofluorescein 
diacetate (DCFH-DA) is converted to highly fluorescent 2, 7- dichlorofluorescein (DCF) in the 
presence of reactive oxygen species (H2O2, HO• and ROO•) [95]. Initially, the DCFH-DA probe 
was suspended in DMSO at a 10mM concentration, before being diluted with LB medium to 
create a 100 μM working concentration. At the 24-hour time point of the bacterial 
suspension studies, 1 ml samples were removed and centrifuged at 1300 rpm for 1 minute. 
The supernatant (40 μl) was removed and incubated with 60 μl of the fluorescent probe for 
thirty min in the dark at 37 ̊C. Using an excitation wavelength of 485 nm and an emission 
wavelength of 520 nm, the fluorescence of the samples was read on a bench top, top read 
fluorimeter (Agilent Cary Eclipse). 
 
 
 
2.2.15 Cell lines cultivation 
 
Human foetal osteoblasts (hFOB 1.19), human foreskin fibroblasts (Hs27) and human 
colorectal adenocarcinoma cells (Caco-2) were purchased from ATCC®. hFOB were 
maintained at 37°C in 5% CO2 in flask in Dulbecco’s Modified Eagle’s Medium Ham/F12 
medium (with L-glutamine and 12 mM HEPES) containing 10% foetal bovine serum (FBS) and 
1% penicillin/streptomycin (P/S). Hs27 were maintained in the same physical conditions, but 
using DMEM (high glucose, with GlutaMAXTM and pyruvate), 10% FBS and 1% P/S. Caco- 2 
cells were maintained at 37°C in 5% CO2 in MEM containing 10% FBS, 1% P/S, 2mM L- 
glutamine and 1% non-essential amino acids. Cell lines were used between passage 4 and 
12. 
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2.2.16 Cell viability study 
 
Cell viability was evaluated by the MTT [3-(4, 5-dimetheylthiazol-2)-2, 5 diphenyl 
tetrazolium bromide] colorimetric technique. Briefly, 5000 cells/ well were plated in a 96 
well plate with 100 µl of complete medium and incubated overnight, to permit cells 
attachment. Meanwhile, stock suspensions of nanoparticles in complete medium were 
sonicated for 4 h at 40 Hz. Aliquots of initial AgNPs solution were added to cell medium to 
final NPs concentrations of 0.1, 1, 10, 25, 50 and 100 μg/ml. After 24 hours of incubation, 
100 µl of treatments were added to each well containing cells and incubated for 2 and 24 h. 
At scheduled time points, the treatments were removed and cells were treated with 100 µl 
of complete medium containing MTT (0.5 mg/ml). The cells were incubated for 4 h in 5% CO2 
incubator for reduction of MTT by metabolically active cells. The reagent was removed and 
the purple formazan crystal inside the cells were solubilized with 100 µl of DMSO. The 
formazan content was quantified by spectrophotometry, at a wavelength of 570 nm 
(SpectraMax® i3x, Molecular Devices). DMSO served as a blank. The experiments were 
carried out at least in triplicate. 
 
 
 
2.2.17 Determination of membrane integrity by LDH assay 
 
To evaluate cell membrane integrity, the lactate dehydrogenase (LDH) leakage assay was 
performed. Cells were plated at 10,000 cells/well. Then, cells were treated with 
nanoparticles in complete medium containing 2% FBS (as the serum may interfere with the 
assay). Spontaneous activity and maximum LDH activity were used as controls. The assay was 
carried out according to the manufacturer’s instructions (Pierce ™ LDH cytotoxicity assay). 
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The absorbance was read at 490 and 680 nm. The absorbance read at 680 nm (background) 
were subtracted from the 490 nm absorbance before calculation of LDH release. 
 
 
 
2.2.18 Intracellular production of ROS 
 
Cells were plated in a sterile black 96 well plate at 25,000 cells/well in 100 µl of medium. 
Cells were incubated for 24 h and then, the medium was removed and the cells were washed 
once with sterile HBSS containing Ca and Mg. The cells were incubated with a solution 28 
µM of DCFH-DA in HBSS for 45 min. After washing with HBSS, the cells were treated with 
complete media (2% FBS), containing nanoparticles, for desired periods of time. 
Fluorescence was measured with a fluorescence reader, with an excitation of 485 nm and 
emission of 525 nm. 
 
 
 
2.2.19 Cell uptake of silver 
 
Human osteoblasts were plated at 30,000 cells/well (1 ml medium) in a 24 well plate and 
incubated for 24 h, as described above. Cells were exposed to nanoparticles at different 
concentrations (1 ml). After 24 hours of exposure, the medium was removed and the cells 
were gently washed twice with cold PBS to remove loosely attached Ag ions and/or NPs from 
the cell membrane. To each well, HPLC grade water (600 µl) was added, and then 70% HNO3 
(600 µl). The nanoparticles were then digested for 20 min and the solutions were brought to 
21 ml with HPLC grade water. Controls were made with just cells. Silver content was 
determined by an inductively coupled plasma optical emission (ICP-OES) spectrometer 
(Spectroblue OEP-TI, Ametek, Germany) equipped with an ASX-520 autosampler. External 
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calibration was performed by analysis of a blank and five solutions of dissolved Ag in 2% 
HNO3 ranging from 0 to 100 μg L−1. The charged Ag ions were measured at two wavelengths 
(328.068 and 328.289 nm) and the results were averaged. The ICP-OES was equipped with a 
SPECTRO SMART ANALYZER software (vs. 6.01.0943). The set parameters for the analysis 
were: 1450 W for plasma power, 30 rpm for pump speed, 13.00 l/min for coolant flow and 
0.75 l/min for nebulizer flow. 
 
 
 
 
2.2.20 Fluorescence imaging of AgNWs uptake 
 
Osteoblasts were seeded on coverslips at a cell density of 10000 cells/well in 24 well plates 
(300 ul of medium). After overnight incubation at 37 ̊C and 5% CO2, cells were treated with 
AgNWs. After 24, cells on coverslips were fixed directly with paraformaldehyde 4% in PBS for 
15 min, washed with PBS, permeabilized for 10 min in 0.1% Triton X-100/PBS, washed twice 
with PBS, blocked with 2% bovine serum albumin (BSA) in PBS for 1 hour, washed twice with 
PBS, stained with Phalloidin Dylight 550 in PBS (2 units/ml, stock solution 300 units/ml in 
methanol) for 1 hour (300 µl, at room temperature), washed twice with PBS, stained with 
DAPI 2 µg/ml in PBS for 10 min and finally rinsed again with PBS. Coverslips were mounted 
on glass slides using PermaFluor Aqueous Mounting Medium. Samples were kept protected 
from light until imaging. Photos were taken with a fluorescence microscope (Zeiss Axio 
Imager Z1) equipped with a Hamamatsu HR camera and also a color AxioCam MRc camera. 
Images were processed by Volocity 6.3 software. 
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2.3 Results 
 
2.3.1 AgNWs physicochemical characterisation 
 
2.3.1.1 UV-vis and TEM characterization   
 
 
 
 
 
Figure 2.1 Physicochemical characterization of synthesised products. UV-spectra of (A) AgNWs and (B) of 
AgNWs-CNT at different temperatures during the synthesis reaction. TEM images of (C) AgNWs (scale bar 500 
nm), (D) AgNWs-CNT (scale bar 500 nm), (E) AgNWs-CNT-mix (scale bar 500 nm), (F) CNTs (scale bar 500 nm), 
(G) AgNWs-CNT, presenting particles aligned along the CNTs (scale bar 200 nm) and (H) AgNWs-CNT-mix with 
NPs aligned along CNTs (scale bar 500 nm). 
 
AgNWs were synthesised via the polyol method using PVP as soft template, whereas 
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AgNWs-CNT were synthesised with the same method, in presence of CNTs, in order to 
evaluate whether the addition of nanotubes influenced the morphological, physical and 
biological properties of the AgNWs. AgNWs-CNT-mix was used as control to investigate 
whether any potential difference between AgNWs in AgNWs-CNT was due to the mere 
presence of CNTs or if they had an effect when introduced in the synthetic procedure. 
The UV-Vis spectra of AgNWs and AgNWs-CNT, at low temperatures, showed a peak at 410 
nm, indicative of the formation of nucleation sites with initial presence of silver nanoparticles 
and nanorods (Figure 2.2 A-B). A shift towards lower wavenumbers and the formation of a 
double peak (350 and 380 nm) was observed as the temperature increased, indicating the 
formation of longer structures such as nanowires [96]. Interestingly, the shift was observed 
at lower temperatures when the synthesis of AgNWs was performed in the presence of CNTs; 
this could be due to the excellent heat conductivity of CNTs that can affect the reaction 
kinetics. This would allow for silver nanoparticles in close proximity to carbon nanotubes to 
benefit from a localised increase in temperature and thus would allow for AgNWs formation 
at lower temperatures of the overall reaction mixture. 
Nanoparticles were also observed by TEM (Fig 2.1 C-H). TEM images confirmed the 
successful formation of AgNWs in both synthesis conditions. However, in all the cases, other 
types of nanoparticles, such as nanospheres and nanorod, were visualized. Moreover, the 
amount of CNTs found in AgNWs-CNT appeared significantly inferior to AgNWs-CNT-mix. 
Interestingly, in both AgNWs-CNT and AgNWs-CNT-mix samples, the smaller particles tended 
to align along the surface of CNTs (Fig. 2.1 G-H). In the synthesis of AgNWs, a coordination 
complex is formed between silver ions and PVP through donation of loan pair electrons of 
oxygen and nitrogen atoms of PVP to sp orbitals of the metallic silver reduced by glycerol. We 
hypothesized that –COOH groups of CNTs can interact with Ag+ forming the first nucleation 
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centres for the growth of silvernanowires. This supports the theory that nucleation centres 
form on the surface of carbon nanotubes and lead to formation of nanowires along the axis 
of CNTs. Average lengths were 5.23 μm (± 1.5), 5.21 μm (± 2.7) and 5.04 μm (± 1.7), for 
AgNWs, AgNWs-CNT and AgNWs-CNT- mix, respectively. Average diameters 73.70 nm (± 
25.79), 67.04 nm (± 25.23) and 68.54 nm (±17.47) for AgNWs, AgNWs-CNT and AgNWs-CNT- 
mix, respectively. One-way ANOVA showed no significant difference in lengths and 
diameters across all three materials (p>0.05). 
 
 
2.3.1.2 Total silver content and Ag+ release   
 
 
Total Ag content in each of the products and the cumulative Ag+ released over time were 
determined by AAS. The total Ag (Fig. 2.2 A) found in AgNWs (97.33± 1.14 wt/wt %) was 
higher than in AgNWs-CNT (89.11±1.25 wt/wt %), but not significantly different (One-way 
ANOVA, p>0.05), meaning that both the synthesis and purification processes lead to a high 
yield of silver products. Furthermore, these values suggest that whereas CNTs might have 
played a role in the nucleation and reduction of heat required in the synthesis, they are not 
chemically bound to AgNWs, and as a consequence, they are efficiently removed by the 
purification process (Ag content: 89.11±1.25 wt/wt %). On the other hand, the amount of Ag 
in AgNWs-CNT-mix was significantly inferior to the other two batches (ca. 35.27±5.33 wt/wt 
%) (p<0.001). This was expected as CNTs and AgNWs, in this case, were added in a 1:1 ratio. 
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Figure 2.2 Silver content and release. (A) Percentage silver content of AgNWs, AgNWs-CNT and AgNWs-CNT- 
mix; One-way ANOVA returned p<0.05; results of Post-hoc Tukey’s multicomparison test, when comparing all 
the formulations to AgNWs, are reported in the graph (*** p=0.001 ); results of Post-doc Tukey’s test, when 
comparing AgNWs-CNT to AgNWs-CNT-mix ($$$ p=0.003). (B) Percentage cumulative release of silver from 
AgNWs (red), AgNWs-CNT (black) and AgNWs-CNT-mix (green). 
 
 
The normalized cumulative release of Ag+ from AgNWs, AgNWs-CNT and AgNWs-CNT-mix, 
in water, is reported in Fig. 2.2 B. Ag+ release started immediately in the aqueous solution 
and its concentration increased over time. After 2 days in water, the percentage amount of 
Ag+ released was of ca. 0.32 wt/wt% from AgNWs, 0.23 wt/wt% from AgNWs-CNT and 0.71 
wt/wt% from AgNWs-CNT-mix. One-way ANOVA revealed no statistical significance among 
the samples (p>0.05). After 30 min, the concentration of Ag+ in suspension was ca. 0.31±0.04 
ppm from AgNWs, 0.22±0.17 ppm from AgNWs-CNT and 0.09±0.02 ppm from AgNWs-CNT- 
mix. Kumar et al. reported that a minimum concentration level of 0.1 part per billion (ppb) 
could provide effective antimicrobial activity [97]. As in our samples, the silver ion 
concentration was higher than 0.1 ppb already after 30 min, the nanomaterials may be seen 
as potential platforms for Ag+ delivery for antibacterial purposes. 
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2.3.1.3 XRD and fluorescence analyses  
 
 
The X-ray diffraction (XRD) performed on samples was used to reveal information about 
the chemical composition of nanoparticles, as well as their detailed crystallographic 
structure. Fig. 2.3 A shows the XRD spectrum of AgNWs sample and of AgNWs-CNT. The 
diffraction peaks at 2θ values of 38.1°, 44.3°, 64.4° and 77.3° were assigned to the crystal 
planes (111), (200), (220) and (311), which are typical of AgNWs [36]. Furthermore, the 
(111)/(200) peak ratio was 3.7, indicating the formation of well-elongated AgNWs. Minimal 
trace impurity of AgCl can be seen at 2θ value of 32.1° and 46.2°. 
 
 
Figure 2.3 XRD and fluorescence spectra. (A) XRD spectra of AgNWs (pink) and AgNWs-CNT (blue). (B) XRD 
spectra of AgNWs (violet), AgNWs-CNT-mix (green) and CNTs (black). (C) The emission fluorescence peaks of 
AgNWs (red), AgNWs-CNT-mix (black), CNTs (grey) and water (blue). (D) Fluorescence microscope image of 
AgNWs-CNT in water: white arrow indicates AgNWs and yellow arrow indicates CNTs. 
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Superimposed spectra of AgNWs and AgNWs-CNT confirmed that the two synthetic 
processes lead to similar products. The (111)/(200) intensity ratio for AgNWs-CNT was 3.2. 
In Fig. 2.3 B the XRD pattern spectra of AgNWs (violet), AgNWs-CNT-mix (black) and swCNTs 
(green) are reported. According to the AAS results, this product was mainly composed of 
swCNTs and a smaller portion of the powder was made of AgNWs, thus the expected AgNWs- 
CNT-mix spectrum should have been a combination of both swCNTs and AgNWs XRD profiles. 
The peaks at 2θ angles of 25.7°, 43.4° and 57.3° of swCNTs profile in Fig. 2.3 B, correspond 
to the graphite d-spacing (distance between atomic layers of a crystal) of the swCNTs and 
the (111) and (200) reflections of carbon, respectively [24]. The origin of peaks at 18.2° and 
35.6° is not explained. The (111)/(200) intensity ratio of AgNWs-CNT-mix was found to be 
3.2, as for AgNWs-CNT. The fluorescence emission of AgNWs, AgNWs-CNT and CNTs aqueous 
solutions was also investigated. Excitation at wavelengths between 390 nm and 400 nm lead 
to fluorescence emission between 450 and 600 nm and lambda maxima at 465 nm, 
corresponding to the blue-green emitting region. In literature, the fluorescence emission 
properties of silver clusters and silver nanoparticles of different dimensions has already been 
described [98-100], but, as far as we know, it is the first time this effect has been reported 
for AgNWs. The autofluorescence of AgNWs can be exploited for different applications, such 
as fluorescence imaging of nanowires in cells. 
Surface zeta potential (ζ) was also measured. The zeta potentials values were found to be 
negative for all the preparations containing AgNWs, as already reported by Visnapuu et al. 
[60]. In particular, the zeta potential of AgNWs was -12.43±1.23, of AgNWs-CNT was - 
18.24±5.92 and of AgNWs-CNT-mix was -19.8±7.66. These results suggested that no one of 
the preparations was stable in suspension, having ζ < -30 mV. 
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2.3.2 Antibacterial properties 
 
2.3.2.1 MIC and MBC   
 
 
Table 2.1 MIC and MBC values (mg/ml) for AgNWs, AgNWs-CNT, AgNWs-CNT-mix, AgNO3 and CNTs. 
MIC and MBC values are reported as a mean ± SD (n≥3). The One-way ANOVA returned p<0.05. Results of the 
post Tukey’s multiple comparisons test was carried out to compare the experimental values among each other. 
For E. coli MIC values: a p<0.05 (compared to AgNO3); for MRSA MIC values: a p<0.01 (compared to AgNO3); 
for S. saprophyticus MIC values: a p<0.05 (compared to AgNO3). For E. coli MBC values: a p<0.01; b p<0.001; c 
p<0.05 (compared to AgNO3); for S. aureus MBC values: a p<0.001 (compared to AgNO3); for MRSA MBC 
values: a p<0.0001 (compared to AgNO3). 
 
Microorganism Material MIC (mg/ml) MBC (mg/ml) 
E. coli 
AgNWs 0.42±0.26 1.16±0.27a 
AgNWs-CNT 0.53±0.54a 1.38±0.55b 
AgNWs-CNT-mix 0.49±0.07a 0.99±0.16c 
AgNO3 0.01±0.00 0.17±0.05 
CNTs >3.00 >3.00 
S. aureus 
AgNWs 0.36±0.24 1.55±0.63a 
AgNWs-CNT 0.28±0.24 1.05±0.80 
AgNWs-CNT-mix 0.44±0.12 0.77±0.16 
AgNO3 0.01±0.00 0.1±0.00 
CNTs >3.00 >3.00 
MRSA 
AgNWs 1.07±0.40a 2.53±0.53a 
AgNWs-CNT 0.85±0.85a 2.00±0.44a 
AgNWs-CNT-mix 0.67±0.14 >3.00 
AgNO3 0.01±0.00 0.07±0.05 
CNTs >3.00 >3.00 
S. saprophyticus AgNWs 0.25±0.21a 0.66±0.42 
AgNWs-CNT 0.08±0.00 0.72±0.60 
AgNWs-CNT-mix 0.08±0.06 0.46±0.36 
AgNO3 0.01±0.00 0.01±0.00 
CNTs >3.00 >3.00 
 
 
The potential bacteriostatic and bactericidal activity of the synthesized materials was 
tested against four different bacterial species: E. coli, S. aureus, MRSA and S. saprophyticus. 
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In order to compare the activity of AgNWs, AgNWs-CNT, AgNWs-CNT-mix and AgNO3, the 
MIC and MBC values obtained were normalized to the amount of Ag present in each material. 
All the studied materials inhibited cell growth at the concentrations tested, except for CNTs 
which didn’t show any antibacterial activity (Table 2.1). In particular, the normalized MIC 
values of AgNWs, AgNWs-CNT and AgNWs-CNT-mix were not statistically different from each 
other (p>0.05) for all bacterial species. Furthermore, the order of efficacy in inhibiting 
bacterial growth was: S. saprophyticus > S. aureus > E. coli > MRSA. All the preparations were 
less efficient than AgNO3 in inhibiting cell growth. The normalized MBC values for AgNWs, 
AgNWs-CNT and AgNWs-CNT-mix were also not statistically different from each other 
(p>0.05) against E. coli, S. aureus and MRSA. In the case of MRSA, it was not possible to 
compare the results, as the MBC of AgNWs-CNT-mix was higher than the maximum tested 
concentration. The order of efficiency was: S. saprophyticus > E. coli = S. aureus> MRSA. All 
the preparations were less efficient than AgNO3 in killing the different bacterial strains. Once 
again, CNTs did not show any bactericidal activity against the studied bacterial species. 
Even though the MIC values found for E. coli and S. aureus were higher than what reported 
by Cui and Liu for AgNWs (28 and 35 µg/ml against E. coli and S. aureus, respectively)[63], 
Hong et al. found values > 100 µg/ml against E. coli. The results could be explained 
considering that the initial bacterial density of our experiment was higher (1 x 107 CFU/ml) 
than the ones used in the other two studies. For instance, Hong et al. tested the AgNWs 
against an initial cell density equal to 1 x 105 CFU/ml. Indeed, it is well known that the efficacy 
of antibiotics, as well as silver nanoparticles, declines with the increase of the bacterial 
density [61]. 
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In this work, AgNWs-CNT-mix was used as a control to check whether the silver 
nanoparticles in AgNWs-CNT presented different characteristics from AgNWs in the first 
synthesis method. As the MIC and MBC values tend to be similar among AgNWs, AgNWs- 
CNT and AgNWs-CNT-mix, we could assume the three preparations had similar antibacterial 
properties with no effect due to the presence of CNTs. 
 
 
 
2.3.2.2 Bacterial growth kinetics  
 
 
In order to study how the bacterial growth kinetics were influenced by different 
 
 
 
 
 
 
processes in order to synthetize transporters and enzymes for the uptake of fundamental 
carbon nutrients [101]. Then, bacteria start to divide asexually in an exponential rate, 
originating the so called exponential phase. When bacteria exhaust nutrient sources, cells 
enter into stationary phase in which no increase in cell number is observed and an 
equilibrium between death and life is reached. 
The activity of AgNWs, AgNWs-CNT against the different bacterial strains is reported in Fig. 
 
 
 
 
concentrations of studied materials, growth was followed by measuring O.D.600nm in LB 
medium. The kinetics of the bacterial growth curves followed a typical pattern (Fig. 2.4): a 
lag phase, an exponential phase and a stationary phase. The lag phase is the time in which 
no bacteria replication happens as the bacteria adapt into the medium after being 
inoculated. During this phase, cells express transient genes that promote transcriptional 
2.4. AgNWs showed an interference in the duration of both lag phase (100 µg/ml, p=0.0359) 
and time to reach the stationary phase (50 µg/ml, p=0.0252) against E. coli (Fig. 2.4 A). MRSA 
showed a significantly longer lag phase than the control only in presence of AgNWs 100 
µg/ml (p=0.0031) and no effect on the time to reach the stationary phase (Fig. 2.4 E). S. 
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the stationary phase was significantly longer even for the lowest tested concentration. 
 
E. coli was more sensitive to AgNWs-CNT (Fig. 2.4 A) than AgNWs: its lag phase (12.5 µg/ml, 
 
 
 
 
 
 
 
 
 
 
 
 
concentration 25 µg/ml than the control. 
aureus (Fig. 2.4 C) was more sensitive than MRSA and E. coli to the action of AgNWs: all the 
tested concentrations, except for 12.5 µg/ml, produced longer lag phases (25 µg/ml had 
p=0.0003, whereas 50 µg/ml and 100 µg/ml had a p<0.0001). The time to reach the 
stationary phase was statistically longer for concentrations equal or higher than 50 µg/ml 
(p=0.0382). Finally, S. saprophyticus (Fig. 2.4 G) lag phase duration was increased for the two 
lowest concentrations (12.5 µg/ml had p=0.0071 and 25 µg/ml had p=0.0141), whereas no 
growth was found for the higher concentrations of nanoparticles and the time for reaching 
p=0.04447, whereas 25, 50 and 100 ug/ml had a p<0.0001) and the time to reach stationary 
phase were significantly longer for the lowest concentration, too. Seemingly, S. aureus (Fig. 
2.4 D) was more sensitive to the action of AgNWs-CNT than AgNWs: no growth was found 
for the highest concentration, whereas 12.5 µg/ml had a p=0.0019 and the higher 
concentrations had a p<0.0001. No difference in the time to reach the stationary phase was 
found for concentrations 12.5 and 25 µg/ml in comparison to the control. MRSA (Fig. 2.4 F) 
growth was affected by AgNWs-CNT: 12.5 ug/ml (p=0.0051), 25 µg/ml (p<0.0001), 50 µg/ml 
(p<0.0001) and 100 µg/ml (p=0.0003). No effect on the time to reach the stationary phase 
was observed. S. saprophyticus lag phase (Fig. 2.4 H) was affected for the two lowest 
concentrations (p=0.0210) and no growth was observed for the higher concentrations. The 
time to reach the stationary phase of S. saprophyticus was statistically longer for the 
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Figure 2.4 Growth curves of bacteria with different concentrations of AgNWs (A, C, E, G) and AgNWs-CNT 
(B, D, F, H). Results are reported as a mean ± SD (n=3). 
 
 
 
For all the studied nanoparticles and bacterial strains whenever the stationary phase  was 
 
reached, no statistical difference in OD values was found among treated and untreated 
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bacteria. 
 
Overall, results suggest that for all the bacterial strains, introduction of AgNWs affected the 
 
 
 
 
 
 
 
 
 
 
 
 
Agnihotri et al. [102] 
 
 
 
2.3.2.3 Leakage of proteins from bacteria  
 
Cui and Liu reported that AgNWs could cause the leakage of cytoplasmic content, such as 
DNA and proteins, from E. coli [63]. This phenomenon may be due to several alterations in 
bacterial cells, such as the inhibition of the activity of membranous enzymes or DNA 
damages. 
In this work, a bicinchoninic acid (BCA) assay was used to determine whether or not, AgNWs 
obtained by the two methods induced release of proteins in the extracellular liquid. All 
bacterial species tested showed an increased release of proteins in comparison to the control 
growth kinetics as compared to the negative control. Similar results were observed by Cui et 
Liu which described the influence of increasing concentrations of AgNWs on E. coli growth 
[63]. However, whereas Cui and Liu showed growth inhibition at concentrations higher than 
25 µg/ml, in this study, none of the concentrations used could inhibit cell growth in the same 
time frame. Variations in the results can be due to microbial strains, but also to 
physicochemical characteristics of AgNWs suspension [102]. Finally, as already found in MIC 
and MBC study, MRSA seemed to be the least sensitive strain among the species studied, 
whereas S. saprophyticus was the most susceptible. On the other hand, similar trends were 
reported for E. coli and S. aureus. These results seemed to show that it is not possible to 
explain the species sensitivity to silver nanoparticles in terms of bacterial classification (Gram 
+ and -), but in terms of specific differences among species, as reported for instance by 
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(Fig. 2.6 A-H). Moreover, this effect is dose-dependent, but no difference was found between 
1 and 24 h, except for S. saprophyticus. Interestingly, higher amount of proteins leaked out 
of E. coli compared to S. aureus and MRSA, suggesting that Gram-negative bacteria could be 
more sensitive than some of the Gram-positive bacteria to the action of AgNWs. A higher 
protein release in gram negative than in gram positive bacteria was already highlighted by 
Soo-Hwan et al. who tested AgNPs (no information about the size) against E. coli and S. 
aureus up to 6 h [103]. In this case, even in the control group an increase in protein release 
was found, probably due to physiological bacterial cell death and the release of extracellular 
proteins. No statistical difference was found between AgNWs and AgNWs-CNT, when 
comparing the same concentrations. 
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Figure 2.6 Absorbance relative to protein release after 1 h and 24 h of treatment for E. coli (A and B), S. aureus 
(C and D), MRSA (E and F) and S. saprophyticus (G and H) treated with 12.5 µg/ml or 100 µg/ml of AgNWs or 
AgNWs-CNT. Data are represented as a mean ± SD (n=4). The One-way ANOVA performed on all the samples 
showed significantly different release for both AgNWs and AgNWs-CNT (p<0.05). Results of the post-hoc 
Tukey’s multicomparison test are shown in the graphs (* indicates p < 0.05, ** indicates p < 0.01, *** indicates 
p < 0.001 and **** indicates p < 0.0001). 
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2.3.2.4 ROS generation from bacteria  
 
Previous studies on silver nanoparticles suggest that the oxidative stress plays a crucial role 
in the origin of the bacterial toxicity of nanoparticles. In this work, the ROS production in the 
medium outside cells was quantified 24 h after treatments with nanoparticles (Fig. 2.7 A-H). 
Fluorescence production was measured through 2’,7’-dichlorofluorescin diacetate (DCF-DA) 
probe. DCF-DA in the presence of ROS is oxidised to form a highly fluorescent product, called 
2’, 7’ –dichlorofluorescein (DCF). Results showed that ROS were produced when bacteria 
were treated with all the types of metallic nanoparticles. Moreover, generally, we could 
observe that the amount of DCF produced increased with the increase of the concentration 
of nanoparticles, as reported in literature for other types of AgNPs, such as nanospheres 
against S. aureus, E. coli and P. aeruginosa [104]. Interestingly, MRSA did not show any 
significantly increased ROS generation in comparison with the no treated cells. For S. 
saprophyticus treated with AgNWs, no significant difference was detected (p>0.05), but 
when cells were treated with AgNWs-CNT, there was statistical difference for concentrations 
equal or higher to 25 µg/ml. 
AgNWs were found to produce statistically more ROS than AgNWs-CNT in E. coli and 
S.aureus. In particular, the unpaired t-test for E. coli showed the following values: 100 µg/ml 
presented p=0.0188, 50 µg/ml presented p=0.0346, 25 µg/ml presented p=0.0007 and 12.5 
µg/ml presented p=0.0064. On the other hand, the unpaired t-test against S. aureus showed 
the following results: 100 µg/ml presented p=0.0243 and 50 µg/ml presented p=0.0154. 
All together these results suggest that bacterial toxicity of AgNWs was probably mediated 
through oxidative stress, in case of E. coli and S. aureus, whereas the ROS levels in MRSA 
were not significant, at the tested concentrations, suggesting that MRSA could present more 
efficient antioxidant mechanisms than E. coli and S. aureus. As regards S. saprophyticus more 
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studies should be carried out to understand the difference between the two treatments. 
 
 
Figure 2.7 ROS production (% of the control) from bacterial cells, after 24 hours from treatment. E. coli (A and 
 
B), S. aureus (C and D), MRSA (E and F) and S. saprophyticus (G and H) treated with 12.5 µg/ml, 25 µg/ml, 50 
 
µg/ml and 100 µg/ml of AgNWs or AgNWs-CNT. Data are represented as a mean ± SD (n=3). The One-way 
ANOVA performed on all the samples showed significantly different ROS production for both AgNWs and 
AgNWs-CNT (p<0.05) for some of the bacterial strains. Results of the post-hoc Tukey’s multicomparison test 
are shown in the graphs (* indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates 
p < 0.0001) 
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2.3.2.5 Morphological changes in bacterial cells treated with AgNWs and AgNWs-CNT 
 
 
SEM images of the 4 bacterial strains were acquired by SEM (Fig. 2.7) to detect potential 
morphological changes, after 8 h treatment with AgNWs and AgNWs-CNT. In Fig. 2.7, it is 
possible to notice that AgNPs and AgNWs tend to deposit on the surface of bacteria and that 
some of the cell surfaces were damaged, in particular E. coli showed some fragmentary 
bacteria, as indicated by arrows. The ability of AgNPs to cause big gaps formation in E. coli 
membrane has already be shown by Das et al.[105]. 
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Figure 2.8 SEM photos of bacteria morphology after treatment either with AgNWs or AgNWs-CNT. (A), (B) and 
 
(C): E. coli; (D), (E) and (F): S.aureus, (G), (H) and (I): MRSA; (J), (K) and (L): S. saprophyticus. 
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2.3.3 In vitro cell toxicity studies 
 
The toxicity of the two types of AgNWs- was tested against three cell lines: osteoblasts 
(hFOB 1.19), human foreskin fibroblasts (Hs27) and Caco-2 cells. These cell lines were chosen 
to mimic three possible route of exposures: such as application of treatments on bone, skin 
and digestive system, respectively. In particular, Caco-2 are an in vitro model for prediction 
of the toxicity and adsorption in the intestine of humans [106]. Cell viability was determined 
by the MTT assay, based on the cleavage of the tetrazolium salt by metabolically active cells 
from a water insoluble formazan dye (Fig. 2.9 A-F). During the MTT assay protocol, the 
medium containing AgNWs was removed prior to the addition of the MTT solution, in order 
to reduce the interference of the NWs with the MTT or formazan. 
The viability results of osteoblasts showed that both the AgNWs treatments decreased the 
metabolism of cells in a dose- and time-dependent-manners (Fig. 2.9 A and B). After the 2 h 
treatment with the highest concentration of AgNWs (100 µg/ml), the viability decreased to 
92.86 ± 17.10 % and to 95.52 ± 20.07 % for AgNWs-CNT. Whereas, after 24 hours of exposure, 
the cell viability was around 62.28 ± 16.68 % for AgNWs and 63.48 ± 18.27 % for AgNWs- 
CNT. One-way ANOVA performed on the same concentration of the two treatments showed 
no statistical difference (p>0.05). 
Fibroblasts viability results showed that the highest concentration of AgNWs and AgNWs- 
CNT (Fig. 2.9 C and D) reduced cell metabolic activity up to 91.40±10.99% and 85.96±3.77%, 
after 2 h. While, after 24 h, cell toxicity reduced to 70.33 ± 20.01% and 66.61 ± 18.16%, after 
24 h. One-way ANOVA performed on the same concentration of the two treatments showed 
no statistical difference. Overall fibroblasts were less sensitive to the effect of AgNWs. 
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Figure 2.9 Cytotoxicity for different types of cell lines, after 2 hand 24 h of treatment. Osteoblasts (A and B), 
fibroblasts (C and D), Caco-2 (E and F). Data are represented as a mean ± SD (n>3). The One-way ANOVA 
performed on all the samples showed significantly different viability for both AgNWs and AgNWs-CNT (* 
indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 and **** indicates p < 0.0001). 
 
 
 
Caco-2 cells (Fig. 2.9 E and F) were the most sensitive to the action of AgNWs. The 
treatment with the highest concentration of AgNWs, showed a cell viability of 96.59 ± 13.00 
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% after 2 h, whereas for AgNWs-CNT viability was 87.26 ± 10.52 %. After 24 h, cell viability 
decreased dramatically to 49.62 ± 17.99 % and 45.56 ± 12.90 % for AgNWs and AgNWs-CNT, 
respectively. One-way ANOVA performed on the same concentration of the two treatments 
showed no statistical difference. 
Overall, these results show that AgNWs present a dose-dependent toxicity and the extent 
of the cell toxicity depends on the cell type, as already reported by Verma et al. [85] 
 
 
2.3.3.1 Oxidative stress in cells  
 
 
Several studies have shown evidence of a link between AgNPs toxicity and production of 
ROS in mammalian cells [107] [108]. In order to measure the AgNWs-induced ROS 
generation, DCF-DA probe was used. The results in Fig.2.10 A-F highlight that ROS induced 
by AgNWs are a significant factor in toxicity for all the cell lines. Indeed, all the cell lines 
presented a singnificant increase of fluorescence values that then decreased over time. 
Fibroblasts seemed to be less affected than Caco-2 and osteoblast cells by AgNWs and 
AgNWs-CNT ROS generation effect. Also Sweeney et al. showed that AgNWs (72 nm x 1.5 
µm) could induce a significant increase of ROS production; they showed that AgNWs 
promoted a significant ROS generation, in human type-I epithelial-like cells (TT1), both at 4 
(≥25 µg/ml) and at 24 h treatment (≥ 10 µg/ml). 
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Figure 2.10 Time course of ROS production in different cell lines: osteoblasts (A and B), fibroblasts (C and D) 
and Caco-2 (E and F) treated with AgNWs or AgNWs-CNT for 15 min. One-way ANOVA returned p<0.05. Data 
are reported as mean±SD (n=3). Results of the post-hoc Tukey’s multicomparison test are shown in the graph. 
Statistical differences are reported in the graph: * was used to compare 100 with 0 µg/ml (* indicates p<0.05, 
** indicates p<0.01, *** indicates p<0.001 and **** indicates p<0.0001); $ was used to compare 50 with 0 
 
µg/ml ($ indicates p<0.05, $$$$ indicates p<0.0001); # was used to compare 50 with 10 µg/ml (# indicates 
p<0.05, ### indicates p<0.001, #### indicates p<0.0001); £ was used to compare 100 with 10 µg/ml (£££ 
indicates p<0.001, ££££ indicates p<0.0001). 
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However, differently from Sweeney et al., in our experiment, we observed a reduction of 
ROS production, over time, in comparison to the percentage of the control. This is in 
agreement with what reported by Onodera et al.: treating BALB/3T3 A31-1-1 cells with 1-nm 
AgNPs, they observed a decrease in fluorescence between 5 min and 60 min [109]. 
Moreover, ROS intensity tend to increase with the increase of AgNWs concentrations, as 
shown for silver nanospheres (26.2 ± 7.6 nm) by Lee et al. in mouse embryonic fibroblasts 
(NIH 3T3) [108], for peptide-coated silver nanospheres (20 nm) by Böhmert et al. in Caco-2 
cells [110] and for Ag nanospheres by Castiglioni et al. in Saos-2 osteoblat-like cells [111]. 
 
 
 
2.3.3.2 Membrane damage evaluation  
 
 
Membrane integrity was assessed by measuring extracellular lactate dehydrogenase (LDH). 
Cells were treated with AgNWs (0, 10, 50 and 100 µg/ml) for 24 h and results are reported in 
Fig. 2.11 A-F. No significant toxicity was observed after 24 h for all the concentrations tested 
in comparison to the spontaneous LDH release (0 µg/ml) (p>0.05). These results are in 
disagreement with what found, for instance, by Gurunathan et al. which found that silver 
nanoparticles (20 ± 3.5 nm) caused an increased and significant LDH leakage from lung 
carcinoma cells (A549), after 24 h treatment, with concentrations ≥ 6.125 µg/ml [112]. 
However, Gliga et al. have previously observed that LDH release from human lung cells 
(BEAS-2) depended on the dimensions of AgNPs. Testing particles of 10, 40 and 75 nm, they 
found no significant LDH release for the NPs ≥ 40 nm of diameter [113]. Thus, we 
hypothesized that AgNWs may cause less membrane damage than other AgNPs due, for 
instance, to their lower specific surface area. 
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Figure 2.11 Percentage LDH release from osteoblasts, fibroblasts and Caco-2 after 24 hours of exposure to 
different concentrations of AgNWs or AgNWs-CNTs. The one-way ANOVA calculated among the different 
concentrations of each test did not show any statistical difference (p>0.05). Data are reported as a mean ± SD 
(n=3). 
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2.3.3.3 Silver uptake by osteoblasts  
 
 
Several studies have reported that AgNWs tend to be uptaken and accumulate in different 
types of lung cells, such as alveolar type-I and type-II epithelial cells[82]. 
In our work, we wanted to find out whether or not AgNWs could be uptaken into osteoblast 
cells and at which concentration. In our study, osteoblast cells were treated with Ag+, AgNWs 
or AgNWs-CNT for 24 h. Concentrations up to 10 µg/ml of NPs and AgNO3 were tested as 
they caused no relevant differences in toxicity to osteoblasts after 24 h of exposure (Fig. 
2.12). 
 
 
Figure 2.12 Amount (µg) of Ag found in osteoblasts after 24 h of exposure to AgNWs, AgNWs-CNT and AgNO3. 
The one-way ANOVA calculated among the different concentrations of AgNWs and AgNWs-CNT returned 
p<0.05. Results of the post-hoc Tukey’s multicomparison test are shown in the graph: * indicates p<0.05, ** 
indicates p<0.01 and **** indicates p<0.0001. Values are reported as a mean ± SD (n=3). 
 
 
We examined the accumulation of both AgNPs and Ag+ at various concentrations applied, 
after digestion of cells in nitric acid. Results showed that all the NWs studied and Ag+ have 
been efficiently taken up in a concentration-dependent manner by osteoblasts, but the Ag 
88 
 
concentration was significantly lower for AgNO3 than for AgNWs and AgNWs, for all the 
concentrations (Tukey’s multicomparison test showed p<0.0001): for instances, detected Ag 
contents in cells exposed to 10 µg/ml of AgNWs, AgNWs-CNT and Ag+ were 0.46 ± 0.07, 0.33 
± 0.08 µg and 0.0007 ± 0.0004 µg, respectively. A similar behavior was found with 
mammalian kidney cells (Pk15) for silver nanoparticles of different sizes (ca. 13.8-61.2 µm) 
by Milic et al [114]. We have hypothesized that as there is not a specific transporter for Ag+, 
but it has to compete for transporters with other ionic species, the amount of Ag that 
entered in the cells was much inferior in comparison to AgNWs that could enter endocytosis. 
 
 
 
Figure 2.13 Phalloidin Dylight 550 and DAPI stained osteoblast cells at 24 hours of incubation with AgNWs 
(10 and 100 µg/ml). (A) (D) and (G) Merged images of Phalloidin (staining F-actin) and DAPI (staining nuclei) of 
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osteoblasts. (B), (E) and (H) AgNWs excited at wavelength of 495 nm and emitting at a wavelength of 519 nm 
(FTIC). (C), (F) and (I) Merged images of Phalloidin/DAPI/AgNWs. Scale bar 270.00 µm. 
Results of ICP-OES were confirmed by fluorescence microscopy (Fig. 2.13). AgNWs 
accumulated in osteoblasts in a dose-dependent manner. Moreover, through fluorescence 
microscopy it was possible to observe that cells presented AgNWs either close to the 
membrane (Fig. 2.13 F) or within the cytoplasm (Fig. 2.13 F and I). 
 
 
 
2.4 Conclusions 
 
In summary, we successfully synthetized AgNWs through two routes. The materials were 
characterized by TEM, XRD, UV-vis and fluorescence spectroscopy and found to be similar. 
Then, we studied their antibacterial properties, confirming their similarity. The toxicity of the 
materials was found to be related both to the generation of ROS and membrane damage. 
Moreover, the cytotoxicity studies indicated that AgNWs had a dose- and time-dependent 
toxicity profile. The cells presented high levels of ROS after exposure to AgNWs and cells did 
not present any significant membrane damage. Furthermore, AAS results on osteoblasts 
revealed that AgNWs could be efficiently uptaken by this cell type. Future work will be 
carried out in order to determine whether AgNWs could determine DNA damage in both 
bacteria and cells. 
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Abstract 
 
Over the past few decades bone related disorders have constantly increased. Among all 
pathological conditions, osteoporosis is one of the most common and often leads to bone 
fractures. This is a massive burden and it affects an estimated 3 million people only in the UK 
furthermore, as the population ages, numbers are due to increase. Therefore, novel 
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biomaterials for bone fracture regeneration are constantly under development. Typically, 
these materials aim at favoring optimal bone integration in the scaffold, up to complete bone 
regeneration. This approach to regenerative medicine is also known as tissue engineering 
(TE). Hydrogels are among the most promising biomaterials in TE applications. They are very 
flexible materials that allow a number of different properties to be targeted for different 
applications, through appropriate chemical modifications. The present review will focus on 
the strategies that have been developed for formulating hydrogels with ideal properties for 
bone regeneration applications. In particular, aspects related to the improvement of 
hydrogels mechanical competence, controlled delivery of drugs and growth factors are 
treated in detail. It is hoped that this review can provide an exhaustive compendium of the 
main aspects in hydrogel related research and therefore stimulate future biomaterial 
development and applications. 
 
 
 
3.1 The bone 
 
The bone is a solid composite living material that represents the main constituent of the 
vertebral skeleton[115]. This dynamic tissue plays many important roles in the human body: 
first of all, by a joint action with the digestive and renal systems, it contributes to the 
regulation of the concentration of electrolytes, such as Ca and P [116, 117]. Secondly, its hard 
and moderately elastic nature allows it to form a framework for the support and attachment 
of softer tissues such as muscles, and for the protection of vital organs and the bone marrow. 
Finally, it provides body support for locomotion and muscular contraction [118]. 
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3.1.1 Bone anatomy 
 
 
Bones are typically formed by an outer layer of compact bone (also called cortical bone) 
and an inner portion of spongy bone (also called trabecular or cancellous bone). Trabecular 
bone is formed by various trabeculae arranged in a honeycomb structure. The relative 
proportion between the cortical and trabecular bone varies with the skeletal segments and 
their function. The major difference between compact and trabecular bone lies in their 
porosity that ranges from 5 to 30% in the compact bone and from 30 to 90 % in the trabecular 
bone. 
Long bones (i.e. humerus, radius and ulna) are constituted by three regions: diaphysis, the 
central shaft; epiphysis, the bulbous extremities; and metaphysis, located between the two. 
In the middle of the shaft a medullary (or marrow cavity) is present. This contains red bone 
marrow for hematopoeisis during infancy and yellow marrow for energy storage during 
adulthood. Short bones include the tarsal and carpal bones; flat bones include the frontal 
and parietal bones of the cranium, ribs, scapula and pelvis; finally, irregular bones include 
the bones of the spine (vertebrae, sacrum and coccyx) and some bones of the skull such as 
sphenoid and ethmoid [119, 120]. Bone shape is genetically determined in order to satisfy 
particular requirements according to the anatomic position and function. Furthermore, 
during life, bone shape is altered by the process known as remodeling, based on a 
combination of periosteal and endosteal apposition and resorption[121-123]. 
 
 
 
3.1.2 Chemical composition 
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At a microscopic level, bone can be divided into three main components: matrix, cells and 
bioactive factors. The calcified bone matrix is formed by an organic protein-rich matrix (20 
% of dry weight), a mineral substance (65 %) and water (ca. 10 %). The organic phase has a 
role in determining the form of the bone and affords resistance to tension. The major 
component of the organic matrix is collagen type I (90 %); the remaining 10 % is constituted 
of noncollagenous proteins, proteoglycans and phospholipids. Moreover, the matrix is 
constituted by growth factors and enzymes such as phosphatase and metalloproteinase. 
Collagen fibrils are formed by three filamentous polypeptide chains in a helical configuration, 
stabilised by intra- and intermolecular cross-links. These bonds allow both mineralisation and 
reinforcement of the tensile strength of the fibrils. The non-collagenous proteins have 
different functions in the bone structure: phospholipids and proteoglycans have a regulatory 
effect in the calcification process [124]. The inorganic phase serves as an ion reservoir 
(predominately Ca, Mg, Na and P) and increases the strength of the bone due to the presence 
of apatite, carbonate, acid phosphate and brushite. The main inorganic component of the 
bone is phosphate hydroxyapatite [Ca10(PO4)6(OH)2] [125, 126]. 
 
 
 
3.1.3 Histology of the bone 
 
The bone consists of cells from two cell lines: mesenchymal stem cells (MSC) and 
hematopoietic stem cells (HSC). 
 
1. MSCs are multipotent stromal cells that can differentiate into diverse cell types such 
as myocytes and adipocytes but also osteoblast progenitors, osteoblasts, bone-lining cells 
and osteocytes. Osteoblasts are the most prevalent cell type in the bone and their function 
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is to secrete matrix components, such as collagen I, in response to mechanical stimuli and to 
promote the mineralisation of the bone matrix. Osteocytes, derived from osteoblasts, have 
mechanosensor and modulator (promotion of nerve growth) activities. Bone-lining cells are 
instead able to release enzymes to remove the layer of osteoids that covers mineralised 
matrix allowing osteoclasts to attach and begin resorption. 
 
 
 
2. HSCs are stem cells that give rise to blood cells such as monocyte, macrophages or 
platelets, but also preosteoclasts and osteoclasts. Osteoclasts are responsible of bone 
resorption; by the secretion of protons, they can lower the pH and so solubilize the mineral 
phase. These cells are responsible for an intricate balance between formation, maintenance 
and destruction of bone tissue. This equilibrium is maintained by the action of hormones, 
cytokines and mechanical factors such as calcitonin and parathyroid hormone (PTH) that can 
control the levels of calcium and phosphate in the blood. Calcitonin is a thyroid hormone 
that reduces blood calcium levels by inhibiting osteoclasts and decreasing Ca resorption in 
the kidneys. Conversely, PTH is a hormone that increases blood calcium levels, acting upon 
the PTH1 receptor in bone and kidney, and the PTH2 receptor in the central nervous system, 
pancreas, testis, and placenta [120]. It is evident from the above brief description that the 
bone is an extremely complex tissue and that many factors can play a role in its physiology 
and function. 
 
 
 
3.1.4 Bone healing 
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Bone tissue possesses the intrinsic capacity of healing itself; the bone repairing process is 
an interplay of biomechanical, cellular and molecular factors [128]. If successful, bone 
regenerates itself with newly formed bone in children and in a mechanically stable lamellar 
structures in adults [129]. The full understanding of this process may help researchers to 
develop new strategies to treat slowly healing or non-healing fractures [130]. First of all, 
when a fracture occurs, the following local tissue damages are observed: interruption of 
skeletal integrity, disruption of vascular structures and of nutrient flow at the fracture site 
leading to oxygen tension and disruption of marrow architecture [131]. These are the 
prelude to the real bone regeneration process [132]. The bone regeneration healing is 
divided into three phases: inflammation phase, reparative phase and remodelling phase (Fig. 
3.2) [129]. During the inflammation phase, blood vessel disruption causes a blood clot, called 
hematoma, while fibroblasts fill the defect site with a fibrin-rich extracellular matrix [132]. 
Later, the immigrating platelets, neutrophils and macrophages release signalling molecules, 
such as fibroblast growth factors (FGF), tumour necrosis factor-α (TNF-α), platelet-derived 
growth factors (PDGF), vascular endothelial growth factor (VEGF), basic fibroblast growth 
factor (BFGF), transforming growth factor (TGF-β) and cytokines, such as IL-1 and IL-6 [131]. 
Hence, IL-1 and IL-6 chemotactically attract mesenchymal cells precursors [132]. Finally, 
mesenchymal precursors proliferate and differentiate into the chondrogenic and osteogenic 
lineages [131]. During the second phase, called repairing phase, it is possible to see that 
chondroblasts form hyaline cartilage while osteoblasts form woven bone. The latter brings 
on a cartilaginous callus that bridges and stabilises the bone wound. Then, the so-called 
endochondral ossification happens: woven and hyaline cartilage are substituted by lamellar 
tissue due to mineralisation of the tissue. The calcified tissue, by the activity of matrix 
metalloproteinase expressing cells, is penetrated by blood vessels and the cartilaginous 
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septum is removed. The last phase is the remodelling phase in which there is the conversion 
of fracture callus into real bone. Firstly, osteoclasts adsorb trabecular bone, creating a 
shallow resorption pit, called Howship’s lacunae. Then, an enzymatic destruction of the bone 
matrix, promoted by the locally present cells, leads to the releasing of growth factors and 
cytokines. The latter induce the conversion of osteoprogenitors to osteoblasts that enter the 
resorption pits created by osteoclasts and create new bone matrix of either the woven and 
lamellar cells. Finally, the entrapped cells within the bone matrix generate osteocytes [131]. 
 
Figure 3.2 Bone healing process 
 
 
 
 
 
3.2 Bone tissue engineering 
 
 
3.2.1 The need for effective bone repair strategies: economic, social and clinical aspects 
 
 
Over the past few decades the prevalence of bone related disorders has steadily been 
on the rise [133]. The most notable cause for this is our increasingly aging population, 
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however other factors such as disease (i.e. Paget’s disease or osteoporosis) and recurrent 
sports injuries are also relevant [134]. While these issues may have taken a back seat in 
comparison to the attention that heart disease and cancer have attracted; bone diseases are 
common and significant healthcare issues, and this has prompted a steady stream of 
research in the field of bone regenerative medicine [133]. 
Osteoporosis is one of the most common diseases leading to bone fractures; it affects an 
estimated 3 million people in the UK and, as the population ages, numbers are due to 
increase [135]. The National Institute for Health and Care Excellence has published a 
guidance indicating that the direct cost from fragility related fractures in the year 2000 was 
estimated to £1.8 billion, with the potential to increase to £2.2 billion by 2025 and to reach 
£6 billion by 2036, in the UK only [136]. 
 
Bone fractures also have a great impact on the patients’ quality of life, for example they 
can infringe on the ability of a person to live independently where the fracture site is along 
a load bearing bone or it can affect self-esteem and social interaction when it affects the 
spine and the posture of the patient [135], leading to high mortality in the elderly [135, 136]. 
Moreover, co-morbidities can reduce the bone regeneration capacity with recurrence of 
delayed- or non-union fractures; these significantly prolong the recovery period and 
constitute a considerable societal burden [137]. 
 
 
 
3.2.2 Limitations of the current treatments 
 
 
Current treatment protocols for complex bone fractures involve the use of auto-/allo-grafts 
or inert metallic/ceramic implants. Autograft implantation represents the golden standard 
for treatment of small bone defects [138]. This technique transplants the donor’s bone from 
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a non-load-bearing site in the patient (i.e. iliac crest) into the defect site of the same patient 
[139]. Bone autografting presents all the essential elements to heal a bone fracture since the 
transplanted bone tissue has osteoconductive, osteoinductive and osteogenic properties. 
However, autografting shows some disadvantages such as high costs and limited available 
tissue from donor sites. Allograft is the second most common bone-grafting technique. This 
method involves the transplantation of bone from a different donor (i.e. cadavers) and the 
main shortcomings are related to infections and demand of donor bone tissue [140]. When 
both auto- and allografts are not successful or adequate, different biomaterials are 
considered. Metallic devices such as plates/screws, rods and fixators are widely used, but 
despite their excellent mechanical properties, they are not bioactive and bioresorbable. 
Thus, limiting their performance and involving additional surgical procedures in case of 
revision [141]. Moreover, due to stress shielding effects they can cause bone resorption and 
consequent implant loosening [141]. Ceramics represent a valuable alternative due to their 
availability and adaptation to various applications. Calcium phosphate (CaP) cements, for 
instance, well resembles bone tissue chemical/functional properties, being both 
biocompatible and bioactive. However, low tensile strength and high brittleness are main 
drawbacks of such materials [142, 143]. CaP showed ability in promoting bone repair, 
although they typically provide poor revascularisation/mineralisation, limited life time, and 
inability to adapt to skeletal changes [144]. Furthermore, a single-phased material cannot 
efficiently guarantee bone growth and tissue engineering approaches are needed [145]. 
 
 
 
3.2.3 Requirements for successful development of bone tissue engineering scaffolds 
 
As reported by the pioneers Langer and Vacanti, the term tissue engineering (TE) defines 
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‘’an interdisciplinary field that applies the principles of engineering and life sciences toward 
the development of biological substitutes that restore, maintain, or improve tissue or organ 
function’’. In general, TE aims at developing temporary 3D multicomponent scaffolds, also 
called composites, to induce the physiological regeneration of functional tissues (i.e. bone), 
overcoming the downfalls of classic biomaterials systems [141, 145, 146]. Scaffolds are firstly 
intended to work as fillers, occupying the available space in the damaged organ/tissue and 
slowly their programmed bioerosion/resoption allows them to provide a framework for 
growth of new tissue that finally partially or completely replaces the scaffold. 
An ideal scaffold for bone tissue engineering (BTE) must present the following three main 
properties [147]: 
 
 
 
1 Osteoconduction refers to the growth of new tissue on the external and internal 
 
(pores) surfaces of the implant. This is greatly dependent on the physical form and chemical 
composition of the material. Factors such as hydrophilicity, porosity, biocompatibility and 
biodegradability of the material will affect its osteocoductive properties. For example, 
porosity (optimal pore size 200-350 µm) is crucial for allowing neovascularization and 
diffusion of nutrients and gases required for the formation of the new bone [148]. 
Mechanical competence of the material is also important to provide an osteoconductive 
scaffold. This review will look at different approaches that have been studied in an attempt 
to improve the mechanical performance of hydrogel scaffolds. 
 
2 Osteogenicity is the property of those scaffolds that contain osteoprogenitor cells 
 
and favour their adhesion and proliferation [149]. This review will look at the different types 
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of stem cells that can be used in bone regeneration and strategies for their inclusion in 
scaffolds hydrogel scaffolds. 
 
3 Osteoinduction is the capacity of attracting immature cells to a healing site and 
 
stimulating these cells to develop into bone-forming cells. Materials that are osteoinductive 
are able to induce bone formation in ectopic sites [147]. This review will consider the 
complexity of controlled drugs and growth factor delivery from bone regeneration scaffolds. 
 
4 Osteointegration, defined at a histological level as the direct contact between the 
 
implant and the new bone without the formation of fibrous tissue and the ability to maintain 
a strong biomaterial/bone interaction over time, should be the overall outcome of the 
application of a scaffold that present all above described properties. Importantly, 
osteointegrated implants should re-establish mechanical function of the repaired bone. 
 
 
 
3.3 Hydrogels as scaffolds and delivery platforms 
 
 
In their letter to Nature in 1960, Wichterle and Lim investigated for the first time the role 
of hydrogels for biological use [150]; the following decades have seen a wealth of research 
aimed at exploiting the particular properties of hydrogels that allow their use for many 
purposes such as: matrices for tissue engineering and regenerative medicine, diagnostics, 
cellular immobilization, separation of biomolecules or cells and barrier materials to regulate 
biological adhesion [125, 151]. 
Hydrogels are three dimensional, hydrophilic, polymeric cross-linked networks[151, 152]. 
They are able to swell without disintegrating and can absorb up to several times their dry 
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weight in water [153]. Their high content in water makes them resemble the living tissue; 
therefore they are ideal for a wide range of biomedical and pharmaceutical applications 
[154]. Hydrogels can be produced by different techniques: one-step methods like 
polymerization and parallel cross-linking of multifunctional monomers, or multiple step 
methods by the synthesis of polymer molecules characterised by the presence of reactive 
groups that originate cross-links in presence of a low molecular weight crosslinking agents 
[155]. The crosslinking points are essential to avoid the dissolution of the polymer chains and 
the type and degree of crosslinking determine many of the properties of the hydrogel [155]; 
for example crosslinking establishes the mesh size of the polymeric network and the water 
content that the gel can reach [156]. While the hydrophilic groups of the network chains 
attract and hold the fluid, the cross-links inside the structure impart an elastic force 
responsible for the solidity and stress resistance of the hydrogel [155, 156]. 
Hydrogels are very flexible materials, amenable to different chemical modifications that 
allow obtaining the desired properties according to the intended application; the present 
review will focus on the strategies that have been developed for formulating hydrogels with 
ideal properties for bone regeneration applications: osteoconduction, osteoinduction and 
osteogenicity. 
 
 
 
3.4 Osteoconductive composite hydrogels: Strategies to improve hydrogels 
mechanical competence 
 
 
It is widely accepted that scaffolds used for bone tissue engineering should be able to 
provide temporary mechanical integrity at the defect site immediately upon implantation. 
Scaffolds mechanical properties should be tailored to match the demands of the implant site 
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to decrease or avoid complications such as stress shielding, implant-related osteopenia, and 
subsequent re-fracture [157, 158]. Consequently, the design of the scaffold will vary with the 
site of implantation and with the type of bone. However, specific mechanical requirements 
for scaffolds are still to be defined by the research community and clinicians. 
The soft nature of hydrogels makes them unsuitable for applications where a certain 
mechanical competence is required. Even though the mechanical properties of hydrogels can 
be increased by manipulating a number of parameters such as type and density of 
crosslinking [159], polymeric molecular weight, chemistry and concentration of the hydrogel 
precursors, it is not always possible to achieve the desired properties [160]. It must be also 
considered that some changes to the hydrogel formulation such as the use of high 
crosslinking density may lead to toxicity [161]. Therefore, designing hydrogel composites 
that are capable of synergising the biocompatibility and flexibility of the polymeric network 
and the structural support provided by the filler materials, can enhance the mechanical 
performance of hydrogels without affecting their beneficial properties. This results in a 
biomimetic approach where the physicochemical properties of nanostructured hybrid 
materials can stimulate cell growth and guide bone healing [162]. Different inorganic/organic 
composites for BTE have been studied; the most common fillers used are bioceramics 
(hydroxyapatite, tricalcium phosphate), bioglass particles, and carbon nanotubes. The 
mechanical properties of these nanocomposites can be controlled either by altering the 
properties of the matrix or of the nanofiller (i.e. concentration and size); interfacial bonding 
also has great importance as it may affect the effectiveness of load transfer. 
 
 
3.4.1 Hydroxyapatite 
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Biomedical applications of nanohydroxyapatite (nHap) bioceramics have gained increasing 
interest due to their superior biological and biomechanical properties. Synthetic 
hydroxyapatite exhibits a strong affinity to host hard tissues due to the chemical similarity 
between hydroxyapatite and mineralised human bone tissue[163]. Several studies have 
combined polymers and nHap to create composite hydrogels, merging the desirable 
properties of the different organic and inorganic phases in order to achieve a synergistic 
effect in the resultant composite properties including the enhancement of the mechanical 
properties. Li et al. developed nHap/polyacrylamide composite hydrogels that presented 
higher fracture tensile stress,  higher  extensibility,  and  higher  compressive  strength  (35.8 
MPa with 15% nHap vs. 22 MPa for pure gel) in comparison to the parent hydrogels; 
furthermore, these composites showed excellent shape recovery[164]. The authors justified 
the enhanced mechanical properties as the result of the chelating effect and the hydrogen 
bonding between the polymer chains and nHap particles. Natural polymers are also 
interesting biodegradable materials used in the formulation of scaffolds for bone tissue 
engineering, mainly due to their similarities with extracellular matrix, chemical versatility and 
overall good biological performance [165]. For example, silk fibroin displays slow 
biodegradation, adjustable mechanical properties, high permeability to oxygen and water 
vapour, resistance to enzymatic degradation, favourable processability and biocompatibility, 
that have produced wide interest in this material for a number of applications [166]. In 
addition, the mechanical integrity and low inflammatory response of silk fibroin ensure its 
role as a promising material for osteogenic applications. A nHap/silk fibroin composite 
hydrogel was developed by Ribeiro et al. [167]. In this composite an increase in nHap 
concentration corresponded to an increase in mechanical properties of the composite with 
values of 90 and 100 kPa obtained. Another natural polymer, agarose, extracted from marine 
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red algae, can form thermoreversible gels via physical crosslinking. It is also a biocompatible 
and relatively bioinert material, promising for the formulation of gel matrices for biomedical 
applications [166]. Hu et al. studied nHAp/agarose composites and reported that with 70/30 
organic/inorganic weight ratio the highest compressive strength value (~400 MPa) was 
obtained, while a 65/35 weight ratio afforded the highest elastic modulus (~1100 MPa, 
twofold that of pure agarose gel). This improvement in mechanical properties was justified 
by the formation of intermolecular hydrogen bonds between the two components, with a 
role also played by the average size (50 nm) of the well-dispersed spherical nHA particles 
[168]. Spherical hydroxyapatite granules prepared by liquid nitrogen method and then 
encapsulated into oxidised alginate–gelatin–biphasic calcium phosphate hydrogel networks 
were produced by Sarker et al. Also in this case, an increase of granules amount led to an 
increase in compressive strength due to mechanical interlocking of granules into the 
hydrogel matrix [169]. Chitin is another biocompatible, biodegradable and bio-resorbable 
biopolymer with also antibacterial and wound-healing abilities and low immunogenicity 
[170]. Chang et al. fabricated hybrid nHap/chitin hydrogels that exhibited porous structure, 
high mechanical strength and excellent biocompatibility [171]. Addition of nHap increased 
10 fold (274 kPa) the reported compressive strength of chitin only hydrogel. The Young’s 
modulus of the hybrid hydrogel was ~320 kPa, compared to ~23 kPa of the chitin only 
hydrogel. 
 
 
 
3.4.2 Bioactive glass 
 
 
Bioactive glasses or bioglasses are inorganic amorphous materials that present variations 
of composition based on the original bioglass (45S5): 45% silica (SiO2), 24.5% calcium oxide 
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(CaO), 24.5% sodium oxide (Na2O), and 6% phosphorous pentoxide (P2O5) in weight 
percentage [172]. They display the ability to degrade at a controllable rate, releasing ions 
during this process and develop a carbonated phosphate surface layer that allows them to 
chemically bond to the native bone [173]. Bioactive glasses induce hydroxyapatite 
precipitation in the presence of a biological fluid, resulting in the enhanced mineralisation of 
bone tissue [173, 174]. They also possess the ability to induce differentiation of 
mesenchymal cells into osteoblasts, to stimulate vascularisation and enhance osteoblast 
proliferation [173, 175]. These properties are dependent primarily on the glass composition 
and microstructure [176]. Nevertheless, these materials are not suitable for load-bearing 
applications because of their intrinsic brittleness. Alone, they exhibit poor flexibility and 
fatigue strength, so their use in the formulation of composite hydrogels has been evaluated 
[177]. 
Gellan-gum represents a good candidate for the formulation of biocompatible scaffolds due 
to its non-cytotoxicity, biodegradability, hydrophilic and affordable nature [178]. However, 
similarly to other natural polymers, it presents relatively poor mechanical properties that 
narrow its applications in bone tissue engineering. Although a combination of physical (i.e. 
temperature) and chemical crosslinking approaches (i.e. photocrosslinking) can produce 
gellan-gum hydrogels with tunable physical and mechanical properties without affecting 
their biocompatibility, the mechanical properties of the hydrogel alone are not suitable for 
bone tissue engineering [179]. Gantar et al. reinforced gellan-gum hydrogels with a 
nanoparticulate glass to improve the microstructure and the mechanical properties of the 
material [180]. The composite hydrogel scaffold containing 50 % bioactive-glass exhibited a 
Young's modulus of ~ 1.2 MPa. Although this value is not sufficient to accommodate 
biomechanical loading, when compared with the gellan-gum alone, the 
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incorporation of the bioglass significantly increased the Young's modulus from 0.4 to ~1.2 
MPa and the failure stress increased from 0.02 to ~0.11 MPa. Photopolymerised 
poly(ethylene glycol) dimethacrylate hydrogels combined with bioactive glass particles were 
synthetised and characterised by Killion et al. who demonstrated that the incorporation of 
bioactive glass increases the mechanical strength of the composite material, with a synergic 
action by the bioactive glass absorbing the initial compressive load and the polymeric matrix 
distributing the load between the reinforcement [181]. Lacroix et al. reported the synthesis 
of a bioactive glass/gelatin composite scaffold with well-controlled porosity [182]. 
Compressive stress–strain tests were performed on pure bioactive glass and composite 
scaffolds: the glass foams presented a step-by-step cracking characteristic of brittle 
materials, while the deformation of the gelatin-bioactive glass composite remained in the 
linear elastic regime. Besides these improved mechanical properties of the composite, its in 
vitro bioactivity was found to be as high as pure bioactive glasses. 
 
 
 
3.4.3 Carbon nanotubes (CNTs) and other carbon materials 
 
 
CNTs are allotropes of carbon composed of rolled up graphene sheets. According to the 
number of sheets concentrically aligned to form the one dimensional nanostructures, single- 
wall nanotubes (SWNTs) or multi-wall nanotubes (MWNTs) can be obtained [183]. CNTs 
present interesting and unique properties such as extreme toughness, high electrical 
conductivity and high surface area [184]; and are of interest in tissue engineering as they can 
support the building of flexible and porous structures similar to the extracellular matrix 
(ECM), environment in which cells physiologically migrate and proliferate to form tissues and 
organs [185]. Seo et al. developed a degradable membrane composed by chitosan/silica 
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incorporating functionalized-carbon nanotubes (f-CNT) for guided bone regeneration [186]. 
In their study, the incorporation of 2 % f-CNT substantially enhanced the mechanical 
properties (tensile strength and elastic modulus) of CNT/chitosan/silica membranes in 
comparison with chitosan/silica or bare chitosan membranes, while it did not have an effect 
on elongation rates. In our lab, thermosensitive chitosan gels were reinforced with chitosan 
grafted CNTs. It was found that CNTs not only increased the resistance of the gels to 
compression but, due to their thermal properties, they also had a major role in determining 
the time of gelation of the composite gels reducing it from around 1h for chitosan only gels 
to about 7-8 min [111]. Nanocomposites of the biodegradable and biocompatible polymer 
poly(propylene fumarate) (PPF) reinforced with three carbon nanostructures (SWNTs, ultra- 
short SWNTs (US-tubes) and fullerenes (C60)) were fabricated by Sitharaman et al. and the 
nanostructure size and surface area effects on the rheological properties of un-cross-linked 
PPF dispersions, as well as the mechanical properties of cross-linked nanocomposites were 
investigated as a function of the nanostructure concentration [187]. The US-tube 
nanocomposites showed the best mechanical enhancement effects. The mechanical 
properties for US-tube nanocomposites peaked at concentrations of 0.5 % and significantly 
enhanced flexural and compressive mechanical properties (up to 200%), when compared to 
the pure PPF. The study concluded that US-tubes and SWNTs contributed to better 
mechanical reinforcement than C60, due to the higher aspect ratios and larger surface areas 
suggesting that the surface area of carbon nanostructures may be a more important 
parameter than size for mechanical reinforcement. Furthermore, it was suggested that the 
fibril-like morphology of the SWNTs and US-tubes may also contribute to the improved 
mechanical properties of the nanocomposites. 
Other carbon structures have also been evaluated; Lalwani et al. compared the efficacy of 
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two dimensional (2D) carbon and inorganic nanostructures as reinforcing agents of 
crosslinked PPF composites: single-walled graphene oxide nanoribbons, multi-walled 
graphene oxide nanoribbons, graphene oxide nanoplatelets, and molybdenum di-sulfite 
nanoplatelets (MSNPs) [188]. The mechanical properties (compressive modulus, 
compressive yield strength, flexural modulus and flexural yield strength) of all the 2D 
nanostructure-reinforced nanocomposites as a function of 2D nanostructure concentration 
(between 0.01 and 0.2 %) were significantly higher in comparison to PPF. It was found that 
the mechanical reinforcement is closely dependent on the nanostructure morphology and 
follows the order nanoplatelets > nanoribbons > nanotubes. The inorganic 2D nanostructure 
MSNPs showed better mechanical reinforcement than 1D or other 2D carbon 
nanostructures. The 2D nanostructures increased the crosslinking density of PPF 
nanocomposites compared to 1D nanostructures. Accordingly the authors suggested that 
harnessing the reinforcing potential of 2D nanostructures could lead to an entire new class 
of ultra-strong, lightweight biomaterials for tissue engineering applications [188]. 
The inorganic components considered above enhance the mechanical properties leading 
to reinforcement of the scaffold structure. Although the composite strategy is very 
promising, so far the scaffolds obtained present mechanical properties far from those of the 
human cortical bone and those that would be clinically relevant. Limited literature reports 
properties such as fracture toughness, reliability, or energy to failure of the composites. 
There are studies that provide some mechanical analysis of the composites produced; 
however only few provide all the characteristics that aid interpretation and comparison of 
the data. [189]. It is necessary to develop standard procedures regarding the mechanical 
analysis of the materials, in order to facilitate the comparison between different studies and 
obtain a complete characterisation of the materials. One of the biggest remaining challenges 
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for composites it is to define and achieve the appropriate mechanical requirements of 
scaffolds for load-bearing defects. 
 
 
 
3.5 Osteoinductive composite hydrogels: controlled delivery of drugs and growth 
factors 
 
 
While a well-designed scaffold can favour new bone formation in healthy patients by simply 
providing a support for the growth of the new tissue, the compromised bone homeostasis in 
osteoporosis and other bone conditions hinders the healing process and requires the use of 
drugs and growth factors to stimulate bone regeneration activity. In many cases controlled 
and sustained release of these pharmaceutical entities is required and hydrogels present an 
ideal platform for their release. Several classes of drugs and different growth factors have 
been evaluated; these are discussed in detail below. 
 
 
 
3.5.1.1 Bisphosphonates  
 
 
Bisphosphonates (BPs) are one of the most important drug classes for treating bone tissue 
diseases such as metastatic bone disease and osteoporosis [190]. They are carbon- 
substituted pyrophosphate analogues and they reduce bone resorption, causing loss of 
osteoclastic activity and accelerating osteoclast apoptosis by inhibiting farnesyl 
pyrophosphate synthase (an enzyme in the 3-hydroxy-2-methylglutaryl-coenzyme A (HMG- 
CoA) reductase pathway) [191]. The bisphosphonates currently used in clinical practice are 
all biologically stable due to presence of a carbon atom connecting the two phosphates (P- 
C-P) [190]: alendronate, clodronate, ibandronate, risedronate and zoledronate [192, 193]. 
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Each bisphosphonate presents a certain bone binding affinity: the higher the affinity, the 
stronger the binding and slower the release and vice versa. These molecules exhibit high 
affinity for the mineralized bone matrix where they can be retained for several years, leading 
to potent pharmacological effects on the bone. The order of efficacy in inhibiting farnesyl 
pyrophosphate synthase synthase is zoledronate > risedronate > ibandronate > alendronate. 
The order in the kinetic binding affinity to hydroxyapatite (Hap) is clodronate < etidronate < 
risedronate < ibandronate < alendronate < pamidronate < zoledronate. Controlled trials have 
highlighted that BPs reduce the incidence of vertebral fractures by 40 to 50 % and non- 
vertebral fractures by 20 to 40 % [194]. Unfortunately, these drugs present some drawbacks 
when orally administered, in particular low adsorption (0.6-1.5 %) and high toxicity 
(esophageal disease, atrial arrhythmias, osteonecrosis of the jaw and atypical femur 
fractures) [195]. 
Hydrogel systems have therefore been developed to allow controlled local delivery with 
minimal invasiveness and time-persistence at the targeted area of the affected tissue. 
Despite the promising effects of these drugs, BPs local release is still poorly explored. A 
common strategy investigated for BPs controlled local delivery is to combine the controlled 
release from a biodegradable particulate system with the diffusion barrier provided by a 
hydrogel scaffold. For example, Posadowska et al. encapsulated alendronate in PLGA 
(poly(lactide-co-glycolide)) nanoparticles by a solid/oil/water emulsification method (final 
drug loading 5 %) [196]. The obtained nanoparticles (average diameter 230 nm) were then 
suspended in a gellan gum (GG) hydrogel and the hydrogel matrix was cross-linked with 
calcium ions to improve stiffness. PLGA was chosen because it is characterized by a tunable 
degradation rate and FDA-approved, while GG is a low cost anionic natural polysaccharide 
widely applied for pharmaceutical purposes. This formulation allowed obtaining a release of 
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17 % of the drug after 1 day, while the entire encapsulated drug was released within 25 days. 
Furthermore, in vitro studies confirmed cytocompatibility of the formulation with MG-63 
osteoblast-like cells and its capacity to inhibit osteoclastic differentiation. 
Furthermore, the high affinity of BPs for HAp can be exploited to facilitate controlled 
release of these drugs from hydrogel scaffolds. Verron et al. [197] formulated a suspension 
of zoledronate (Zol) granules loaded onto calcium deficient apatite (CDA-Zol) in a cellulosic- 
derived hydrogel. CDA was chosen to reinforce the osteoporotic site, while Zol to inhibit 
osteoclast resorption activity. The implantation of CDA-Zol in distal femurs of osteoporotic 
female rats showed a significant increase in bone volume fraction (BT/TV) and improved 
trabecular architecture compared to apatite alone. Further histological examination did not 
show the presence of abnormal tissue (e.g. fibrosis, necrosis, and granuloma) in the new- 
mineralised area. 
 
 
 
3.5.1.2 Statins  
 
 
 
Statins are competitive inhibitors of HMG-CoA reductase. They are generally used for 
lowering serum cholesterol, blocking the conversion of HMG-CoA to mevalonate. Hence, 
they are commonly used for treating diseases such as hyperlipidemia and arteriosclerosis. 
More recently, some studies have highlighted statins ability to increase new bone formation 
in cell cultures and in animal models [198, 199]. This anabolic effect has been firstly 
elucidated by an increased mineral density in bones of type 2 diabetes patients when treated 
with statins [200]. Bradley et al. demonstrated that these effects are associated with an 
increased expression of bone morphogenetic protein-2 (BMP-2) and nitric oxide synthase 
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[4]. However, clinical use of statins is limited by the really low systemic availability (~ 2 %) 
and serious side effects such as liver toxicity, acute hepatic failure and episodes of myalgia 
[201-204]. Hence, local delivery (via bypassing hepatic metabolism) could lead to higher 
concentrations at the bone and a reduction of the side effects. In this context, the 
formulation of an appropriate scaffold is really important to achieve appropriate release 
kinetics and a local action. Simvastatin (SIM) is recognised as the most potent statin in 
stimulating bone growth, with a biological half-life of 1-3 hours and susceptibility to 
cytochrome P450 metabolic activity [203]. This fungal metabolite induces osteoblastic 
differentiation by increasing the expression levels of osteogenic markers such as alkaline 
phosphatase, osteocalcin and osteopontin. Many studies have been carried out for testing 
different materials and developing a suitable hydrogel scaffold [205]. 
Tanigo et al. successfully obtained a controlled release of SIM from gelatin/micelles 
composite hydrogels [206]. In particular, SIM was firstly water-solubilized into lactic acid 
oligomer grafted gelatin micelles. These micelles were then loaded into gelatin hydrogels, 
with tunable degradation rate based on degree of crosslinking. The system allowed 
controlled release of SIM over 20 days and enhanced the effect of the drug on bone 
regeneration in a rabbit tooth defect model. Sukul et al. prepared a three components 
hydrogel scaffold for the controlled release of SIM composed of: β tricalcium phosphate (β- 
TCP), an osteoconductive material; nanofibrillar cellulose, a slow degrading polymer that can 
improve control over the release rate of the gel; and crosslinked gelatin as the main hydrogel 
matrix [207]. The presence of nanofibers and β-TCP produced a scaffold with 
osteoconductive properties and able to better control the drug release over a period of time 
exceeding 30 days. Furthermore, a concentration of 0.5 µM SIM was identified as the most 
effective both in vitro (highest proliferation and differentiation of rat MSCs) and in vivo in a 
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8-mm rat calvarial defect with 33% new bone formation after 8 weeks treatment (compared 
to 25 and 17% obtained with lower and higher concentrations, respectively). Another well 
studied statin for bone regeneration applications is fluvastatin. Benoit et al. explored the 
covalent binding of this drug to the gel forming polymer, as a strategy for controlled release 
[201]. They used a biodegradable poly(lactic acid) spacer to load fluvastatin to a 
poly(ethylene glycol) dimethacrylate hydrogel. The release rate of the drug was controlled 
by the length of the spacer; the longer the spacer the quicker the release due to the presence 
of a higher number of hydrolysable bonds and an increased probability of release. This 
system showed potential for controlled release over 40 days, in vitro the drug was able to 
induce hMSCs differentiation, increase BMP-2 production and facilitate calcium deposition. 
 
 
 
3.5.1.3 Growth factors  
 
 
Growth factors such as Bone Morphogenic Protein (BMP) are clinically relevant 
therapeutics for tissue regeneration in musculoskeletal conditions. However, their current 
use has shown very limited success because even though collagen scaffolds have been 
developed for the controlled release of BMP, the protein short half-life and diffusion to other 
tissues requires the use of very high doses (10 µg) rendering the treatment costly and unsafe. 
Complications such as ectopic bone formation, compromised airways function, swelling at 
surgery site and neurological side effects have all been reported in spinal fusion application 
of BMP [208, 209]. Thus developing new strategies for the formulation and delivery of these 
growth factors could address unmet clinical need for a safe use of bone inducing 
biomaterials. Furthermore, research has demonstrated that physiological bone healing 
involves several different factors released at different times (Figure 1), indicating that release 
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of a single growth factor would be an oversimplification in an attempt to mimic the 
physiological response [150]. 
As seen in the case of controlled release of smaller drugs, also for the delivery of growth 
factors, composite gels are used. The strategies for sustained release are very similar; in  
general a biodegradable or bioerodible multiparticulate system is introduced in the gel to 
further delay the release of the entrapped macromolecule. Strategies such as core-shell and 
layer-by-layer deposition are commonly used for the encapsulation of one or more growth 
factors [150]. 
The limitations of the current clinically available BMP-2 formulations have induced a lot of 
research into improving the mechanism of controlled release of this protein, to provide 
better release and address its short half-life and rapid local clearance. A commonly used 
strategy is that of exploiting the known affinity of BMP-2 for heparin therefore including 
heparin into hydrogels; a study conducted by Bhakta et al. demonstrated that both the initial 
burst, from the plain hyaluronic acid gel, and the prolonged sustained release of BMP-2, 
obtained with the addition of heparin to hyaluronic acid gels, were essential for efficient 
bone formation and suggested that a compromise between diffusion and affinity release 
must be found for best performance of the gel [210]. Chung et al. exploited the same strategy 
in their fibrin gel loaded with heparin-functionalised nanoparticles in which the presence of 
heparin was instrumental in reducing the rate of release of BMP-2 and enhance quantity and 
mineralisation of the newly formed bone in vivo [211]. Recent advances have looked at 
introducing multiple control systems, this is for example the case of a dual interaction 
nanoparticles developed by Seo et al. [212]. They proposed a hydrogel that forms in situ after 
injection of polymeric nanoparticles that bind to BMP-2 by both ionic and hydrophobic 
interactions; and demonstrated that dual interactions were essential in generating a more 
115  
effective formulation in vivo. 
 
As recently reviewed by Bayer et al., growth factor delivery is moving towards the 
sequential release of 2 factors from individual scaffolds with the release of a factor involved 
in angiogenesis in the first release phase, followed by a growth factors such as BMP-2 in a 
second release phase [150]. Table 3.1 summarises the growth factors involved in bone 
healing that have been most commonly studied for bone tissue engineering applications. 
Dyondi et al. carried out a study to investigate the effect of dual growth factor release [213]. 
They developed a gellan-xanthan gum gel loaded with chitosan nanoparticles. BMP-2 was 
adsorbed on the surface of the nanoparticles while FGF was loaded in the gel. A comparison 
between single and dual growth factor release was carried out in vivo and showed that the 
combined release of the two growth factors resulted in a higher ability to promote osteoblast 
proliferation and differentiation. Interestingly, the gels also presented antimicrobial 
properties. Doubtlessly, as demonstrated by the examples reported above, due to their 
physical and chemical flexibility, hydrogels formulations and even more hydrogels composite 
formulations, represent an essential tool in the development of controlled release systems 
for the local delivery of therapeutic molecules to the bone. 
 
Table 3.1. Growth factors employed in bone tissue engineering applications [150]. 
Growth factor Mechanism of action Limitations 
BMP-2 
 
(Bone mophogenic protein) 
Induces osteoblasts proliferation and MSCs 
differentiation. 
 
Induces VEGF-A secretion therefore has a role 
in angiogenesis1 
Needs to be delivered in a controlled 
manner 
 
Variable outcomes have been seen 
in humans 
 
Limited capacity to initiate vascular 
proliferation 
VEGF 
 
(Vascular endothelial 
growth factor) 
Induces endothelial cells mitogenesis 
 
Attracts MSCs and induces their differentiation 
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PDGF 
 
(Platelet derived growth 
factor) 
Attracts cells that stabilise growing vasculature 
Recruits MSCs 
Upregulates VEGF production 
Delivered alone they lead to the 
Inability to produce organized 
bone regeneration 
FGF 
 
(Fibroblast growth factor) 
Involved in the formation of new capillaries 
IGF 
 
(Insulin like growth factor) 
Involved in adult neo angiogenesis 
 
 
 
3.6 Osteogenic composite hydrogels 
 
 
Osteogenesis is characterised by a high number of cells compared to the mature bone 
tissue. These are osteoprogenitor cells that produce the extracellular matrix, which will 
support bone formation and will be later resorbed [214]. A good strategy to be employed in 
bone regeneration is that of recreating the environment in which osteogenesis takes place; 
this can be mimicked with a 3D hydrogel network that allows osteoprogenitor cells to 
proliferate and differentiate into osteoblasts. In fact hydrogels are able to create a complex 
and dynamic network that replicates the characteristics of the extracellular matrix providing 
physical structure, mechanical integrity and biocompatibility with the host tissue [215]. 
Studies have investigated the use of different cell types that will be considered in detail 
below [126]. 
 
 
3.6.1 Mesenchymal stem cells 
 
 
Stem cells are undifferentiated cells capable of self-renewal and differentiation into 
specialised cells [202]. Bone mesenchymal stem cells (MSCs), otherwise known as bone 
1pro- or anti- osteogenic effect can be observed depending on the type of BMP used and the type of cells targeted. 
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marrow stromal cells, are multipotent adult stem cells which can be found in the bone 
marrow [155, 200]. MSCs can proliferate in vitro and differentiate into diverse mesenchymal 
lineages (adipocytes, chondrocytes, myocytes, osteoblasts and tenocytes) in response to 
appropriate signaling by chemicals, growth factors and hormones (i.e. dexamethasone, β- 
glycerophosphate and ascorbic acid) [200, 216]. Interestingly, MSCs possess trophic factors 
that suppress the local immune system, decreasing the risk of autoimmune rejection and 
promote local vascularization [126, 217]. Moreover, they are easy to isolate from bone 
marrow and to manipulate, in fact they can be enriched to obtain a relatively pure population 
of cells and differentiate into osteoblasts that are capable of secreting extracellular matrix 
[202]. Many researches are focusing on the identification of a suitable three-dimensional 
scaffold for cell transplantation to promote the localised healing of the desired tissue. The 
aim is to develop a scaffold that is both biodegradable and injectable in order to allow the 
growth of the new tissue as degradation of the polymer scaffold occurs and to perform a 
single minimally invasive procedure [218]. However, the shortcomings of current methods 
underline the need of combining our understanding of what cell types can form bone and 
what scaffold best facilitates the differentiation of these cells [219]. Several hydrogels 
including alginate, collagen, fibrin glue, hyaluronic acid, oligo[poly(ethylene glycol) 
fumarate], pluronic F127 and silk fibroin have been studied to encapsulate MSCs and to 
promote their osteogenic differentiation [202, 220]. 
Nuttleman et al. successfully proposed the encapsulation of hMSCs into a 
photocrosslinkable, injectable scaffolding system based on a dimethacrylated PEG (MW 4.6 
kDa) as the hydrogel precursor [221]. These gels presented an excellent cytocompatibility 
(relative cell survival: 99 %) and osteogenic-specific differentiation was confirmed by the 
expression of osteonectin, osteopontin and alkaline phosphatase genes. Finally, a staining 
118  
procedure revealed extensive mineralisation of the PEG hydrogels. Dimethacrylated PEG is 
also suitable to prepare scaffolds via the novel approach of biorprinting. Gao et al. [222] 
loaded hMSCs on photocrosslinked PEG-hydrogel scaffolds enriched with natural cell binding 
motifs (Arg-Gly-Asp or RGD peptide and matrix metalloproteinase-sensitive peptide). The 
bioprinting process allowed them to condense multiple steps of scaffold fabrication into one 
single step and to obtain a matrix that leads to a homogeneous development of bone and 
cartilage. Moreover, the bioprinted PEG-peptide scaffold showed excellent mineral and 
cartilage matrix deposition and the addition of the peptides showed a sustained effect over 
time on cell differentiation compared to the polymer only gel. 
Another well studied polymer for BTE is hyaluronic acid (HA), a naturally derived, linear, 
high molecular weight polymer and one of the major components of ECM [223]. Many 
studies have been carried out in order to modify its structure, allowing the attachment of 
therapeutic drugs, functional groups, crosslinkers, and other bioactive moieties to HA [217, 
224]. Kim et al., following a similar approach to the one by Nuttleman et al. described above, 
prepared an acrylated HA hydrogel for loading BMP-2 and hMSCs [223]. The formulation had 
a gelation time of 10 min at physiological conditions; however mechanical testing (complex 
modulus 1.8 kPa, elastic modulus 1.8 kPa) revealed this hydrogel was not strong enough for 
load bearing applications. Even though the formulation presented a relatively low in vitro 
cell viability (72 % within 2 days, increased to 81 % with the addition of BMP-2), the in vivo 
results showed that it was able to induce angiogenesis and osteogenesis. The HA hydrogel 
alone demonstrated good compatibility but no activity, while the addition of BMP-2 and 
hMSCs revealed a synergistic effect with formation of thicker and denser new bone, 
compared to the hydrogels containing only one of the two components. 
Collage type I matrices are currently used in clinical practice for example for the delivery of 
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BMP-2 (InductOs); collagen is one of the most abundant fibrous proteins in the human body, 
found in tendons, ligaments, bone, teeth, skin, arteries and, in general, in extracellular matrix 
[225]. Collagen is a common tissue culture matrix due to its ability to facilitate cell 
attachment and its cell-based degradation. The ability of collagen type I hydrogels to favour 
attachment, migration and proliferation of rat bone marrow stromal cells was demonstrated 
by Hesse et al. [226]. 
Fibrin glue is another polymeric gel already exploited in the clinic, which has attracted 
interest in bone regeneration applications for the implantation of stem cells [227]. Seebach 
et al. implanted fibrin glue hydrogels loaded with rat derived MSCs into rat femoral bone 
defects to test host cell-recruitment, immunomodulation and tissue regeneration [228]. 
Results highlighted fibrin-MSC composite promoted host macrophage invasion, in 
comparison to cell-free fibrin hydrogels, due to the MSCs expression of trophic factors (e.g. 
IL-6, VEGF and MIP-2). Then, MSCs seemed to stimulate femoral bone healing, despite a light 
induction of a pro-inflammation process (TNF-α and IL-1β). 
MSCs harvesting from the bone marrow requires painful procedures of aspiration from the 
iliac crest or from bone marrow biopsies that can however give low cells yields [219]. Hence, 
due to these practical constrains, researches have focused on the use of multi-lineage 
mesenchymal progenitor cells from other sources. 
 
 
 
3.6.2 Adipose derived stem cells 
 
 
Human adipose-derived stem cells (ASCs) are a subset of MSCs that can be found in human 
adipose tissue [222]. The adipose tissue is a highly complex tissue that consists of mature 
adipocytes (90 % of the total volume) and a stromal vascular part composed by pre- 
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adipocytes, fibroblasts, vascular smooth muscle cells, endothelial cells, resident 
monocytes/macrophages lymphocytes and ASCs [223]. ASCs are an interesting cell-lineage 
for regenerative medicine since they present morphological, immunological and 
phenotypical properties similar to stem cells isolated from bone marrow and umbilical cord 
blood, with some advantages [222, 225, 226]. In fact, ASCs have the potential to differentiate 
into bone, cartilage, tendons, skeletal muscle and fat under specific conditions and they are 
easy to access and abundant in the subcutaneous adipose tissue and isolated by an 
uncomplicated enzyme-based procedure [226]. The combination of ASCs with biomaterial 
scaffolds is currently a very promising strategy for restoring tissue functions, but further 
advances are needed. 
Heo et al. [229] loaded ASCs on a photo-curable gelatin-gold nanoparticle (GNPs) hydrogel 
in order to study the effects of GNPs on stem cells. According to recent studies, GNPs have 
shown to have a positive effect on osteogenesis of MSCs and MC3T3-E1 osteoblast-like cells, 
other than presenting low costs and non-toxicity [230, 231]. In Heo’s study, the hybrid 
hydrogel was obtained by irradiation of the mixture of the photo-initiator and methacrylated 
gelatin leading to successful loading of the GNPs inside the hydrogel network. Assays showed 
an increase in viability and osteogenic differentiation of ADSCs in comparison with the 
hydrogel only and similar results in comparison with BMP loaded hydrogel, both in vivo and 
in vitro. Moreover, all the studied hydrogels had a positive effect on bone healing in the 
defect sites and were biologically degradable by collagenase. 
Graphene, a two dimensional carbon structure that presents unique physical properties 
such as high surface area, high mechanical strength, high electrical conductivity and ease of 
functionalization has been recently reported to be able to form hydrogels and to promote in 
vitro osteogenic differentiation and proliferation of stem cells [229, 232, 233]. Lyu et al. 
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examined the osteoinductivity of hADSCs loaded self-supporting graphene hydrogels (SGH) 
obtained by electrostatic stabilization of graphene and its gelation  by  filtration  [234-  236]. 
They found that in comparison to conventional graphene and carbon fibre films, SGH films 
had higher mechanical strength, flexibility, cell viability (after one day culture, 95.43 % 
± 0.96 %), mineralisation and osteoinductivity. This finding opens new avenues in the 
development of hydrogels for bone regeneration applications. 
 
 
 
3.6.3 Stem cells from human exfoliated deciduous teeth 
 
 
Stem cells from human exfoliated deciduous teeth (SHEDs) have been recently identified 
as an alternative source of multipotent adult stem cells because of their capacity to 
differentiate into various cell lineages: neural cells, odontogenic cells, osteogenic cells and 
adipocytes [235, 236]. Moreover, they were reported to have a higher proliferation rate 
compared to MSCs and dental pulp stem cells and to be easier and more convenient to 
isolate [235-237]. Unfortunately, few studies about the loading of SHEDs into hydrogels have 
been published until now, underling the importance of further research in this field. 
Su et al. [236] investigated the effects of chitosan/gelatin/β-glycerophosphate 
thermosensitive hydrogels containing strontium phosphate or tricalcium phosphate (TCP) on 
the osteogenic differentiation of SHEDs in vitro. Strontium has been added to the scaffold 
since it is a molecule that has shown to positively influence bone formation by improving 
bone formation and inhibiting bone resorption [238, 239]. Scanning electron microscopy 
analysis revealed all the studied hydrogels presented homogenous porous structures (100 
µm-300 µm) with high interconnected channels that had high cytocompatibility. 
Nevertheless,   the    presence    of    bioceramic   supplements,    allowed    cells continuous 
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proliferation for longer cultivation times (14 days). Strontium hydrogels also significantly 
increased calcification and expression of osteogenic genes compared to tricalcium 
phosphate. 
 
 
3.6.4 Embryonic stem cells 
 
 
Embryonic stem cells (ESC) are pluripotent stem cells derived from the inner cell mass of 
blastocysts and they can differentiate to form cell populations derived from ectoderm, 
mesoderm and endoderm, hence any cell type [240]. They possess a nearly unlimited self- 
renewal capacity and their growth is not restricted by contact inhibition and proliferative 
senescence. As reported by Li et al., ESCs are a promising cell source for regenerative 
medicine, even though some challenges need to be overcome, such as achieving large-scale 
expansion culture systems, mainly due to the involvement of animal components [241, 242]. 
Even though the propagation of embryonic stem cells has usually been carried out in two- 
dimensional (2D) systems, 3D scaffolds would facilitate convenience in transplantation and 
consistency in cell performance and scalability in number [243]. Hence, the use of natural 
and synthetic hydrogels for hESC propagation in 3D has been proposed [243-247]. However, 
the study of ESCs properties and propagations on hydrogels for bone tissue engineering 
needs to be further explored. 
Zur Nieden et al. studied the chemical modification of gelatin hydrogels through 
glyceraldehyde cross-linking to provide a suitable scaffold for ESC osteogenesis [215]. On one 
hand, gelatin was used as the main component of the matrix for its desirable properties: low 
toxicity, easy sterilization and limited higher ordered protein structure. On the other hand, 
glyceraldehyde is an ideal cross-linker since it is non-toxic and makes gelatin stable at 37°C. 
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The obtained gel was able to provide an initial soft non-adhesive surface for promoting the 
formation of embryoid bodies and to provide a harder surface that gradually disappeared as 
osteoblasts differentiated. 
 
 
 
3.7 Concluding considerations 
 
 
The wealth of research into hydrogels formulations for bone regeneration applications 
demonstrates the great potential of these systems. Hydrogels fulfil many of the 
requirements of ideal scaffold such as injectability, biocompatibility, biodegradation, etc.; 
furthermore, they can easily be chemically modified or co-formulated with other 
components that bestow further properties such as osteoconduction, osteoinduction and 
oesteogenicity. The great majority of hydrogels are composed of polysaccharides and their 
capacity of functioning as diffusion barrier for both small and large molecular weight drugs 
has been widely exploited for controlled drug delivery applications. All proposed systems 
seem to provide incremental improvements on the performance of the hydrogels but 
perhaps the development of fundamentally innovative ideas is the key to move to clinically 
applicable formulations. Approaches such as bioprinting or the development of 
fundamentally new hydrogels such as those formed by graphene oxide could open novel and 
more promising avenues towards the successful clinical use of composite hydrogels for bone 
regeneration. 
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Abstract 
 
Notwithstanding the considerable attention attracted by one-dimensional nanostructures 
such as silver nanowires (AgNWs) due to their outstanding electrical, thermal and 
antimicrobial properties, their application in bone tissue regeneration has not been explored 
yet. Here, we report on the development of an innovative scaffold prepared from chitosan, 
hydroxyapatite and AgNWs (CS-HACS-AgNWs) having both bioactive and antibacterial 
properties. In vitro analysis highlighted the antibacterial potential of AgNWs against both 
gram- positive and gram-negative bacteria. The CS-HACS-AgNWs composite scaffold 
demonstrated suitable Ca/P deposition, gel strength and gelation time. Further antibacterial 
studies showed that the composite formulation was capable of inhibiting bacterial growth in 
suspension and preventing biofilm formation on the scaffold. 
Finally, the hydrogels revealed their potential to serve as platforms for cell proliferation and 
differentiation. In summary, the developed CS-HACS-AgNWs composite hydrogel 
demonstrated potential as a scaffold material to be employed in regenerative medicine; it 
allows cell proliferation while decreasing the risk of infections. The results presented justify 
further investigation into clinical applications. 
 
 
4.1 Introduction 
 
Over the last few decades, significant advancements in the synthesis and characterisation 
of one dimensional (1D) nanostructured materials have led to novel applications in various 
fields such as material science, energy technologies, engineering and biomedical science. A 
wide range of nanostructures, such as nano-tubes, -fibres, - filaments, -whiskers, -horns, - 
needles, -ribbons, -wires are classified as 1D nanostructures [100] that are all characterised 
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by a high aspect ratio[15, 91]. These structures present remarkable variation in electrical, 
optical andmagnetic properties when compared to the bulk materials due to their reduced 
dimensions, controlled structure and large surface-to-volume ratio[184]. The carbon and 
metal silver variants are of particular interest3,[89]. 
Silver one, two and three-dimensional nanostructures have been synthesised, with many 
studies focusing on silver nanowires (AgNWs). AgNWs are anisotropically grown to obtain an 
aspect ratio higher than 10 and are typically 10-200 nm in diameter and 5-100 µm in 
length[15]. To date, silver nanoparticles (AgNPs) have been much more extensively studied 
than AgNWs, and their distinctive high thermal and electrical conductivity, surface-enhanced 
Raman scattering, chemical stability, catalytic activity and non-linear optical behaviour have 
been highlighted; as well as their antibacterial activity that has extended their usage into 
several biomedical fields[89]. They are promising agents against a wide range of fungi, 
viruses and bacterial species; even though the mechanism of action is still not entirely 
understood, it is believed that nanosilver serves as a source for Ag+ ions that can rupture 
microbial cell walls, denature proteins, block cell respiration and eventually induce cell 
death[248]. AgNPs have been used as antimicrobial agents in wound dressing [249], coating 
of catheters [250] and of cardiovascular implants[251], bone cements [252] and dental 
materials [253]. Currently literature on biomedical applications of AgNWs is still limited [91], 
emerging applications include textiles [31], wound coatings [45], drug release and tissue 
regeneration[69]. In the present work, for the first time, we explore the potential use of 
AgNWs in composite materials for bone regeneration. Bone defects remain a major problem 
in orthopedics given to the deficiencies of current commercially available bone grafts and 
alternative materials are needed [254]. Hydrogels - 3D, hydrophilic, cross- linked polymeric 
networks that resemble the extracellular matrix with a porosity and aqueous environment 
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that allows transportation of substances such as nutrients - are very good candidates to 
overcome these obstacles. The main challenge within the field is to produce a bioactive and 
non-toxic hydrogel scaffold with sufficient mechanical strength [111, 254]. Chitosan (CS), a 
polysaccharide that is biocompatible, biodegradable and possesses antibacterial properties 
has been employed to formulate such scaffolds, however, it has poor mechanical properties 
and has inferior bone induction capability [255]. Our previous work has focused on the 
development of reinforced bioactive CS scaffolds containing hydroxyapatite (HA), which 
favours biomineralisation of the scaffold, and carbon nanotubes that provide mechanical 
enhancement[255]. The present work aims at substituting carbon nanotubes with other 1D 
nanostructures, namely AgNWs that afford the two-fold advantage of mechanically 
reinforcing the hydrogel structure while enhancing its antibacterial properties. In fact, the 
success of bone-defect surgical treatment can often be compromised by bacterial infection 
that may result in chronic inflammation, implant failure and even death [3, 256]. To date, 
few studies have been carried out to evaluate the antibacterial properties of AgNWs 
alone[91], and very limited work has been done in the investigation of their activity within 
composite materials. Here, we present the synthesis via the polyol method and full 
characterization of AgNWs, followed by the in vitro characterisation of the composite 
hydrogels containing the nanowires with particular emphasis on the antimicrobial, bioactive 
and biocompatible, properties of the scaffolds. 
 
 
 
 
 
4.2 Materials and methods 
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4.2.1 Materials 
 
Yeast extract for microbiology, tryptone enzymatic digest from casein, sodium chloride, 
agar, glycerol phosphate disodium salt hydrate, poly(vinylpyrrolidone) powder (55 kDa), 
chitosan from shrimp shells low viscosity (degree of deacetylation ~85%, calculated by 1H- 
NMR), phosphate buffered saline tablets, TRIS base, lysozyme from chicken (hen egg-white), 
silver standard for AAS, 10% fetal bovine serum, trypsin-EDTA 0.25% solution, antibiotic 
antimycotic solution, β-glycerophosphate, ascorbic acid, sucrose, haematoxylin/eosin and 
Eukitt were purchased from Sigma-Aldrich (Irvine, UK). Isopropanol, glycerol 99% and L-(+)- 
lactic acid 90 % were purchased from Acros Organics (Geel, Belgium). N,N- 
dimethylformammide, silver nitrate, sodium hydrogen carbonate, potassium chloride, 
magnesium chloride hexahydrate, hydrochloric acid 37%, calcium chloride dehydrate, 
sodium sulphate hydrate, sodium dihydrogen phosphate dehydrate and calcium chloride 
dehydrate were purchased from Fisher (Loughborough, UK). Di-potassium hydrogen 
phosphate anhydrous was purchased from BDH (VWR, Lutterworth, UK). Glutamax and BCA 
Protein Assay Reagent Kit were purchased from Thermo Fisher (Basingstoke, UK). Alkaline 
Phosphatase Assay kit was purchased from Abcam (Cambridge, UK). ATPlite Luminescence 
ATP Detection Assay System was purchased from PerkinElmer (Coventry, UK). OCT cryostat 
embedding medium (Tissue Tek®) was purchased from VWR (Lutterworth, UK). The 
osteoblastic cell line MC3T3-E1 was purchased from DSMZ (Leibniz-Institut DSMZ-Deutsche 
Sammlung von Mikroorganismen und Zellkulturen GmbH). Alpha-minimal essential medium 
(α-MEM) was from Life Technologies (Baltimore, US) and fetal bovine serum and 
penicillin/streptomycin were obtained from FBS Sigma (ST. Louis, US). 
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4.2.2 Synthesis and physicochemical characterisation of Silver Nanowires (AgNWs) 
 
AgNWs were synthesised via the polyol method, using silver nitrate (AgNO3) as the Ag 
source [257]. PVP (3 g) was fully dissolved in glycerol (95 ml) by heating to 80 °C. The solution 
was cooled down and AgNO3 (0.79 g) was added under vigorous stirring (800 rpm) until the 
powder was fully dissolved. Subsequently, NaCl (5 mM in final solution) was mixed into 10 
ml of glycerol and added to the PVP/glycerol solution. The reaction temperature of the 
mixture was raised to 210 °C. Once the temperature was reached, it was maintained for 
further 10 min. Samples (1 ml) were taken at different temperatures, diluted with water and 
analysed by UV (300-900 nm, Thermo Scientific Nicolet Evolution 100 UV-Visible 
Spectrophotometer) to follow the formation of the AgNWs. Finally the reaction was cooled 
down to room temperature, diluted 1:1 with deionized water and centrifuged (4000 rpm, 1 
hour), the pellet was then washed twice with isopropanol (4000 rpm, 30 min) and twice with 
deionized water (4000 rpm, 10 min). The product was stored in deoxygenated purified water 
at room temperature, protected from light. Freeze dried AgNWs were suspended in chitosan 
solutions (1%, in lactic acid 0.1 M), to achieve different concentrations (0.5-1 mg/ml), by 
vortexing and sonicating for several min. These were spread onto SEM specimen stubs and 
dried for 2 days under vacuum. Samples were gold-coated with a Polaron e500 (Quoram 
Technologies, UK) sputter coater and analysed with a Jeol JSM-6160L scanning electron 
microscope with electron backscatter. For TEM Imaging AgNWs were suspended in water 
(0.1 mg/ml in water) and dropped onto TEM grids (Formvar/Carbon 300 Mesh Copper) (Agar 
Scientific, UK) and allowed to dry at room temperature and pressure. Dry grids were stored 
in sealed petri dishes in a desiccator until analysis by JEOL JEM-1400 TEM (JEOL, USA). SEM 
images were analysed with ImageJ to determine the size distribution of the wires obtained. 
AgNWs have been measured 3 times each. The crystal structure of AgNWs was determined 
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with a Bruker D2-Phaser diffractometer. Instrumental parameters were: CuKα radiation, 
30kV, 10 mA, LynxEye PSD detector with an angular opening of 5°, 2θ range 6-84°, step size 
0.020°, time per step 2 s, spinner 15 rpm. The alignment of the instrument was calibrated 
using an international standard (NIST 1976b). A low-background silicon crystal specimen 
holder (Bruker) was used. The analysis was performed at room temperature (25°C). The XRD 
pattern was evaluated using the software Bruker EVA 14.2 (DIFFRACplus Package) coupled 
with the database PDF-2 (ICDD). Finally, AgNWs were analysed for size and zeta potential by 
photon correlation spectroscopy (Malvern Zetasizer Nano-ZS, Malvern Instruments, 
Worcestershire, UK). 
 
 
 
 
4.2.3 Formulation and characterisation of hydrogels 
 
Chitosan based hydrogels were formulated according to the composition listed in table 4.1, 
following the method previously described by Cancian et al. [255]. The freeze dried scaffolds 
were stored in a desiccator until further use. Gelation time was assessed using the inverted 
tube test, as described by Ganji et al. [258]. Formulations were prepared as described above 
but in 2 ml aliquots; after the addition of GP, the composites were vortexed (2 min) and stored 
at 4°C for 12 h to remove air bubbles. The vials were then incubated at 37°C in a temperature 
controlled bath (Grant, SUB Aqua Pro). The sol-gel transition was determined by inverting 
the vials horizontally; the time at which the gel stopped flowing was recorded as the gelation 
time. 
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Table 4.1. Components used in the formulation of each millilitre of hydrogel. 
 CS hydrogel CS-HACS CS-HACS-AgNWs CS-AgNWs 
 Lactic acid (0.1 M) 0.9 ml 0.9 ml 0.9 ml 0.9 ml 
 
Chitosan 
 
20 mg 
 
20 mg 
 
20 mg 
 
20 mg 
 
HACS 
 
-- 
 
8.6 mg 
 
8.6 mg 
 
-- 
 
AgNWs (powder) 
 
-- 
 
-- 
 
4 mg 
 
4 mg 
 
GP (1.12 g/ml) 
 
0.1 ml 
 
0.1 ml 
 
0.1 ml 
 
0.1 ml 
 
 
Texture profile analysis was performed by a texture analyser (XT plus, Stable Micro Systems 
Ltd, UK) depressing a polycarbonate probe (10 mm dia) into the gels at 1 mm/s and to a 
depth of 5 mm, six measurements were taken at room temperature before and after the 
sol/gel transition took place. Force/distance curves were obtained and the maximum force 
value recorded was reported as gel strength (N). Equilibrium of swelling was determined on 
freeze-dried hydrogels, weighed and allowed to swell in PBS (15 ml, pH=7.4) at 37°C. At 
different time points, the hydrogels were removed from the buffer and weighed, after 
removing excess liquid. The experiment (carried out in triplicate) was continued until 
equilibrium was reached. The swelling ratio (Q) was calculated according to equation: 
 
 
𝑊𝑠−𝑊𝑑 
Q(%) = ( 
𝑊𝑑 
) x 100 
 
 
 
 
where Ws and Wd represent the weight of the swollen and dry state samples, respectively. 
The porosity of the scaffolds was determined on dried gels according to the methods 
described by Nanda et al.[259]. The in vitro degradation of pre-weighed dried scaffolds was 
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carried out in 5 ml sterile phosphate-buffered solution (PBS, pH 7.4) containing 1.0 mg/ml 
lysozyme. The PBS/lysozyme solutions was changed every 3-4 days. The 50 ml sterile flasks 
were incubated at 37°C with gentle mechanical agitation for the period of study (80 rpm). 
After 7, 14 and 21 days, samples were removed from the medium, rinsed with distilled water, 
freeze dried and weighed. The experiment was carried out in triplicate. The extent of in vitro 
degradation was calculated using the following equation: 
 
 
Mass loss (%) = ( 
𝑊𝑖−𝑊𝑑 
𝑊𝑑 
) x 100 
 
 
 
where Wi  is the initial weight of the scaffold and Wd  is the weight of the scaffold after the 
 
degradation  experiment.  In vitro calcification  studies  were  performed to  investigate the 
 
ability of the composite hydrogels to induce calcium salts deposition. Simulated body fluid 
 
(SBF) was prepared according to Kokubo and Takadama [260]. The freeze dried samples were 
 
submerged  into  15  ml of  SBF  and incubated  at 37  °C for 7, 14  and 21 days;  the SBF was 
 
changed  every  4  days.  Finally,  samples  were  freeze  dried.  Controls  were  hydrated  in 
 
deionised water for 5 h and dried as above. All samples were analysed by SEM (as described 
 
above), coupled with EDS (Silicon Drift Detector (SDD)—X-MaxN, Oxford Instruments, UK). 
 
EDS images for calcium (Ca) and phosphorus (P) were analysed using ImageJ 3D Viewer after 
 
being overlaid to the corresponding SEM images. The total area of Ca and P overlapping onto 
 
the total sample surface area was used to calculate percentage of Ca and P salt deposition 
(n = 3). In order to further explore the overall salt deposition within the scaffolds micro-CT 
was used. Non-coated scaffolds were scanned with the microCT scanner (Versa 510, Zeiss, 
CA) set to a voltage of 40 kV and a current of 76 μA. An isotropic voxel size of 4.077 μm and 
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exposure of 3 s were used. The images were then analysed using ImageJ (v1.50, NIH, USA) 
as described by Cancian et al. [255] and Fig. 4.6. 
 
 
 
 
4.2.3.1 Ag+ release studies  
 
 
Silver cation release kinetics was evaluated. Dried AgNWs and freeze-dried hydrogels were 
soaked in HPLC- grade water. Then, they were transferred to a water bath maintained at 
37°C, with shaking (90 rpm). At scheduled times, the AgNWs in water were centrifuged at 
2000 rpm for 3 min (this step was not required for CS-HACS-AgNWs) and 1 ml of supernatant 
was taken and substituted with 1 ml of fresh water. The concentrations of silver ions were 
determined by a furnace atomic absorption spectro-photometer (Varian SpectrAA 220FS) at 
a wavelength and spectral bandwidth of 328.1 and 0.2 nm, respectively. The experiment was 
carried out in triplicate. 
 
 
 
 
 
4.2.4 Antimicrobial activity of AgNWs 
 
 
 
The antibacterial activity of AgNWs was examined by a suspension assay against gram- 
 
negative  Escherichia  coli  (ATCC  25922)  and  gram-positive  Staphylococcus  aureus (ATCC 
 
25923),  Methicillin-resistant   Staphylococcus  aureus   (ATCC  12403)  and   Staphylococcus 
 
saprophyticus (ATCC 15305). The bacteria were transferred from -80°C (15 % glycerol) into 5 
ml of fresh sterile LB medium by a sterile toothpick and incubated (at 37°C and 200 rpm) until 
the bacterial suspension was cloudy (1 day for E.coli and S. aureus, 2 days for MRSA and 3 
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days for S. saprophyticus) (MaxQ™ 8000, Thermo Scientific). Then, 50 µl of bacterial 
suspension were transferred into 5 ml of fresh sterile LB medium and the bacteria were 
further incubated at 37°C until the suspension was newly cloudy (1 day for E. coli, S. aureus 
and MRSA and 2 days for S. saprophyticus). 1x106 CFU/ml of cells (equal to an OD600nm of 
0.001) were grown in 50 ml of liquid LB medium supplemented with 12.5, 25, 50 and 100 
µg/ml of AgNWs. The stock suspensions of AgNWs were prepared the day before the use 
and stored at 4°C. This was accomplished by firstly weighing the dried AgNWs and finally 
resuspending them in sterile LB by sonication (40 kHz, CamLab) until the suspension was 
homogeneous. This step ensured the sterilization of the AgNWs suspension due to high 
frequency ultrasounds. Pure medium with bacterial cell inoculation and pure LB served as 
controls. Growth rates and bacterial concentrations were detected by measuring the optical 
density (OD600 nm) of the inoculated LB broth medium at 600 nm at different time points. 
Different concentrations (12.5, 25, 50 and 100 µg/ml) of the stock AgNWs suspension and 
pure LB were used as blanks. The experiment was carried out into autoclaved 250 ml glass 
flasks at 37°C and 200 rpm. 
 
 
 
 
 
4.2.5 Antimicrobial activity of composite hydrogels 
 
 
The antibacterial activity of CS-HACS and CS-HACS-AgNWs scaffolds was examined by a 
 
The  scaffolds were 
 
sterilized by firstly submerging them in 70% (v/v) ethanol for 15 min and then  rinsing them 
 
three times with sterile PBS. Finally, they were autoclaved in LB and sonicated for 15 min at 
 
40 kHz before discarding the LB. All the scaffolds were then placed into 2 ml of 1x105 CFU/ml 
suspension assay against the micro-organisms listed in section 2.4. 
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cell suspension in 14 ml glass vials and analysed as described below. 
 
 
 
 
 
 
4.2.5.1 Biofilm formation assay  
 
 
For the determination of biofilm formation, after incubation at 37°C and 100 rpm for 24 
hours, the hydrogels were gently soaked in PBS for 10 seconds to remove loosely adherent 
bacteria and subsequently fixed in paraformaldehyde (4% in PBS) overnight, before being 
washed in PBS (3 times) and soaked into 5%, 10%, 20% (2 hours) and 30% (overnight) sucrose 
solutions. The scaffolds were transferred into aluminum cases and embedded into optimal 
cutting temperature compound (O.C.T.). Then, they were rapidly frozen into a beaker 
containing pentane, submerged into liquid nitrogen. The hydrogels were stored at -80°C until 
cryosectioning. The hydrogels were cut into 7-9 μm slices. The slices were placed onto poly- 
L-lysine coated slides. The sections were air-dried for 30 min and stored at -20°C until 
staining. Prior to staining, the sections were washed with deionized water for 1 hour and 
stained with carbol fuchsin (for gram-negative cells) or crystal violet (for gram- positive cells). 
Slides were stained for 1 minute and then washed with running deionized water for 5 min. 
The slides were left to dry and observed with an optical microscope (GXM-L1500BHTG, 
GTVision, UK). 
 
 
4.2.5.2 Antimicrobial testing of the dried hydrogels  
 
 
To test the antimicrobial properties of the scaffolds, these were prepared as above but 
 
samples of the incubation medium were taken at scheduled times (3, 7 and 24 hours), the 
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washed with sterile PBS (1 ml) vortexing for 30 seconds. The last step was done for collecting 
 
the not fully attached bacteria. The PBS solution was then transferred into the 15 ml tube. 
 
 
sterile 2 ml tubes and plated in triplicate on LB agar plates (100 µl per plate). After static 
 
 
forming units (CFUs) were manually counted. Controls were prepared with: LB only; scaffolds 
 
and LB; and individual bacteria in LB only. 
 
 
 
4.2.6 Cell culture studies 
 
 
The osteoblastic cell line MC3T3-E1 was cultured with proliferation medium composed of 
α-MEM containing 10% fetal bovine serum and 1% penicillin/streptomycin. Cells were grown 
at 37°C in a humid atmosphere with 5% CO2. Medium was refreshed three times a week. 
Freeze-dried hydrogels were hydrated for 5 min, then immersed in 70% ethanol, washed 
with phosphate buffer saline (PBS) four times, transferred into a 24-well plate, and irradiated 
with UVA light overnight. Samples were equilibrated in proliferation medium for 1 h, the 
medium was then removed and 1.8x104 cells were seeded in each well in osteogenic 
differentiation medium which contained α-MEM without nucleosides, 10% FBS, 1% 
penicillin/streptomycin, 1% glutamax, 10 mM β- glycerophosphate, 50 µg/ml ascorbic acid 
and 10 nM dexamethasone. After 7 and 14 days from seeding, cell proliferation, and 
differentiation were evaluated. Cell viability was assessed using the Luminescence ATP 
Detection Assay according to the manufacturer’s instructions. Briefly, substrate solution was 
added to cell lysates and the luminescence was measured with VICTOR3 1420 Multilabel 
bacterial suspensions were transferred into a sterile 15 ml tube and the scaffolds were 
The total collected bacterial suspension was serially diluted in PBS (from 10-1 to 10-15) into 
incubation for 18 hours at 37 °C (HeraTherm Incubator, Thermo Scientific) the colony 
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Counter (PerkinElmer). Counts per seconds were converted in cell number by using a 
standard curve previously obtained with known cell numbers (from 104 to 105 cells). The 
detection of ALP activity was carried out by using the Alkaline Phosphatase Assay kit, 
following manufacturer’s instructions. Briefly, cell lysates were centrifuged and supernatants 
were treated with 5mM p-nitrophenyl phosphate in the dark. Optical density (OD) was 
revealed at 405 nm by using the EL 311 SX microplate autoreader (BioTek Instruments, Inc., 
Winooski, VT, USA). OD values were converted in nanomoles of ALP by using a standard curve 
previously obtained with known ALP quantities (from 4 to 20 nanomoles). Protein content of 
each samples was analyzed with a BCA kit. Finally, results were expressed as nM ALP/µg 
protein. 
 
 
 
4.2.7 Statistical analysis 
 
 
Statistical analysis has been performed and is detailed in each figure caption. 
 
 
 
4.3 Results 
 
 
4.3.1 Synthesis and physicochemical characterisation of silver nanowires 
 
 
 
AgNWs were successfully synthesised using the polyol method. During the synthesis, as the 
temperature was increased, a typical change in colour from clear to yellow, then orange, red, 
grey and green was observed (Fig. 4.1A). This correlated to the changes in the UV-Vis 
spectrum with increasing temperatures (Fig. 4.1B). As can be seen in Fig. 4.1B, below 180°C 
a peak was present at 410 nm, this is due to the surface plasmon resonance (SPR) signal of 
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Ag nanoparticles and nanorods that initially form as nucleation sites for the growth of 
nanowires. As the temperature increases, peaks appear at 350 and 380 nm, these are 
attributed to the formation of Ag nanowires, as confirmed by SEM (Fig. 4.1C)[261]. UV-vis 
spectra just show the range The XRD pattern (Fig. 4.1D) confirmed the formation of face- 
centered cubic metallic Ag. In fact the d-values perfectly matched to PDF Number 04-0783 
(Silver-3C, syn); also the intensity of the peaks corresponded, except for (111). In the card 
04-0783, the (111)/(200) intensity ratio is 2.5, whereas in our pattern was 3.4 indicating the 
formation of well-elongated AgNWs [262, 263]. Minimal trace impurity of AgCl (PDF No. 31- 
1238, Chlorargyrite) can be seen at 2θ 32.2° and 46.2° (Fig. 4.1D), an aspect sometimes 
reported in the synthesis of AgNWs. Thus, our AgNWs synthesis product was mainly 
composed of metallic silver, even though small traces of ionic silver were found, indicating 
that both the synthesis and the washing steps were efficient enough to guarantee a nearly 
pure product. We also studied the morphology of AgNWs obtained at the end of the 
synthesis. They had an average length of 5.03 ± 1.85 µm and an average diameter of 99.45 ± 
20.20 nm (See Supplementary Fig. S4.1), as determined by analysing SEM images with 
ImageJ. These dimensions are in good agreement with those reported by Yang et al. [257]. The 
zeta potential of AgNWs in deionized water was found to be -10.88 ± 1.86 mV, indicating 
their tendency to aggregate in aqueous media. 
139  
 
 
 
Figure 4.1 Physicochemical characterization of AgNWs: (A) Typical colour of the reaction mixture at different 
temperatures; (B) the corresponding UV spectra; (C) SEM image of AgNWs suspended in a solution of chitosan 
in lactic acid; (D) XRD pattern of the synthesised AgNWs (red bars: Ag, PDF No. 04-0783; blue bars: AgCl, PDF 
n. 31-1238). 
 
 
TEM images highlighted that even though the majority of the reaction product was 
composed of AgNWs, traces of other nanoparticles (e.g. nanorods and nanospheres) were 
present, suggesting that longer reaction times would be necessary to fully complete the 
reaction (Fig. 4.2A and 4.2B). 
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Figure 4.2 TEM photos of AgNWs. (A) Lower magnification image of AgNWs (scale bar 500 nm); (B) higher 
magnification image of AgNWs (scale bar 100 nm). 
 
 
4.3.2 Characterisation of composite gels 
 
 
 
AgNWs were used to formulate composite chitosan gels; the thermosensitive gels were 
composed of chitosan crosslinked with glycerol phosphate and mixed with a 
chitosan/hydroxyapatite composite (HACS), previously described 18. A significant reduction 
in time of sol/gel transition was observed on addition of the HACS composite to the chitosan 
gel (from 12.0 ± 3.3 min to 3.2 ± 0.4 min; p = 0.000007; Fig. 4.3A), no further significant 
change was observed on addition of AgNWs. When only AgNWs were added a non-significant 
(p =0.582796) reduction to 10.3 ± 2.4 min was observed (see Supplementary Fig. S4.2). 
AgNWs induced a further significant increase in gel strength (to 0.138 ± 0.005 N, p = 0.005068) 
after the increase initially observed  on  addition of  HACS  (from 0.035 ± 0.001 N to 0.089 ± 
0.024 N, p = 0.002747; Fig. 4.3B). Also AgNWs alone were able to significantly increase the 
strength of the chitosan gel (to 0.136 ± 0.001 N, p = 0.000034, see Supplementary Fig. S4.3). 
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Figure 4.3 Physical characterisation of the hydrogels: CS (black), CS-HACS (light grey) and CS-HACS-AgNWs 
(dark grey). (A) Gelation time calculated by the inverted tube method. Data are reported as mean ± SD (n = 9). 
One-way ANOVA returned p < 0.0001. Post-hoc Tukey’s comparison test results are shown in the graph: **** 
indicates p < 0.0001 as compared to the control (CS). (B) Gel strength calculated by texture analysis before 
(empty bars) and after (filled bars) gelation. Data are represented as mean ± SD (n = 3). The t-test performed 
on all samples before and after gelation showed significantly different strength values for all gels ($$ indicates 
p < 0.01 and $$$$ p < 0.0001). One-way ANOVA to compare the different formulations returned p < 0.01 before 
and p < 0.0001 after gelation. Post-hoc Tukey’s test results showed that before gelation only CS is different 
from all other gels (# p < 0.05), while the individual results for after gelation are reported on the graph (** p < 
0.01; **** p < 0.0001). 
 
 
Equilibrium swelling provides an idea of the maximum amount of water a hydrogel can 
absorb once in contact with a liquid. Addition of HACS significantly increased the total amount 
of water absorbed at equilibrium from 47.5 ± 8.4 % to 93.5 ± 34.7 % (p = 0.019271, Fig. 4.4A), 
this is likely due to the significant increase in porosity from 14.5 ± 3.6 % to 26.3 ± 1.9 % (p = 
0.002538, Fig. 4B) and/or to a higher interconnectivity within the scaffold and/or a higher 
number of available hydrophilic groups. 
Degradation studies have been performed to understand what factors affect the 
degradation of the composite hydrogels (see Supplementary Fig. S4.4). In the degradation 
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experiment, control hydrogels were incubated in PBS for three weeks and an initial weight 
loss was observed at 7 days. This was then maintained (p > 0.05) for the duration of the three 
weeks, indicating that an initial weight loss due to solubilisation of lightly crosslinked chains 
is likely to happen in the first week after implantation, however in absence of enzymes, this 
degradation does not proceed (Fig. 4.3C). A smaller weight loss was observed for CS-HACS (p 
= 0.876728) and CS-HACS-AgNWs (p = 0.003344) at 7 days, confirming that enhanced 
crosslinking is present in these composites. An unchanged residual weight was recorded also 
for these two composites at two and three weeks. When lysozyme was added, CS gels 
showed significantly increased degradation during the three weeks with a final total weight 
loss of 91.7 ± 7.1 %. A similar pattern was observed also for the composite gels, for a 
significant weight loss was observed after three weeks. At all-time points, the weight loss of 
CS-HACS-AgNWs was significantly lower (p < 0.01) than both CS and CS-HACS gels. 
Biomineralisation of hydrogels was studied soaking them in SBF for three weeks to evaluate 
Ca\P deposition by SEM-EDS. A significant increase in Ca/P deposit was observed after 3 
weeks of incubation of hydrogels in simulated body fluid (SBF), this was particularly true for 
CS-HACS hydrogels (Fig. 4.4D and Fig. 4.5). This was expected as the already present 
hydroxyapatite can function as nucleation site for the deposition of calcium salts [111]. On 
the other hand, the absence of hydroxyapatite in CS gels lead to a non-significant deposition 
of salts (p > 0.05). 
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Figure 4.4 Further physical characterization, enzymatic degradation and bioactivity determination of 
hydrogels: CS (black), CS-HACS (light grey) and CS-HACS-AgNWs (dark grey). (A) Equilibrium swelling (Q%); data 
are reported as mean ± SD (n = 6). One way ANOVA returned p < 0.05, results of the post-hoc Tukey’s 
multicomparison test are reported in the graph (* p < 0.05). (B) Gels porosity determined by gravimetric 
method; data are reported as mean ± SD (n = 3). One way ANOVA returned p < 0.05, results of the post-hoc 
Tukey’s multicomparison test are reported in the graph, (* p < 0.05 and ** p < 0.01). (C) Gels degradation in 
the presence of lysozyme (full bars), the empty bars represent the relative control gels treated in PBS; data are 
reported as mean ± SD (n = 3). One way ANOVA returned p < 0.05, results of the post-hoc Tukey’s 
multicomparison test are reported in the graph (# p < 0.05). A t-test was performed against the control for each 
gel at each time point; * p < 0.05, ** p < 0.01 and *** p < 0.01. (D) Percentage surface calcification of hydrogels 
incubated at 37°C in SBF for 7, 14 and 21 days as calculated by image analysis via ImageJ and BoneJ. Controls 
were only incubated for few hours in deionised water. Results are reported as mean ± SD (n = 3). Samples 
labelled with the symbol # resulted to be significantly different from their control sample (p < 0.05). One way 
ANOVA returned p < 0.05 only when testing CS-HACS at different time points, the results of the post-hoc Tukey’s 
multicomparison test are reported in the graph (* p < 0.05, ** p < 0.01). 
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Figure 4.5 EDS coupled SEM images (1000x magnification) of CS, CS-HACS and CS-HACS-AgNWs hydrogels 
incubated in SBF for 7, 14 and 21 days and controls. The yellow colour indicates co-deposition of Ca and P. 
 
 
For further investigation of salt deposition within the scaffold, dry scaffolds were scanned 
by micro-CT with low x-ray energy and low applied voltage (40 kV). As reported by Cancian 
et al., the region of interest (ROIs) characterized by a higher density may be attributed to 
salts, such as Ca-P [255] (Fig. 4.6). As expected, quantitative analysis of the hydrogels 
highlighted a significantly higher salt deposition within the scaffolds containing HACS in 
comparison to the controls. Moreover, an increase of salt deposition by time was noticed for 
both CS-HACS and CS-HACS-AgNWs hydrogels (Fig 4.7). 
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Figure 4.6 Reconstructed microCT slices of (A) CS, (B) CS-HACS and (C) CS-HACS-AgNWs after 14 days of 
soaking in SBF; Otsu threshold of ROI of (D) CS, (E) CS-HACS and (F) CS-HACS-AgNWs: ROI are marked in red. 
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Figure 4.7 Average % salt deposition on different types of hydrogel samples (from microCT). Data are reported 
as mean ± SD (n = 3). One-way ANOVA returned p < 0.05 for both gels containing AgNWs, compared to control, 
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and P <0.001 was obtained for CS-HACS hydrogels both at 14 and 21 days compared to the control. # was used 
to compare CS-HACS or CS-HACS-AgNWs to CS gels at each time point. * was used to compare CS-HACS to CS- 
HACS-AgNWs at each time point. 
 
 
4.3.3 Ag+ release 
 
 
AAS was used to determine the total Ag+ release from AgNWs and CS-HACS-AgNWs 
scaffolds. Silver release was studied over a period of 38 days, using ultrapure water as 
medium (Fig. 4.8). After 38 days, approximately 11 ppm of Ag+ were released from AgNWs, 
while nearly 1 ppm was released from the hydrogels. 
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Figure 4.8 Cumulative release profile of silver cations from AgNWs (dots) and CS-HACS-AgNWs (square). 
 
 
 
4.3.4 Antimicrobial activity of AgNWs 
 
The antimicrobial activity of AgNWs was tested against four bacterial strains. Three are 
gram-positive (Staphylococcus aureus, Staphylococcus saprophyticus and Methicillin- 
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resistant Staphylococcus aureus) while Escherichia coli is gram-negative. Staphylococci 
comprise nearly two-thirds of all pathogens implicated in orthopaedic implant infections and 
thus are clinically relevant in testing materials developed for bone regeneration [3]. 
Antibacterial efficacy was also assessed against E. coli as it often serves as a gram-negative 
bacterial representative and allowed us to estimate the broadness of the potential 
antibacterial spectrum. Based on these previous results, we monitored bacterial growth in 
liquid culture medium in the presence of increasing concentrations of AgNWs (Fig. 4.9) and 
determined the lag time before exponential growth (the period when the bacteria are 
adjusting to the nascent environment), the time required by the bacterial populations to 
reach stationary phase (when the OD600nm stabilizes due to the rate of cell death equaling the 
rate of cell division) and the maximum optical density (OD600) reached at stationary phase. S. 
aureus growth was completely inhibited by 100 μg/ml AgNWs (see Supplementary Fig. S4.5). 
The lag phase was found to be statistically increased for the concentration 50 
µg/ml (p = 0.007773) in comparison to the control. While, the time to reach the stationary 
phase and the maximum OD600nm were not statistically different from the control (see 
Supplementary Fig. S4.5). Firstly, the lag phase was prolonged compared to the control for 
all the studied concentrations (p < 0.001 for 12.5 and 25 µg/ml and p < 0.0001 for both 50 
and 100 µg/ml; see Supplementary Fig. S4.5). Moreover, this effect seemed to increase 
when higher AgNWs concentrations were employed. 
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Figure 4.9 Growth curves of different bacteria in suspension in the presence of 0 (grey), 12.5 (green), 25 
(blue), 50 (red) and 100 (black) µg/ml of AgNWs. 
 
 
 
 
4.3.5 Antibacterial activity of the composite scaffolds 
 
 
 
One of the main objectives of this study was to develop scaffolds imparting antibacterial 
activity through silver nanowires incorporation and thus we tested the antibacterial activity 
of CS-HACS-AgNWs hydrogels against CS-HACS scaffolds towards S. aureus, E. coli, MRSA and 
S. saprophyticus. The analyses were performed incubating the bacterial suspensions with the 
sterile dried composites. Biofilm formation on CS-HACS and CS-HACS-AgNWs hydrogels was 
investigated after 24 hours, staining the fixed hydrogels to highlight the presence of bacteria. 
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Both of the scaffolds were found to suppress the bacterial growth, hence biofilm formation, 
on the scaffolds, as no bacteria have been imaged on the considered surfaces. Hence, both 
chitosan and silver nanowires appeared to prevent biofilm formation within the considered 
period of time (see Supplementary Fig. S4.6). The antibacterial activity of the composites 
was studied in the suspension, too. As reported in Fig. 4.10, CS-HACS-AgNWs scaffolds 
showed a remarkable bactericidal activity against all the four bacteria strains, giving an 
inhibition of the growth of 100% ± 9.6x10-6 (p = 0.000275) against E. coli, 100 % ± 9.2x10-7 (p 
< 0.000001) against S. aureus, 99.99% ±0.0065 (p = 0.02041) against MRSA and of 100% ± 0 
(p < 0.000001) against S. saprophyticus, at 24 hours. On the other hand, CS-HACS scaffolds 
did not show the ability to stop the bacterial growth within 24 hours, except for S. 
saprophyticus. Interestingly, AgNWs gels showed an inhibitory effect on MRSA viability, 
whereas AgNWs only did not have any effect on cell growth. On another hand, AAS data 
suggested that Ag+ concentration in CS-HACS-AgNWs medium should have been nearly 10 
times lower than from AgNWs, at 24 hours. By the way this trend can be explained 
considering that the gels were submitted to sterilization procedures prior antibacterial tests: 
the sterilization procedures may have altered the properties of the gel and partially degraded 
them, favouring a much higher Ag+  release than the in vitro studies conducted in paragraph 
4.4.4. Moreover, whereas the antibacterial activity of AgNWs were tested though OD600nm 
readings which does not differentiate between live and dead bacteria, the cell availability on 
cements was accessed directly counting living bacteria. Overall these results highlighted that 
the addition of AgNWs was essential to lead to a bactericidal activity of the hydrogels. 
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Figure 4.10 Antibacterial activity of hydrogels in suspension. Growth of S. aureus, E. coli, MRSA and S. 
saprophyticus in suspensions containing CS-HACS (light grey squares), CS-HACS-AgNWs (dark grey triangles) 
and LB only (black circles). Results are reported as mean ± SD. One-way ANOVA was performed between 
different samples, when significant a Tukey’s post-hoc multicomparison test was performed, results are 
reported on the graph. * represents the statistical difference between scaffolds and bacterial suspensions while 
# represents the statistical difference between CS-HACS and CS-HACS-AgNWs scaffolds. 
 
 
 
 
4.3.6 Proliferation and differentiation of MC3T3-E1 
 
 
 
The biocompatibility of the hydrogels was verified by determining the growth of MC3T3-E1 
cells through the adenosine triphosphate (ATP) assay, a well-known reproducible and reliable 
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assay of cell viability (Fig. 4.11A) [264]. The cells responded well to all the hydrogels with an 
increase in cell number. A significant enhancement of cell growth was detected in HACS 
containing hydrogels, as shown by the increase in cell number at both day 7 and 14. HACS 
gels supported cell growth better than the hydrogels containing CS only. At 14 days no 
significant difference between the CS-HACS and the CS-HACS-AgNWs was detected and both 
of them showed better cell proliferation than CS only. Furthermore, the differentiation of 
the pre- osteoblast MC3T3-E1 cells was determined in order to evaluate the potential of the 
hydrogels to support osteoblast differentiation for bone repair. The alkaline phosphatase 
(ALP) assay was performed as ALP activity is considered to be a biochemical marker for 
osteoblast differentiation and an indicator of bone tissue formation [265]. The MC3T3-E1 
cells began to differentiate into osteoblasts in all the samples, as confirmed by the presence 
of ALP activity after 7 days in culture (Fig. 4.11B). ALP activity was higher in CS samples than 
those observed in the other hydrogels. With the addition of the hydroxyapatite a decrease 
in ALP was observed at day 7 while at 14 days no difference between CS and CS-HACS gels 
were detected. At day 14, a decrease in enzyme activity was visible in all cultures; this is 
expected as the highest concentration of ALP is expressed during the early stages of bone 
formation [266]. 
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Figure 4.11 Cell proliferation and differentiation. (A) ATP produced by MC3T3-E1 cells grown in the presence 
of the following hydrogels: CS (black), CS-HACS (light grey) and CS-HACS-AgNWs (dark grey). Data are reported 
as mean ± SD (n=3). One-way ANOVA returned p < 0.019 for 7 and p < 0.0001 for 14 days. (B) ALP expression 
by MC3T3-E1 cells grown in the presence of the same hydrogels. Data reported as mean ± SD (n=3). One-way 
Anova returned p < 0.05 for 7 days and p = 0.557 for 14 days. The results of the post-hoc Tukey multi comparison 
test for (A) and (B) are reported in the graph: ***, p<0.0001; **, p<0.001; *, p < 0.01 compared to the control; 
#, p < 0.05, ##, p < 0.01. 
 
 
 
 
4.4 Discussion 
 
Bone fractures are often exacerbated by the occurrence of bacterial infections that can lead 
to prolonged or even absent bone healing. Therefore, 3D-engineered scaffolds with both 
bone regeneration and infection control capabilities are urgently needed. In this study, we 
aimed to develop the first biodegradable, osteoconductive and osteogenic injectable 
hydrogel enriched with AgNWs with intrinsic antibacterial properties. Thus, we initially 
explored the physicochemical characteristics of the hydrogels, related to their potential 
osteoconductivity, or their ability to promote formation of new tissue within and outside the 
scaffold itself. 
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Injectable hydrogels are potentially ideal pharmaceutical formulations for bone 
regeneration as they reduce the discomfort of the patient due to their non-invasive 
administration. However, a relatively fast gelation time, once administrated, is essential for 
this type of formulations as this allows an effective entrapment of additives or cells at the 
site of application. CS-GP hydrogels are known for been thermosensitive as they undergo 
solution- gel transition in a temperature-dependant manner [254]. Our in vitro studies 
demonstrated that addition of HACS significantly diminished gelation time, at body 
temperature, in comparison to CS only gels, whereas AgNWs did not affect this property. This 
behavior may be attributed to the higher number of functional groups available for ionic 
interactions in CS-HACS than in CS hydrogels. Even though chitosan-based hydrogels are ideal 
scaffolds for tissue regeneration as they mimic the ECM, they present inadequate mechanical 
performance, which makes them too weak for applications in the musculoskeletal system. 
Multiple approaches have been taken by researchers to overcome this problem, like 
incorporating nanoparticles [267]. In this study, the addition of HACS significantly enhanced 
the compressive gel strength in comparison to the controls. This result was further improved 
by the addition of AgNWs, due to their metallic nature and one- dimensional morphology. A 
further important property of a hydrogel for tissue regeneration is its swelling capacity: 
swelling is related to water uptake from the surrounding tissues that favours nutrients and 
cells migration [149, 268]. Chitosan is known for its hydrophilic nature due to the presence 
of several hydroxyl and amino groups able to form hydrogen bonding with the surrounding 
water. The inclusion of HACS into CS-based hydrogels ensured a higher water uptake, due to 
the higher number of hydrophilic groups but also to the higher porosity of these gels in 
comparison to the CS only gels. Thus, HACS is not only acting as a crosslinker, as shown by the 
enhanced mechanical behavior, but also as a spacer between polymeric 
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chains enhancing the porosity and hydrophilicity of the composites. 
 
During bone repair, the aim is to employ materials that will be resorbed while the new bone 
is forming and will allow drug release; thus degradation studies have been performed to 
understand what factors affect the resorption of the composite hydrogels. The in vitro 
degradation studies were carried out in presence of lysozyme, an enzyme that degrades 
chitosan in vivo. Based on gravimetric analysis and observation by SEM, CS-HACS-AgNWs 
hydrogels showed significantly reduced degradation in comparison to the control. The 
addition of HACS composites had no effect on the degradation in comparison to chitosan 
hydrogels, in good agreement with the findings reported by Dhivya et al.[269]. This may 
suggest that the introduction of AgNWs might be used to regulate and delay the degradation 
of the gels. 
A further important step for bone regeneration is mineralization of the tissue. The in vitro 
apatite formation ability of a scaffold can be correlated to its in vivo bone-bonding ability 
and capacity to absorb calcium and phosphate ions from the surrounding body fluids. Indeed, 
Ca and P are used by human body to form hydroxyapatite, the bone mineral that constitutes 
nearly the 65% of bone weight. Thus, the presence of hydroxyapatite on the surface of the 
scaffolds is essential to promote the nucleation and growth of calcium phosphate. Our in vitro 
study showed that more Ca/P deposits where present on the external and internal surface of 
the hydrogels over time if hydroxyapatite was present in the composite. The data presented 
support the key role played by hydroxyapatite in the bioactivity of the composite hydrogels 
and at the same time demonstrate that the addition of AgNWs did not interfere with Ca/P 
deposition. 
As mentioned, bacterial infections are a burden after bone fracture surgeries. Controlled 
release of silver cation is a key factor for preventing and treating infections. Indeed, Ag+ can 
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interact with electron donor groups in biological molecules containing sulphur, oxygen or 
nitrogen, causing damages of microorganism functions[91]. Silver is present in AgNWs in the 
metallic state, this has no antibacterial properties, however it is able to react with moisture 
and O2 in the culture medium, producing ionized Ag+. This is highly reactive as it directly 
interacts with proteins and promotes structural changes in the bacterial cell wall, leading to 
cell distortion and death. As reported by Kumar et al., steady and prolonged release of silver 
from scaffolds at a minimum concentration level of 0.1 part per billion (ppb) can provide 
effective antimicrobial activity [97]. In our study we have explored the antibacterial activity 
of AgNWs and CS-HACS-AgNWs. The cumulative release profiles of silver cations from AgNWs 
and hydrogels indicate that the total silver ion release, for all the points, is well within the 
potential toxic limit mentioned for human cells which is 10 ppm (µg/ml), but high enough to 
have the potential to inhibit bacterial growth. 
The antibacterial properties of AgNWs against suspension cultures of E. coli, S. aureus, 
MRSA and S. saprophyticus were evaluated. AgNWs were able to prevent the growth of S. 
aureus and S. saprophyticus at concentrations higher than 50 µg/ml, they affected the lag 
phase of S. aureus at concentrations higher than 50 µg/ml and of E. coli for all the studied 
concentrations. Moreover, the OD600 of E. coli stationary phase was statistically different for 
the concentration 50 µg/ml. Our results are in good agreement with Cui and Liu [63]: they 
carried out a similar experiment for E. coli showing that AgNWs were able to affect the lag 
phase for concentrations equal or higher than 12.5 µg/ml. However, in their work, 
concentrations of AgNWs equal to 50 µg/ml were able to prevent bacterial growth. In 
agreement with our study, Hong et al. reported a 6 hours delay of E. coli growth for the 
AgNWs concentration 50 µg/ml, without any inhibition[61]. Finally, in our work, E. coli 
exhibited greater sensitivity to AgNWs than S. aureus. This trend has been reported for silver 
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nanoparticles, too[270]. 
 
The antimicrobial properties of the composite hydrogels were evaluated both in suspension 
and on the scaffold. On one hand, chitosan is known to exhibit antimicrobial properties 
against fungi, yeasts, viruses and bacteria, including E. coli and S. aureus, inhibiting DNA 
transcription and mRNA synthesis[271]. On the other, the introduction of AgNWs was 
expected to enhance these antibacterial properties mainly due to the release of Ag+ from the 
scaffolds. Indeed, CS-HACS-AgNWs could reduce the bacterial growth of over 99% for all the 
studied species over a period of 24 hours in suspension, in comparison to CS- HACS hydrogels. 
Moreover, biofilm formation was prevented on the hydrogels with or without AgNWs, over 
a period of 24 hours. The ability of CS-HACS hydrogels to inhibit bacterial growth on the 
scaffold, may be explained by the direct interaction of positively charged chitosan with 
negatively charged bacterial cell surface, which caused cell membrane disruption leading to 
death[272]. These results are in good agreement with previous literature studies, regarding 
the ability of low viscosity chitosan to prevent Staphylococcus and E. coli growth[273, 274] 
dependently on the amount of chitosan added. A further important property of a scaffold 
for bone tissue engineering is osteogenicity. Researchers define as osteogenic a scaffold that 
favours the adhesion and proliferation of osteoprogenitor cells, therefore proliferation of pre-
osteoblasts (MC3T3-E1) was studied. Cell number significantly increased on CS-HACS and CS-
HACS-AgNWs more than in gels with CS only over a period of 14 days. This indicates a good 
biocompatibility of the studied biomaterials. Cells differentiation into osteoblasts was 
confirmed by ALP assay that is a marker of early stages of osteoblast differentiation. ALP 
plays a role in the conversion of inorganic pyrophosphate into inorganic phosphate, a process 
that promotes the formation of bone matrix, before the mineralization process [275]. Over 
a period of 14 days, all the studied hydrogels promoted 
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cell differentiation at the same level. However, there was a decrease for all the studied 
cultures between 7 and 14 days. ALP decrease over time might be explained due to the cells 
entering a new development stage and not because the hydrogels are unable to sustain 
osteogenic differentiation. Further studies should be carried out in order to evaluate 
osteoblast differentiation through the expression of markers such as Runx2, osteocalcin, 
Osterix and collagen II. In particular, Runx2 is a critical transcription factor for osteoblast 
differentiation and chondrocytic maturation, whereas Osterix provide specificity in 
osteoblast differentiation. Osteocalcin is a bone matrix protein, released by osteoblasts, and 
it is a marker for bone production [276, 277]. 
 
 
4.5 Conclusions 
 
AgNWs were incorporated into the scaffolds in order to provide antibacterial properties to 
the chitosan-hydroxyapatite based hydrogels. The addition of silver nanowires did not 
interfere with the rapid sol/gel transition at body temperature, enhancing the mechanical 
properties as well as the bioactive properties of the scaffolds. Furthermore, the presence of 
AgNWs induced a reduction of the degradation rate of the hydrogels. The scaffolds 
demonstrated antibacterial properties, both preventing bacterial cell growth in suspension 
and onto the scaffolds for the considered time-span. Therefore, the use of this type of 
hydrogel into clinic should potentially decrease the risk of infections. Furthermore, the gels 
proved to be bioactive and biocompatible allowing in vitro cell attachment and proliferation. 
Further investigation should be carried out to confirm differentiation of MC3T3-E1 into 
osteoblasts. Overall, results suggest that CS-HACS-AgNWs hydrogel developed in this work 
have proven bioactive, antimicrobial and biocompatible properties. 
158  
Acknowledgments: The authors wish to thank the University of Portsmouth Research and 
Innovation Development Fund and the Institute of Biology and Biomedical Science (IBBS) for 
financial support. 
Competing interests statement: The authors declare no competing interests. 
 
Data Statement: All data generated or analysed during this study are included in this 
published article (and its Supplementary Information). 
 
 
 
 
 
 
 
 
4.6 Supplementary information 
 
 
 
 
 
 
 
Figure S4.1 AgNWs size distribution obtained by SEM image analysis. (A) Length (mean 5.03 ± 1.85 µm; n = 
 
28) and (B) diameter (mean 99.45 ± 20.20 nm, n = 28). Shapiro-Wilk normality test returned p > 0.05 for both 
length and diameter. 
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Figure S4.2 Physical characterisation of the hydrogels: CS (black), CS-HACS-AgNWs (black background with 
dark grey lines), CS-HACS (light grey) and CS-HACS-AgNWs (dark grey). Gelation time calculated by the inverted 
tube method. Data are reported as mean ± SD (n = 9). One-way ANOVA returned p < 0.0001. Post-hoc Tukey’s 
comparison test results are shown in the graph: **** indicates p < 0.0001 and ** indicates p < 0.001. 
 
 
 
Figure S4.3 Gel strength calculated by texture analysis before (empty bars) and after (filled bars) gelation. 
Data are represented as mean ± SD (n = 3). The t-test performed on all samples before and after gelation 
showed significantly different strength values for all gels ($$ indicates p < 0.01 and $$$$ p < 0.0001). One-way 
ANOVA to compare the different formulations returned p < 0.01 before and p < 0.0001 after gelation. Post-hoc 
Tukey’s test results showed that before gelation only CS is different from all other gels (# p < 0.05), while the 
individual results for after gelation are reported on the graph (** p < 0.01; **** p < 0.0001). 
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Figure S4.4 SEM images (200× magnification) of the degradation process in PBS and in lysozyme for CS, CS- 
HACS and CS-HACS-AgNWs gels at 7, 14 and 21 days. 
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Figure S4.5 Bacterial growth lag time, time to reach the stationary phase, and O.D. at stationary phase for 
different bacteria in suspension treated with 0 (grey), 12.5 (green), 25 (blue), 50 (red) and 100 (black) µg/ml of 
AgNWs. Data are reported as mean ± S.D. (n=3). One-way ANOVA was performed between different AgNWs 
concentrations against the same bacteria, when significant a Tukey’s post-hoc multicomparison test was 
performed, results are reported on the graph. The symbol* indicates statistical difference when compared to 
0 µg/ml, the symbol # indicates comparison with 100 µg/ml, the symbol $ is used for specific comparisons as 
indicated in the graph. 
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Figure S4.6 Microscopy images of biofilm formation on CS-HACS, CS-HACS-AgNWs hydrogels and controls 
after fuchsin (E. coli) or crystal violet (S. aureus, MRSA and S. saprophyticus) staining. Magnification 100x. 
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Abstract 
 
PMMA-based cements are the most used bone cement in interventions such as 
vertebroplasty, but they present several drawbacks, including lack of antibacterial 
properties, monomer leakage toxicity and highly exothermic polymerization reactions 
which can damage the surrounding tissues. Postoperative infections of orthopaedic 
implants are a serious problem that can negatively affect the complete fracture repair. 
Moreover, an increasing number of bacteria are developing resistance against commonly 
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used antibiotics. Silver nanowires (AgNWs) have been attracting increased attention due to 
their antibacterial activity and lower toxicity compared to cationic Ag and silver 
nanoparticles (AgNPs). Furthermore, several additives, such as chitosan (CS), can be 
included in the PMMA cements in order to reduce the polymerization temperature, 
without reducing the mechanical performances. Finally, the introduction of a methacrylic 
group on chitosan (CSMCC) may promote crosslinking with MMA and reduce the quantity 
of MMA required for polymerisation. The purpose of this study, therefore, was to combine 
AgNWs (0 and 1% wt/wt) and CS or CSMCC at various ratios (0, 10, 20 and 30% wt/wt) into 
PMMA-based cements, testing two different ratios of powder and MMA (P/L) and to 
evaluate the mechanical, thermodynamic, antibacterial and cytotoxic properties of the 
resulting composite cements. Only cements with concentrations of chitosan higher than 
10% presented a significantly reduced polymerization temperature. The mechanical 
performances were affected for concentrations higher than 20% with a P/L concentration 
equal to 2:1. Concentrations of AgNWs as low as 1% wt/wt conferred antimicrobial activity 
against S. aureus, whereas biofilm formation on the surface of the cements was increased 
when chitosan was included in the preparation. The combination of chitosan and AgNWs 
allowed a higher concentration of Ag+ to be released over time than just PMMA-AgNWs. 
Inclusion of AgNWs did not affect cell availability on the scaffolds. Our work demonstrates 
that a combination of chitosan and AgNWs may be beneficial for both reducing 
polymerization temperature and biofilm formation, without significantly affecting 
mesenchymal stem cells proliferation on the scaffolds. No advantages have been noticed 
as a result of reducing P/L ratio or using methacryloylchitosan instead of chitosan. 
 
5.1 Introduction 
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Osteoporosis is a progressive medical condition characterized by osteopenia and bone 
mass loss [278]. This disease makes the bones increasingly weak and prone to fractures, 
amongst the most common are vertebral compression fractures (VCFs); if multiple thoracic 
fractures occur, they can lead to lung and heart problems. The most used treatment to 
reduce morbidity is percutaneous vertebroplasty that consists in the administration of a 
filler through a needle to the vertebrae cavity [279]. This therapy can restore the vertebral 
body and reduce the pain in the majority of the patients. 
To date, poly(methyl methacrylate) or PMMA is the most used bone cement in 
vertebroplasty with the aim of both reinforcing and stabilising the vertebral body destroyed 
by osteoporosis or tumours and for providing local antineoplastic effects, such as delivering 
anticancer drugs [280]. Moreover, PMMA is used in total hip replacement as a grout to fix 
a prosthesis or implant against the bone. PMMA beads and the liquid monomer (methyl 
methacrylate, MMA) are mixed to form a slurry that, once injected, conforms to the shape 
of its surrounding, allowing distribution of implant loads and formation of strong 
mechanical bonds with bone following monomer polymerization. However, if the cement 
mantle becomes loose (this may be due by bacterial infection among other causes), the 
surrounding bone may resorb and ultimate failure of the implant may occur [281]. Further 
drawbacks related to PMMA cements are: lack of bioactivity, stiffness mismatch between 
the bone and the cement, high exothermic reaction temperature that can cause tissue 
necrosis and monomer toxicity that is characterized by a sudden drop in blood pressure [2, 
282]. Moreover, it has been reported that MMA can cause allergic reactions through direct 
contact of the MMA liquid with the skin (dermatitis) or through inhalation [283]. Finally, an 
important risk related to any biomaterial implantation is the occurrence of infections that 
can lead to biofilm formation and implant failure [284]. 
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One strategy employed to promote better PMMA-bone integration, is to increase the 
cement porosity with the addition of biodegradable materials. For instance, chitosan is a 
biodegradable material that can degrade, over time, leaving a rough and porous 3D 
structure in which the bone can grow, promoting a more stable fixation thanks to the 
improved interlocking between bone and cement. A further advantage of the use of 
additives in bone cements is their potential to dissipate the heat generated from the 
polymerization reaction throughout the bone cement material, minimizing the risks of bone 
necrosis; glycidyl methacrylate (GMA) and trimethoxysilyl propyl methacrylate (3MPMA)  
have  been  used  to  reduce   polymerization   temperature.   Alternatively,   the 
functionalisation of chitosan with glycidyl methacrylate (GMA) to promote crosslinking with 
MMA can have a similar effect [285]. 
As mentioned above, bone implant surgeries can be complicated by the occurrence of 
infections. Osteomyelitis is a bacterial infection of the bone mostly caused by the bacterium 
Staphylococcus aureus [286]. This infection can lead to destruction of the bone and 
consequently to increased rates of treatment failure, delayed osseous-union and even 
amputation [253]. Furthermore, more and more bacteria are becoming resistant to 
antibiotics and new treatments are needed [287]. 
Silver nanowires (AgNWs) present antibacterial properties [279] and can offer a 
prolonged silver ion release. However, their potential use in biomedical applications has 
been poorly explored and, unlike for Ag nanoparticles, no studies have been carried out on 
their integration in bone cements. Oleic acid capped silver nanospheres (5.3±2.3 nm) were 
loaded into PMMA-based cements and the samples showed antibacterial activity against a 
wide variety of microorganisms such as Methicillin Resistant Staphylococcus aureus (MRSA) 
and S. aureus, at a NPs concentrations as low as 0.05% wt/wt[288]. Slane et al. formulated 
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a PMMA bone cement loaded with silver NPs (30-50 nm) functionalized with 
polyvinylpyrrolidone at concentrations 0.25%-0.5% and 1% wt/wt. No antibacterial activity 
was found in suspension, but all concentrations of AgNPs were able to significantly reduce 
biofilm growth on the scaffold[289]. However, all these systems presented a critical 
problem related to the extremely poor biodegradability and interconnectivity of PMMA. If 
the plastic does not degrade, the silver contained inside its mass, will not make in contact 
with the human fluids, will not oxidize and will not interact with bacterial cells. 
In the present work, we report the preparation of novel cement composites formulated 
with PMMA, methacryloyl chitosan (CSMCC) and AgNWs, and discuss the results of our 
investigation into their cytocompatibility and antibacterial and mechanical properties. 
 
 
5.2 Materials and methods 
 
5.2.1 Materials 
 
Agar, ammonium hydroxide (28-30%), ammonium sulphate, calcium chloride, chitosan 
from shrimp shells low viscosity (degree of deacetylation ~85%, calculated by 1H-NMR), 
dimethyl sulfoxide cell culture tested, methacryloyl chloride (≥97.0%), methane sulfonic 
acid  (≥99.0%), poly(vinylpyrrolidone) powder  (55 kDa), silver standard for  AAS, tryptone 
 
enzymatic digest from casein, sodium chloride and yeast extract for microbiology were 
purchased from Sigma Aldrich (Irvine, UK). DePuy SmartSet MV Medium Viscosity Bone 
Cement (see Table 5.1 for composition) was purchased from eSutures.com (Mokena, IL, 
USA). DMEM high glucose with glutaMAX and phenol red, glycerol, heat inactivated fetal 
bovine serum, isopropanol, MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide), PBS pH 7.4, trypan blue stain, silver nitrate, trypsin 0.25% EDTA with phenol red 
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and x100 penicillin streptomycin were from Fisher (Loughborough, UK). ATPlite 
Luminescence ATP Detection Assay System was purchased from PerkinElmer (Coventry, 
UK). Deuterium chloride (D, 99.5%, DCL 20%), deuterium oxide (D, 99.9%), dimethyl 
sulfoxide-d6 (D, 99.9%) + 0.05% v/v TMS (tetramethylsilane) were purchased from 
Cambridge Isotope Laboratories (Tewksbury, MA, USA). 
 
 
 
Table 6.1. Chemical composition of SmartSet MV cement. 
 
Bone cement powder 
Poly(methyl methacrylate) (%wt/wt) 67.05 
Poly(methyl methacrylate-co-styrene) 
(%wt/wt) 
21.10 
Benzoyl peroxide (%wt/wt) 1.85 
Barium sulphate (%wt/wt) 10.00 
Bone cement liquid 
Methyl methacrylate (%wt/wt) 98.00 
N,N-Dimethyl-p-toluidine (%wt/wt) ≤2.00 
Hydroquinone (ppm) 75 
 
 
 
 
5.2.2 Synthesis and characterization of cement components 
 
5.2.2.1 Synthesis of CSMCC  
 
 
Chitosan (CS) (2 g) was dissolved in concentrated methanesulfonic acid (11 ml) over 2 h 
at 0°C with overhead stirring. Methacryloyl chloride (12 ml) was then added dropwise into 
the chitosan gel, and the light brown reaction mixture was further stirred for 4 h at 0 °C, 
under protection from light. The solution was poured into cold water and a light cream 
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precipitate was obtained after neutralization with aqueous ammonia (35% v/v). The 
precipitate was dialyzed against deionized water for 1 day and the solid was recovered by 
centrifugation at 2880 g for 20 min (three times); the pellet was dried under vacuum, (40°C) 
and then pulverized to afford a fine powder. 
 
 
 
5.2.2.2 Synthesis of AgNWs  
 
AgNWs were synthetized according to literature [257] with some minor modifications. 
PVP (3 g) was fully dissolved in glycerol (95 ml) by heating to 80 °C. The solution was cooled 
down and AgNO3 (0.79 g) was added under vigorous stirring (800 rpm) until the powder was 
fully dissolved. Subsequently, NaCl (5 mM in final solution) was mixed into 10 ml of glycerol 
and added to the PVP/glycerol solution. The reaction temperature of the mixture was 
raised to 210 °C. Once the temperature was reached, it was maintained for further 10 min. 
 
 
 
5.2.2.3 Physicochemical characterization of CSMCC  
 
FT-IR spectra were recorded using a Varian FT-IR 640-IR Instrument (Agilent, Santa Clara, 
CA, USA) and spectra were processed using Agilent Resolutions Pro software. For 1H-NMR 
analysis: CSMCC was dissolved in DMSO-d6 containing 0.5% TMS standard; chitosan was 
dissolved in D2O:DCl (98:2); methacryloyl chloride (200 µl) was mixed with 800 µl of CDCl3. 
All the samples were analysed using a JEOL Eclipse+ 400 MHz NMR instrument (Oxford 
Instruments, Oxford, UK). The degree of substitution in the reaction product (DS%) was 
determined according to the following formula: 
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DS(%)={[((I(1)v1+I(2)v2))/2]*(Iglucopyranose ring)}*100 
 
 
where, Iv1 and Iv2 are the integral intensities of the signals assigned to the two vinylic 
protons present in methacryloyl chloride, while Igp is the integral intensity of protons 
belonging to glucopyranose ring of chitosan. 
The powder particle size was determined by laser diffraction using a Helos particle sizer 
coupled with a RODOS dry dispersion unit and ASPIROS micro dose module (Sympatec 
GmbH, Clausthal-Zellerfeld, Germany); a pressure of 2 bar was used for the measurements. 
 
5.2.2.4 Antibacterial properties of CS and CSMCC against S. aureus in suspension  
 
CS and CSMCC 10 mg/ml stock suspensions, in sterile lysogeny broth (LB) were prepared 
and sterilized under UV light overnight and sonicated for 20 min at 40 Hz before testing. 
Antibacterial studies were carried out in suspension according to Ardila et al. with some 
modifications [252]. S. aureus (ATCC 25923) were transferred from -80°C (30 % glycerol) 
into 5 ml of fresh sterile LB by a sterile toothpick and incubated (at 37°C and 200 rpm) until 
the bacterial suspension was cloudy. Then, the suspension (50 µl) was transferred into 5 ml 
of fresh sterile LB and the bacteria were further incubated at 37°C until the suspension was 
cloudy again. The experiment was carried out into 8 ml autoclaved sealed bottles in which 
the bacteria (106 CFU/mL) were added to CS and CSMCC suspensions (0.2, 0.4, 0.8, 1, 2, 5 
and 10 mg/ml) and the volume was brought to 2 ml with sterile LB medium. The experiment 
was carried out in triplicate (n=3). After incubation at 37°C and 200 rpm for 12 hours 
(MaxQ™ 8000, Thermo Scientific), bacterial concentration was determined by measuring 
the optical density (OD600nm) of the suspension. Different concentrations of the stock CS 
and CSMCC suspensions, as well as and pure LB were used as blanks. 
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5.2.3 Preparation and physicochemical testing of composite PMMA cements 
 
Different cement formulations have been tested, by changing the concentrations of 
additives and/or powder to liquid monomer ratio (Table 5.2). The general method to 
prepare the cements is here reported. Powders were uniformly mixed, using a vortex. The 
cements were prepared by manually combining the liquid monomer with the powders, at 
the required P/L ratio, until the powders were fully wet. If AgNWs were included in the 
preparation, freeze-dried AgNWs were suspended in MMA by sonication for at least 20 min 
at 40 Hz. When the mixture became dough-like and easier to handle, the mass was poured 
into a custom made 10 well PTFE mould (6 mm diameter, 12 mm height) and manually 
pressed. The cements were allowed to cure for 1 hour, removed from the mould and stored 
in a desiccator until further use. 
 
 
Table 5.2. Formulation of composite cements and average weight loss and water uptake after 4 weeks of 
incubation in PBS. Weight loss and water uptake are reported as mean ± SD (n≥3). Dunnett’s multiple 
comparison test was carried out to compare the results to the control (PMMA_2:1): (a p<0.05 and b p<0.01, c 
p<0.001, d p<0.0001). PMMA= poly(methyl methacrylate); CS=chitosan; CSMCC = methacryloyl chitosan; 
AgNWs = silver nanowires. PMMA= poly(methyl methacrylate); CS=chitosan; CSMCC = methacryloyl chitosan; 
AgNWs = silver nanowires. 
 
 
CEMENT TYPE 
PMMA 
(g) 
MMA 
(ml) 
CS 
(g) 
CSMCC 
(g) 
AgNWs 
(wt/wt%) 
Weight loss 
(%) 
Water 
uptake (%) 
 
PMMA_1 
 
2 
 
1 
 
- 
 
- 
 
- 
 
0.09±0.09 
 
2.84±1.03 
 
PMMA _0.8 
 
2 
 
0.8 
 
- 
 
- 
 
- 
 
0.12±0.12 
 
3.44±0.71 
 
PMMA_AgNWs_1 
 
2 
 
1 
 
- 
 
- 
 
1 
 
0.23±0.15 
 
2.76±0.66 
 
PMMA_AgNWs_0.8 
 
2 
 
0.8 
 
- 
 
- 
 
1 
 
0.13±0.22 
 
2.77±0.73 
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PMMA_CS 10%_1 
 
1.8 
 
1 
 
0.2 
 
- 
 
- 
 
0.16±0.25 
 
3.86±1.40 
 
PMMA_CS 10%_0.8 
 
1.8 
 
0.8 
 
0.2 
 
- 
 
- 
 
0.21±0.24 
 
3.99±3.93 
 
PMMA 
2:1_CS10%_AgNWs 
 
1.8 
 
1 
 
0.2 
 
- 
 
1 
 
0.11±0.12 
 
7.15±4.39(a) 
 
PMMA 
2:0.8_CS10%_AgNWs 
 
1.8 
 
0.8 
 
0.2 
 
- 
 
1 
 
0.16±0.01 
 
2.02±1.31 
 
PMMA 2:1_CS20% 
 
1.6 
 
1 
 
0.4 
 
- 
 
- 
 
0.62±1.28 
 
8.70±2.44(b) 
 
PMMA 2:0.8_CS20% 
 
1.6 
 
0.8 
 
0.4 
 
- 
 
- 
 
1.03±0.65(a) 
 
9.14±2.43(b) 
 
PMMA 
2:1_CS20%_AgNWs 
 
1.6 
 
1 
 
0.4 
 
- 
 
1 
 
1.10±2.07 
 
10.30±2.80(b) 
 
PMMA 
2:0.8_CS20%_AgNWs 
 
1.6 
 
0.8 
 
0.4 
 
- 
 
1 
 
0.93±0.95(a) 
 
9.76±2.10(b) 
 
PMMA 2:1_CS30% 
 
1.4 
 
1 
 
0.6 
 
- 
 
- 
 
3.66±1.03(b) 
 
13.36±5.00(b) 
 
PMMA 2:0.8_CS30% 
 
1.4 
 
0.8 
 
0.6 
 
- 
 
- 
 
4.00±1.54(a) 
 
8.65±2.96(a) 
 
PMMA 
2:1_CS30%_AgNWs 
 
1.4 
 
1 
 
0.6 
 
- 
 
1 
 
2.61±0.25(c) 
 
11.59±4.92(b) 
 
PMMA 
2:0.8_CS30%_AgNWs 
 
1.4 
 
0.8 
 
0.6 
 
- 
 
1 
 
3.29±.0.51(a) 
 
8.42±3.71(a) 
 
PMMA 2:1_CSMCC10% 
 
1.8 
 
1 
 
- 
 
0.2 
 
- 
 
0.27±0.27 
 
3.41±3.09 
 
PMMA 
2:0.8_CSMCC10% 
 
1.8 
 
0.8 
 
- 
 
0.2 
 
- 
 
0.21±0.30 
 
6.33±4.29 
 
PMMA 
2:1_CSMCC10%_AgNWs 
 
1.8 
 
1 
 
- 
 
0.2 
 
1 
 
0.21±0.16 
 
5.49±1.79 
 
PMMA 
2:0.8_CSMCC10_AgNWs 
 
1.8 
 
0.8 
 
- 
 
0.2 
 
1 
 
0.20±0.07 
 
2.18±1.57 
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PMMA 2:1_CSMCC20% 
 
1.6 
 
1 
 
- 
 
0.4 
 
- 
 
0.32±1.30 
 
4.85±0.97 
 
PMMA 
2:0.8_CSMCC20% 
 
1.6 
 
0.8 
 
- 
 
0.4 
 
- 
 
0.42±0.51 
 
9.22±2.40(b) 
 
PMMA 
2:1_CSMCC20%_AgNWs 
 
1.6 
 
1 
 
- 
 
0.4 
 
1 
 
0.53±0.21 
 
7.60±1.56(a) 
 
PMMA 
2:0.8_CSMCC20%_AgNWs 
 
1.6 
 
0.8 
 
- 
 
0.4 
 
1 
 
1.79±0.30(b) 
 
8.57±2.19 
 
PMMA 2:1_CSMCC30% 
 
1.4 
 
1 
 
- 
 
0.6 
 
- 
 
2.31±0.97(b) 
 
9.09±3.36(b) 
 
PMMA 
2:0.8_CSMCC30% 
 
1.4 
 
0.8 
 
- 
 
0.6 
 
- 
 
2.28±0.73(a) 
 
8.79±2.52(c) 
 
PMMA 
2:1_CSMCC30%_AgNWs 
 
1.4 
 
1 
 
- 
 
0.6 
 
1 
 
3.12±1.01(c) 
 
10.68±1.84(b) 
 
PMMA 
2:0.8_CSMCC30%_AgNWs 
 
1.4 
 
0.8 
 
- 
 
0.6 
 
1 
 
3.62±2.57(a) 
 
9.64±2.90(d) 
PMMA= poly(methyl methacrylate); CS=chitosan; CSMCC = methacryloyl chitosan; AgNWs = silver nanowires. 
 
 
 
5.2.3.1 Polymerisation temperature and time  
 
The temperature changes during the setting reaction were measured according to the 
method of Chen et al. with minor adjustments [290]. The MMA was added to the powders 
and mixed until the dough was fully wet (total powder mass = 3 g). This was poured into 
plastic containers (3.5 cm diameter x 1 cm height) under ambient conditions. Three 
thermocouples were inserted few mm under the surface of the dough and the temperature 
was measured and recorded at 5 s intervals for 25 min, using data acquisition software, 
Pico Log from Pico Technology. Temperature was plotted versus time to determine the 
peak temperature and setting time. The maximum temperature within the dough was 
assigned to the peak temperature during polymerization of the composite cement. The 
setting time was the time point when the exothermic temperature rises to the midpoint 
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between the ambient and the peak temperature. The setting temperature was determined 
using the equation below: 
 
 
 
𝑇𝑠𝑒𝑡 = 
(𝑇𝑚𝑎𝑥 + 𝑇𝑎𝑚𝑏) 
2 
 
 
 
where, Tset is the setting temperature, Tmax is the maximum temperature reached during 
curing, and Tamb is the ambient temperature prior to mixing. The experiment was carried 
out at ambient temperature (21–22°C). The experiment was carried out once for each 
cement type. 
 
 
 
5.2.3.2 Degradation studies  
 
The degradability of the composite cements was evaluated by determining weight loss, 
water absorbance and porosity changes following incubation in PBS. Cement specimens 
were immersed in PBS (pH=7.0) and placed in an incubator at 37°C for 4 weeks, shaking at 
90 rpm (Grant, Cambridge, UK); the PBS medium was changed every week. At scheduled 
time points, samples were removed from PBS and weighed (after removal of any excess 
liquid). Samples were then dried in a vacuum oven at 37°C for 3 days before measuring 
their final weight. Water absorption and weight loss were determined applying the 
equations reported by Kim et al9. Total porosity and pore size were examined using X-ray 
micro-CT (Versa 520, Carl Zeiss Ltd., CA) and the 3D data was then analysed with Avizo 
(9.3.0, FEI company). The images were collected with the X-ray tube operating at a peak 
voltage of 60 kV, a power of 5 W, a tube current of 84 μA and with a Zeiss LE1 filter in place. 
An isotropic voxel size of 6.11 μm was achieved using the 0.4x objective and a total of 1601 
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projections were collected over 360 degrees of rotation. Each projection was acquired 
using a 3 s exposure time. The 2D X-ray projection images were reconstructed using the 
filtered back projection algorithm within the manufacturer’s reconstruction software. 
Reconstructed volumes of each sample were cropped (edges were cropped to eliminate 
edge artefacts and air from all around the samples) and a threshold was applied to highlight 
the regions of interest. Then, border kill tool was used to discard the pores on the edges. 
Finally, the volumes were analysed by the tools ‘Label Analysis’ and ‘Volume Fraction’ to 
obtain the values of volume pore size and porosity, respectively. Six samples per type were 
tested for weight loss and water uptake. One sample per type was analysed three times for 
porosity and pore size determination. 
 
 
5.2.3.3 Mechanical tests of cements 
 
Compressive tests were carried out to evaluate ultimate compressive strength (UCS), 
Young’s modulus (E) and yield point. A servohydraulic Test System (MTS Systems Corp., 
Eden Prairie, MN) was used to compress the cements. The cement sample faces were 
sanded and then, the diameter and length of each sample were measured using a Vernier 
caliper. Cements were inserted into metallic end caps on both sides (epoxy resin glue was 
used to stick the endcaps to the cements). Then, samples were compressed at a 
compression speed of 0.02 mm/sec to 25% strain. Six samples per cement type were tested, 
before and after degradation. Stress and strain were calculated and stress versus strain 
curves were plotted for each sample. The stress (MPa) was calculated using the equation 
below: 
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𝑆𝑡𝑟𝑒𝑠𝑠 (𝜎) = 
F 
 
 
cross sectional area 
 
 
 
where, F (N) is the load applied to the specimen to cause a displacement in the sample 
and the cross sectional area was expressed in mm2. The strain was calculated using the 
equation below: 
𝑆𝑡𝑟𝑎𝑖𝑛 = 
∆𝐿 
 
 
L 
 
where, ΔL (mm) is the displacement and L (mm) is the original length of the sample. A 
typical stress strain curve is reported in Fig. 5.1. 
 
 
 
 
 
 
Figure 5.1 Representative stress-strain curve of PMMA cement. The initial region (violet region) was 
discarded; the slope (orange curve) of the elastic region represented the elastic modulus. A second line 
parallel to the elastic region and with 0.2%-strain offset (orange dashed line) was used to intersect the stress- 
strain curve and to identify the yield point. The intercept between the equation describing the elastic region 
and the plateau region (yellow curve) was identified as ultimate compressive strength. The two images of a 
PMMA cement represent the specimen before (left) and after (right) compression. 
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5.2.3.4 Morphological characterization  
 
The external surfaces of cements before and after degradation were investigated using a 
high resolution scanning electron microscope (SEM, Jeol JSM-6160L). Samples were gold- 
coated using a Polaron e500 instrument (Quoram Technologies, UK). ImageJ (version 1.8.0) 
software was used to determine the superficial pore size. Results are reported in 
Supplementary information (Fig. S5.2A-F). 
 
 
 
5.2.3.5 Silver release studies  
 
The release of silver cations was studied by soaking the cements in 5 ml of HPLC-grade 
water at 37°C, with shaking (90 rpm). At scheduled times, 1 ml of supernatant was taken 
and substituted with 1 ml of fresh water. The concentration of silver ions was determined 
by a furnace atomic absorption spectrophotometer (VarianSpectrAA 220FS) at a 
wavelength and spectral bandwidth of 328.1 nm and 0.2 nm, respectively. A calibration 
curve was prepared by diluting a silver standard (1 g/l) in deionized water (1, 2.5 and 5 
mg/l). 
 
 
 
5.2.3.6 Biofilm formation on cement surfaces  
 
Cements were directly prepared in 96- well plates. The day after, they were soaked in 70 
 
% EtOH for 30 min and washed three times in sterile water. Then, they were irradiated with 
UV light in a laminar flow for 1 h. One hundred microliters of a 1x106 CFU/ml suspension of 
S. aureus in LB medium were plated in each well. The plates were then incubated for 24 h 
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at 37 °C, under aerobic conditions. Then, the medium was removed and each well was 
gently washed once with PBS in order to remove loosely adherent bacteria. An MTT assay 
was carried out in order to quantify the total bacteria on cement surfaces: 100 μl of 0.5 
mg/ml of MTT solution in PBS was added to each well and the plates were incubated for 1 
hour in the dark.10 The supernatant was removed and DMSO was added to dissolve the 
formazan salts inside the cells. Then, the violet solutions were transferred to a new 96- well 
plate and the absorbance was read at 570 nm using DMSO as blank. The experiment was 
performed in triplicate. 
 
 
5.2.4 Cytotoxicity studies 
 
5.2.4.1 Cell culture preparation  
 
Primary sheep mesenchymal stem cells were obtained under project licence number 
PPL70/8247, ethical approval was granted by the animal welfare and ethical review board 
(AWERB) at the Royal Veterinary College, London, UK. Cells were used between passage 2 
and passage 5. Cells were grown in high glucose DMEM supplemented with 1% 
penicillin/streptomycin and 10% heat inactivated FBS. Cells were grown until 70% 
confluence in an incubator at 37°C and 5% CO2 and then detached with 0.25% Trypsin- 
EDTA. The cell suspension was centrifuged at 400 x g for 5 min (Eppendorf Centrifuge 5702, 
UK) and the pellet was resuspended. Finally, cells were stained with Trypan Blue and 
visually counted. 
 
 
5.2.4.2 Cytotoxicity studies of the cement extracts   
 
Cements were prepared as reported in paragraph 5.2.3. After 1 day since manufacturing, 
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cements were submerged in complete DMEM at a weight to volume ratio 1:5 and incubated 
at 37°C for 24 h [291]. The solutions were then filtered through a 0.22 μm filter and frozen 
until use. Cells were grown overnight at a cell density of 5x10^3 cells/well in a 96- well 
plate. Then, the medium was removed and 100 μl of cement extracts were added to each 
well and the plates were incubated for 24 and 48 h. At these scheduled time points, the 
medium was removed and an MTT assay was performed. The cells were plated for 4 h with 
0.5mg/ml MTT in complete medium. Then the medium was removed and 100 μl/well of 
DMSO was added. Absorbance was read at 570 nm using DMSO as blank. The experiment 
was performed in triplicate. 
 
 
5.2.4.3 Cell proliferation studies  
 
Cell proliferation was determined using an ATP bioluminescence assay. The cements were 
prepared in the same manner as described for the biofilm studies. Cells (5000 cells/well) 
were seeded and their proliferation was measured with an ATP assay, according to the 
manufacturer’s instructions (ATPlite, Perkinelmer). Luminescence readings were taken in a 
96 well plate (SpectraMax i3x, Molecular DEVICES, USA). Six replicates per type were 
tested. 
 
 
5.2.5 Statistical analysis 
 
Statistical analyses were performed using GraphPad Prism 7.03 software. Details of the 
different statistical analyses used are reported where relevant. 
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5.3 Results and discussion 
 
5.3.1 Physicochemical characterization of CSMCC 
 
 
Figure 5.2 Characterization of CSMCC by FT-IR and 1H-NMR. A) Schematic representation of the synthesis 
of methacryloyl chitosan (CSMCC). B) FT-IR spectrum of chitosan (black), methacryloyl chloride (dark grey) 
and methacryloyl chitosan (light grey). C) 1H-NMR spectrum of CSMCC. 
 
 
The product was synthetized by substituting the proton of the primary hydroxyl group in 
chitosan with a methacryloyl moiety, via a nucleophilic acyl substitution reaction carried 
out in a strongly acidic environment (pka of methanesulfonic acid = -1.9) (Fig. 5.2 A). The 
unreacted methacryloyl chloride was removed during the washing steps as the ammonium 
salt of methacrylic acid [292]. The formation of CSMCC was confirmed by FTIR (Fig. 5.2 B): 
the new peak at 1710 cm-1 may be attributed to the C=O bond in the newly formed 
methacryloyl group. The chemical structure of CSMCC was also confirmed by 1H-NMR (Fig. 
5.2 C), with signals of vinyl protons appearing t δ 5.71 and 6.02 ppm, and the three methyl 
protons of the methacryloyl group at δ 1.01 ppm. The 1H-NMR spectrum also shows a signal 
181  
at 2.24 ppm from the three methyl H atoms (N-acetyl glucosamine), a signal at δ 1.48 ppm 
from H2 (glucosamine), several overlapping signals (from δ 1.7 to 2.0 ppm) from H3–H6 
connected to the non-anomeric C3–C6 carbons in the glucopyranose ring, and δ 2.3 ppm 
from the anomeric proton. The degree of substitution of CSMCC was ca. 25.7%. 
For the bone cement preparation, the particle size is important in order to guarantee a 
homogenous dispersion of the powders into the liquid monomer. The average size of 
PMMA, CS and CSMCC particles is reported in table 5.3. CS and CSMCC particles presented 
an irregular shape (Fig. S 5.1) and had a significantly higher particle size than those in the 
PMMA powders. The particle size of the employed PMMA was in the range 30-150 μm, as 
typically found in commercial bone cements [293]. When comparing the VMD (volume 
median diameter) values of CS and CSMCC, a statistically significant difference was found, 
indicating that CSMCC powder was slightly bigger than CS powder (Table 5.3). 
 
 
Table 5.3. Average particle size, as determined by laser diffraction, expressed as Sauter mean diameter 
(SMD) and volume median diameter (VMD) of CS, CSMCC and PMMA powders. The values are reported as 
mean ± SD (n≥3). Dunnett’s multicomparison test was used to compare SMD and VMD of CS and CSMCC with 
the ones of PMMA: a p<0.05. T-test was used to compare CS and CSMCC: b p<0.05. 
Material SMD (μm) VMD (μm) 
PMMA 34.6 ± 19.6 290.5 ± 171.6 
CS 120.3 ± 21.8(a) 533.0 ± 32.1(a) 
CSMCC 138.7 ± 53.9(a) 630.3 ± 39.9(a,b) 
 
 
 
5.3.1.1 Antibacterial properties of CS and CSMCC powders  
 
The bacteriostatic potential of CS and CSMCC powders were tested against S. aureus by 
measuring the absorbance of the bacterial suspension after 12 h of incubation in LB (Fig. 
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5.3). The compounds were studied in suspension as this is the physical form in which the 
chitosan and modified chitosan were incorporated in the poly(methyl methacrylate) 
cements. While bacterial growth was detected for all concentrations studied, results 
showed that concentrations equal or higher than 2 mg/ml were required to significantly 
affect bacterial growth. In this respect, no differences were noticed between chitosan and 
modified chitosan. 
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Figure 5.3 Antibacterial properties of CS and CSMCC. Optical density (OD600nm) of S. aureus suspension in 
presence of medium as control (black bars), CS (light grey bars) and CSMCC (dark grey bars) in suspension at 
different concentrations. Data are reported as a mean ± SD (n=3). One-way ANOVA returned p <0.05, results 
of the Dunnett’s multiple comparison test are reported in the graph (*p=0.047; **p=0.0027; ***p=0.003; 
****p<0.0001). The t-test performed between CS and CSMCC at different concentrations revealed no 
statistical difference (p>0.05). 
The poor antibacterial activity observed for all chitosan powders studied in comparison 
to other literature reports can be possibly explained considering the relatively high pH of 
the suspension (in our study the pH was neutral, around 7.0), while the majority of studies 
using chitosan have been carried out at a pH lower than the pKa of chitosan; in an acidic 
environment chitosan is protonated, and thus capable of interacting with the negatively 
 
 
 
 
 
 
  
 
O
 D
 6
 0
 0
 n
 m
 
183  
charged bacteria surface). For example, Erdem et al. tested the antibacterial activity of 
chitosan against S. aureus at different pH values [294]. The higher activity was observed 
with lower pH values and it was significant for pH lower than 6. Tsai and Su have shown 
that at pH 7.0, chitosan reduced cell number by 3 log, while at pH 9.0 no bactericidal activity 
was found [295]. 
 
 
5.3.1.2 Experimental peak temperature and setting time of cements  
 
Commercially available acrylic bone cement is typically activated by mixing a powder 
containing PMMA, benzoyl peroxide (radical initiator) and barium sulphate (radiopaque 
agent), with a liquid composed of MMA (monomer), hydroquinone (stabilizer) and N,N- 
dimethyl-p-toluidine accelerator that encourages the polymer and monomer to polymerise 
at room temperature (cold curing cement). 
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Figure 5.4 Imaging of cements. (A) Representative micro-CT image of a whole PMMA_2:1 cement and (B) a 
cross section of the same specimen. (C) SEM image of PMMA_2:1 PMMA_2:1 surface region of interest; the 
arrow shows a PMMA bead within the solidified cement. 
When the two components are mixed together, the liquid monomer polymerizes around 
the pre-polymerized PMMA particles (Fig. 5.4 C) to form hardened PMMA (Fig. 4.4 A- 
B)[296]. 
One of the major problems with the clinical use of PMMA cements is that the exothermic 
radical process initiated by mixing induces a risk of local tissue necrosis. According to ISO 
5833:2002 the maximum temperature for acrylic resin cements should be ≤ 90°C, where 
temperatures lower than 56°C would ensure a reduced tissue necrosis (e.g. collagen) at the 
interface between the cement and the natural tissue [297]. Thus, in this study we registered 
the temperature, within the cements, during the polymerization process. For each bone 
cement investigated in this study, the maximum temperature decreased compared to 
PMMA 2:1 control (66.7±8.7°C) (Fig. 5.4 A and B). In particular, concentrations of 
CS/CSMCC equal to or higher than 20% showed a significant reduction in polymerization 
temperature (e.g. CS20%_0.8 resulted in p < 0.01 and CSMCC20%_1 resulted in p < 0.05). 
On the other hand, when the P/L ratio decreased to 2:0.8, the exothermic reaction 
temperature decreased, even though it was not statistically different for any of the samples 
(p>0.05). The lowest polymerization temperatures of CS enriched cements were recorded 
for PMMA CS30%_0.8 (45.4±3.4°C) and PMMA CS30%_AgNWs_0.8 (44.22±1.4°C), whereas 
for  CSMCC  for  PMMA  CSMCC30%_0.8  (44.9±7.6°C)  and  PMMA CSMCC30%_AgNWs_1 
(45.0±2.5°C). It was previously shown that the introduction of nanoparticles, such as MgO, 
HA, CS, BaSO4 and SiO2 reduced the peak polymerization temperature. This behavior may 
be due to the potential of homogeneously distributed additives to dissipate the heat 
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generated by polymerization reactions throughout the bone cement material [298]. 
Furthermore, Haas et al. suggested that by decreasing the ratio between the initiator and 
MMA, the exothermic temperature can decrease due to the incomplete polymerization 
occurring in the system [299]. 
According to ISO 5833:2002, the ideal setting time for acrylic resin cements, depending 
on the usage, should be between 3 to 15 min. In our work, we found that the setting time 
increased with the addition of increasing concentrations of CS/CSMCC (Fig. 5.5 C and D), 
from nearly 667.17±28.1 sec (ca. 11 min) of PMMA_1 to 843.8±2.9 sec (ca. 14 min) of 
PMMA CS30%_1. These findings are in good agreement with what was reported in 
literature for the reaction rate of free radical homo polymerization reactions. Indeed, it has 
been shown that the polymerization rate is proportional to the monomer concentration 
and to the square root of initiator concentration. Thus, the lower the concentration of 
initiator (benzoyl peroxide in our formulation), the longer the polymerization time required 
[300]. Moreover, we observed that the setting time of PMMA decreased with increasing 
the P/L ratio. The faster setting times with an increased ratio between initiator and MMA 
could be explained by a faster radical formation. 
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Figure 5.5 Setting properties of cements. Peak polymerization temperatures of PMMA cements containing 
CS (A) or CSMCC (B) and setting time of PMMA based cements, containing CS (C) or CSMCC (D), with different 
ratios of P/L. Data are reported as a mean ± SD (n=6). One-way ANOVA returned p <0.05, results of the 
Dunnett’s multi comparison test, used to compare all the samples with the PMMA control, are reported in 
the graph (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
 
 
 
5.3.1.3 In vitro degradation studies.   
 
The porosity and pore size distribution of composite cements was evaluated by X-ray 
micro computed tomography (X-ray micro-CT). During the polymerization process, voids 
and bubbles are inevitably created due to the entrapment of air that cannot be released 
mainly due to the cement paste viscosity. Moreover, in cements containing biodegradable 
materials, such as chitosan, it is expected that a degree of degradation would take place 
over time with an increase in porosity. Micro-CT allows to distinguish between different 
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materials according to their different X-ray attenuation. In this study, samples of PMMA 
control and cements containing 20% CS or CSMCC were scanned. 
PMMA-CS sample analyzed before degradation seemed to have a significantly higher 
porosity than PMMA only (p<0.05), whereas the PMMA_2:1_CSMCC20% was not 
statistically different. Furthermore, the cement containing CS (p<0.05) and CSMCC 
underwent degradation during a 4-week incubation period in PBS, but not significant 
degradation was shown in the PMMA only cements (Fig. 5.6 A). 
 
 
 
Figure 5.6 Pore volume and pore size of cements. Percentage pore volume (A) of PMMA (black), PMMA 
after 4 weeks (grey), CS_20% (red), CS_20% after 4 weeks (orange), CSMCC_20% (dark green) and 
CSMCC_20% after 4 weeks (light green). Data are reported as a mean ± SD (n=3). The t-test was performed 
between the same cement type before and after soaking ($p=0.029). One-way ANOVA returned *p=0.040 
when comparing the % pore volume of CS_20% or CSMCC_20% to PMMA before degradation in PBS; results 
of the Dunnett’s multiple comparison test are reported in the graph. One-way ANOVA returned &p=0.0062 
when comparing the % pore volume of CS_20% or CSMCC_20% to PMMA after degradation in PBS; results of 
the Dunnett’s multiple comparison test are reported in the graph. (B) Diameter distribution of pore diameter 
(μm) with relative frequency for PMMA (black), PMMA after 4 weeks (grey), CS_20% (red), CS_20% after 4 
weeks (orange), CSMCC_20% (dark green) and CSMCC_20% after 4 weeks (light green). 
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Results from pore size analysis (Fig. 5.6 B) show PMMA_2:1 cements presented an 
average pore size of 12.2 ± 10.1 μm before degradation; the pore size was statistically not 
different after incubation; PMMA_2:1_CS20% average pore size was 11.6 ± 13.4 μm before 
and 13.1 ± 10.9 μm after degradation and the degree was degradation was statistically 
different between the two time points; similarly PMMA_2:1_CSMCC20% had a pore size of 
11.59±9.22 μm before and 13.59±12.42 μm after degradation, but it was not statistically 
different (p>0.05). PMMA cements before and after degradation had a narrower pore size 
distribution in comparison to the cements containing CS or CSMCC both before and after 
degradation. 
In order to further assess the composite cements, in vitro degradation was evaluated by 
a gravimetric method. This method is considered the golden standard for in vitro wear 
assessment [250]. This provides information about global mass loss, though it does not give 
any information about the distribution of wear within the material. As shown in Table 5.2, 
PMMA-only cements showed a poor weight loss (0.09±0.09% and 0.12±0.12%, for 
PMMA_2:1 and PMMA_2:0.8, respectively), whereas CS and CSMCC based cements 
presented higher weight loss, that increased with the increase of the polysaccharides 
concentration, as expected. For instance, the calculated weight loss for PMMA_CS_2:1 
samples increased from 0.16±0.25 to 0.68±0.57 and finally 3.66±1.03%, for 10, 20 and 30% 
chitosan content, respectively. No statistical difference between the two MMA 
concentrations was found. These results indicate that the degradation rate of these 
cements can be controlled by changing the additives concentration. 
Water absorbance increased with the increase of CS or CSMCC up to nearly 13 % (Table 
5.2). Similar trends are reported in literature for chitosan-based polyester and poly(methyl 
methacrylate) cements[249]. This trend can be justified in two different ways: the presence 
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of chitosan that is hygroscopic promoted the water absorption by the scaffold, while this 
was not possible in PMMA only cements that are hydrophobic. Alternatively, a higher 
porosity and/or interconnectivity of the material, due to chitosan degradation, could 
promote water retention within the scaffold (as suggested from micro-CT scans). No 
statistical difference was determined between CS and CSMCC based cements (p<0.05). 
 
 
 
 
5.3.1.4 Mechanical properties  
 
The evaluation of the mechanical properties of PMMA cements is crucial for determining 
their long-term stability in their conventional application where they are required to 
transfer loads between bones and implants[248]. One of the major problems related to 
standard PMMA cements is the mismatch between the mechanical properties of the 
cement and the bone, especially in the case of osteoporotic bone. Standard PMMA cements 
have an elastic modulus of about 3 GPa, while trabecular bone has a value between 20 and 
800 MPa [301-303]. Compressive strength of PMMA cement and vertebral cancellous bone 
are around 100 MPa and 1–15 MPa, respectively.27 Consequently, vertebral augmentation 
with PMMA has been shown to increase the risk of fracture of the adjacent vertebral bodies 
[302].Therefore, it is important to reduce both the stiffness (elastic modulus) of the scaffold 
and its compressive strength, without compromising the long-term functionality of the 
prosthetic fixation. Knets et al. reported that increasing the porosity of the PMMA based 
bone cements, it was possible to reduce the flexural modulus of elasticity [304], without 
affecting the flexural strength. Another solution to reduce the Young’s modulus of the 
PMMA cements is to load the cements with additives: for instance, Tan et al. added 
hydroxypropyltrimethyl ammonium chloride chitosan (HACC) into PMMA 
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bone cement at different mass ratios, showing a significant reduction of the elastic modulus 
when mass ratios ≥ 20% were used [305]. Thus, in this study we incorporated increasing 
mass ratios of CS/CSMCC in order to study whether the mechanical properties of PMMA 
cements could be improved. 
Surgical PMMA cement is brittle in nature. Like all brittle materials, it is weak under 
tension but quite strong in compression, and is capable of yielding under uniaxial 
compression. Therefore, the yield strength was determined in compression. Another 
reason for this choice is that the main direction of load on bone cement in a total hip 
implant is compression. 
The compressive strength and elastic modulus of PMMA loaded with CS and CSMCC at 
different mass ratios are shown in Fig. 5.7. The compressive strength and elastic modulus 
generally decreased increasing the mass ratio of CS or CSMCC in the mixture. This trend is 
in good agreement with what reported by Dunne et al. for PMMA bone cements  (Palacos 
R) loaded with chitosan, at lower concentrations (1, 3 and 5 % wt/wt) [306]. or by Tan et al. 
which incorporated 20% chitosan into PMMA bone cements (CMW Endurance Bone 
Cement) [307]. When AgNWs were included in the formulation, no statistical differences 
were reported from the corresponding cement. This trend has been also reported by Slane 
et al., who incorporated 1.0% wt/wt silver nanoparticles into acrylic bone cements [289]. 
When the ratio between powder and liquid was 2:1, the compressive modulus and elastic 
modulus were significantly decreased with the inclusion of 30% CS. The decreased 
mechanical properties when CS or CSMCC were incorporated can be attributed to the 
presence of less chemical links inside the cements and possibly the presence of loose 
powder. On the other hand, when the ratio between powder and liquid was 2:0.8, the 
compressive strength was significantly different for lower concentrations of CSMCC (20%). 
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The mechanical performance was also evaluated after the in vitro degradation study 
carried out for 4 weeks, however no significant differences were determined with an 
unpaired t- test (p>0.05) (data not shown). 
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Figure 5.7 Compressive strength (MPa) and Young’s modulus (MPa) of composites cements, based A) CS 
and B) CSMCC. Results are reported as a mean ± SD (n=6). One-way ANOVA returned p<0.05, results of the 
Dunnett’s multicomparison test (used to compare all the samples with the PMMA_2:1) are reported in the 
graph (*p<0.05). Unpaired t-test was performed to compare each formulation containing a weight to volume 
ratio of 2:1 with the respective formulation containing a weight to volume ratio of 2:0.8 ($ p<0.05). Young’s 
modulus (MPa) of C) CS and D) CSMCC. One-way ANOVA returned p<0.05, results of the Dunnett’s 
multicomparison test, used to compare all samples with PMMA control, are reported in the graph (*p<0.05). 
Unpaired t-test was performed to compare each formulation containing a weight to volume ratio of 2:1 with 
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the respective formulation containing a weight to volume ratio of 2:0.8 ($ p<0.05). Results are reported as a 
mean ± SD (n=6). 
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5.3.1.5 Silver release studies from cements  
 
A release study of silver ions was performed in deionized water for a period of 21 days, 
and the cumulative release profiles are presented in Fig. 5.8. The bone cements loaded 
with AgNWs continuously released Ag+ ions to the surrounding water (the amount of silver 
increased significantly within the first day, but then it reached a plateau phase). No 
statistical difference was found between the different cements studied (p>0.05), even 
though the cements containing CS/CSMCC presented a higher Ag+ release at any time point. 
The total cumulative release was well below the potential toxic limit of 10 ppm for human 
cells [308]. 
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Figure 5.8 Cumulative release of silver ions from bone cements: PMMA_AgNWs_1 (black), 
PMMA_AgNWs_0.8 (red), PMMA_CS20%_AgNWs_1 (blue), PMMA_CS20%_AgNWs_0.8 (green) 
PMMA_CSMCC20%_AgNWs_1 (yellow), PMMA_CSMCC20%_AgNWs_0.8 (purple). Data are reported as a 
mean ± SD (n=3). One-way ANOVA, at 21 days, returned p >0.05. 
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5.3.1.6 Antibacterial properties of cements  
 
The antimicrobial properties of the bone cements were determined using an MTT assay 
after 24 h of immersion in a suspension of S. aureus. PMMA only cements presented lower 
bacteria attachment than the cements containing also CS or CSMCC powders (Fig. 5.9). In 
particular, when CS or CSMCC were used at concentrations higher or equal to 20%, the 
bacterial attachment was statistically higher than PMMA only. The lack of antibacterial 
activity of chitosan powders into PMMA cements was already highlighted by Dunne et al. 
[309], which incorporated chitosan at concentrations up to 5%. Indeed, they reported that 
the adherence of S. aureus was similar to the controls both at 6 h and 72 h. On the other 
hand, our results are in contrast with what reported by Shi et al, which showed a significant 
reduction in S. aureus adherence to a PMMA cement (Smartset without gentamicin) loaded 
with a CS to bone powder ratio of 15% [310]. However, Shi et al, studied the bacterial 
attachment at 3 h, whereas in our study, we used an attachment time of 24 h to allow a 
higher bacterial adhesion. Furthermore, they have used a different bacterial strain (ATCC 
25923) from our study (ATCC 12403). 
We have hypothesized that this behavior may be due to the physical form of CS or CSMCC 
powders that act as physical supports for the attachment of bacteria, as previously 
reported for chitosan microspheres [311] or powders/flakes [312]. Attachment of bacteria 
to chitosan is due to electrostatic interactions between the positively charged chitosan with 
the negatively charged cell surface. 
On the other hand, when AgNWs were incorporated within the formulation they induced 
a significant reduction of the viable bacteria attached to the cement for all the studied 
formulations (p<0.05), except for CS/CSMCC 10%. These results re in good agreement with 
what reported by Prokopovich et al. which showed significant reduction of bacterial 
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attachment on PMMA cements loaded with 0.05% silver nanospheres (5.3±2.3 nm)[288]. 
Our findings show that also AgNWs loaded PMMA cements can reduce biofilm formation 
on bone cements. Future studies should focus on testing lower concentrations of AgNWs 
in order to understand the extent of this antibacterial activity. 
 
 
 
Figure 5.9 Biofilm inhibition formation. Absorbance relative to number of bacterial cells on cements 
(P/L=2/1) surfaces obtained by MTT assay after 24 hours. (A) PMMA based cements containing CS. (B) PMMA 
based cements containing CSMCC. Data are reported as mean ± SD (n=4). One-way ANOVA returned p<0.05, 
results of the post-hoc Tukey’s multicomparison test are reported in the graph (*p<0.05). Unpaired t-test was 
performed to compare each formulation with and without AgNWs. * represents p<0.05, ** represents 
p<0.01, *** represents p<0.001 and **** represents p<0.0001. 
 
 
 
5.3.2 Evaluation of the cytocompatibility of the composite cements 
 
In this study, we explored the indirect effect of cement eluates (Fig. 5.10 A and B) and the 
direct toxicity of PMMA cements (Fig. 5.10 C and D). 
The use of eluates has the advantage of simulating the postsurgical release of toxic 
leachables into the surrounding bony environment. Moreover, through serial dilutions it is 
possible to evaluate the dose-dependent effect. To investigate the toxicity of the extracts, 
cements were soaked in complete medium, using a liquid to solid ratio of 5:1, according to 
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EN ISO 10993-12 standard (1996). The extracts were sterilized by filtration using a 0.2 μm 
pore membrane to avoid artefacts due to any other sterilization process. Herein, the 
cytotoxicity of cement extracts was evaluated on sheep mesenchymal stem cells. Data 
show the percentage cell viability after 1 and 2 days of incubation with extracts. No 
statistical difference was found for the same formulation after 24 and 48 hours of exposure 
(p>0.05), except for PMMA_AgNWs_1 (p=0.0119). The cell viability at 24 h was higher than 
80% for all cements with a P/L 2:1 at 24 hours, except for the cements containing 20% of 
CS or CSMCC and AgNWs that seemed to significantly decrease the cell viability since the 
first day of exposure, e.g. PMMA_CS20%_AgNWs_1 (51.6±31.5%), 
PMMA_CSMCC20%_AgNWs_1 (55.6±36.6%), PMMA_CS20%_AgNWs_0.8 (52.4±9.3%) and 
PMMA_CSMCC20%_AgNWs_0.8 (45.2±30.9%). Instead, the diluted extracts (50%) 
presented a cell viability that was always superior to 80%, indicating a dose-dependent 
effect (data not shown). When comparing the two different concentrations of MMA at 
different time points, no statistical difference was found (p>0.05). Overall these results 
suggest that with the addition of CS/CSMCC (and consequently reduction of bone cement 
powder) in the formulation, less liquid cement could react with the initiator and more 
toxicants seemed to be released from the cements over time. Future studies are needed to 
confirm this hypothesis, through the characterization of the eluents using mass 
spectrometry techniques. 
Adenosine triphosphate (ATP) is a common marker for cell viability and cell proliferation 
as it is present in all metabolically active cells. The amount of light produced during the 
assay is proportional to the ATP concentrations within the cells. In this work, this assay has 
been employed to assess the cell proliferation after 1 and 3 days of seeding cells onto the 
cement surfaces. It was found that there was a significant difference in ATP levels during 
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the incubation time for samples containing PMMA only with (p=0.021) and without AgNWs 
(p<0.0001) and CS/CSMCC in low amounts: PMMA_CS10% (p<0.0001), 
PMMA_CS10%_AgNWs (p=0.0170), PMMA_CSMCC10% (p=0.0203) and PMMA_CS20% 
(p=0.0125). For higher concentrations, the increase of ATP was not statistically significant 
(p>0.05). Moreover, it can be seen that an increase of CS/CSMCC lead to a significantly 
reduced cells number in comparison to the control at any time point. These results are in 
good agreement with what reported by Tan et al. that loaded PMMA-based cements with 
chitosan powder at 20% wt/wt (PMMA-C) 34. Compared with PMMA, PMMA-C cements 
presented a lower proliferation rate. These results are in agreement with the cytotoxicity 
studies on the extracts: the increase of the ratio between bone cement liquid and bone 
cement powder decreases cell viability, over time. 
On the other hand, the inclusion of AgNWs did not interfere with cell proliferation in 
comparison to their controls. 
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Figure 5.10 Cytotoxicity of cements on mesenchymal stem cells. Cytotoxicity was tested against the cements 
eluates (A and B) and by direct contact of cells with cements (C and D). Toxicity of extracts from cements of 
P/L ratio 2:1 (A) and 2:0.8 (B) at 24 (left column) and 48h (right column). Data are reported as mean ± SD 
(n≥3). One-way ANOVA returned p <0.05, results of the post-hoc Tukey’s multicomparison test are reported 
in the graph (*p<0.05). Unpaired t-test was performed to compare each formulation with or without AgNWs. 
ATP assay for MSCs after 1 day and 3 days of incubation on CS cements (C) and CSMCC cements (D) One-way 
ANOVA was carried out to compare ATP levels of each cement to PMMA 2:1 at day 1 and day 3 and showed 
statistical difference (p<0.05). Results of Dunnett’s multi comparison are reported in the graph; in particular, 
$ represents p<0.05, $$ represents p<0.01, $$$ represents p<0.001 and $$$$ represents p<0.0001, at day 1. 
£ represents p<0.05, ££ represents p<0.01, £££ represents p<0.001 and ££££ represents p<0.0001, at day 
3.The t-test was performed to compare each type of cement at 1 day and 3 day (* represents p<0.05, **** 
represents p<0.0005). 
 
 
 
 
5.4 Conclusions 
 
CS and CSMCC were added to PMMA cements in concentrations ranging from 10 to 30% 
wt/wt. Reduction of the polymerization temperature was found to be dose-dependent and 
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to be significantly reduced for concentrations higher than 10%. 
 
An increased water uptake and weight loss was found in the cements containing chitosan 
or modified chitosan in comparison to the controls; the effect was more noticeable with an 
increase in their concentration. The compressive strength and elastic modulus generally 
decreased with the increasing mass ratio of CS or CSMCC in the mixture; the same trend 
was observed for cytotoxicity. No statistical differences were observed between the 
materials containing either chitosan or methacryloyl chitosan. 
The results of the in vitro studies have demonstrated that the incorporation of AgNWs in 
PMMA-chitosan cements in a concentration of 1% wt/wt can be a viable approach to 
prevent S. aureus infections on the scaffold, while not affecting their mechanical properties 
and cytocompatibility. These systems demonstrated a long term release of Ag+ ions in an 
aqueous medium, suggesting potential antimicrobial activity over an extended period of 
time. 
This study suggests that the inclusion of CS/CSMCC (between 10 and 20%) and AgNWs 
(1%) in the existing commercial materials can provide bone cements with good results in 
terms of cytocompatibility combined with appropriate thermal, mechanical, and 
antibacterial properties. 
Future studies should focus on testing methacryloyl chitosan with higher degrees of 
substitutions in order to evaluate whether mechanical properties and toxicity properties 
may be improved. 
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5.5 Supplementary information 
 
5.5.1.1 Imaging of powders  
 
 
As part of the study, photos of powders were taken using a light microscope (Fig. S5.1). 
 
Figure S5.1 Light microscope images of (A) PMMA, (B) CS and (C) CSMCC particles. Magnification 10X. Scale 
bar 84.46 μm. 
 
 
 
 
5.5.1.2 SEM characterization of cement surfaces  
 
 
SEM images of cement surfaces were taken before and after degradation in PBS for 4 
weeks. The SEM images (Fig. S5.2) revealed the presence of PMMA beads (arrow), 
incorporated into a homogeneous polymerized MMA cement interspersed with uneven 
holes of different diameters. These features can be attributed to the manual powder mixing 
method and cylinder preparation in comparison to the clinical one. According to previous 
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studies, some studies have shown better osteoconductivity for substitutes with the pore 
size between 200 and 600 μm, whereas other reports have shown no significant difference 
in osteoconductivity among different pore sizes. Images showed an increased porosity on 
the cements surfaces before and after degradation, whenever CS/CSMCC were present in 
the formulation. 
 
 
Figure S5.2 SEM images of cements surfaces. X200 magnification. (A) PMMA_2:0.8, (B) 
PMMA_2:0.8_CS20 and (C) PMMA_2:0.8_CSMCC20. Arrow indicates PMMA beads within the cement. 
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Conclusions and Future work 
 
 
6.1 Conclusions 
 
Bone-related infections are common complications that can follow repair of a traumatic 
bone fracture of the surgical intervention for joint replacement. They can be exacerbated by 
osteomyelitis, which involves the inflammatory destruction of the joint and the bone with 
consequent implant failure, and as such they have a big impact on patience quality of life 
and cost of treatment [167]. Furthermore, the increased number of bacteria developing 
resistance to commonly used antibiotics further complicates the problem. As such, current 
treatment strategies for device-related infections are limited, often causing significant 
patient morbidity, at high economic cost. Thus, the development of alternative strategies to 
prevent bacterial bone infections is a topical and timely need. As an alternative to antibiotics, 
silver nanoparticles have been attracting increasing attention since they have shown 
potential antibacterial properties against a wide range of microorganisms combined with 
optical and electrical properties that make them interesting for a variety of biomedical uses 
[69, 91]. 
The aim of this project was to develop and characterize novel composite materials with 
inherent antibacterial properties for bone repair and bone regeneration applications. In 
particular, we formulated a hydrogel and a bone cement containing AgNWs as antibacterial 
agents. 
In the first part of the work, we successfully synthesized AgNWs, in presence and absence 
of CNTs and observed that the two materials presented similar physiochemical 
characteristics. CNTs were found to guide the formation of AgNWs on their external surface 
and promote AgNWs formation at lower temperature. Both nanomaterials presented 
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bacteriostatic and bactericidal activity against four different bacterial strains (E. coli, S. 
aureus, MRSA and S. saprophyticus) in a dose dependent manner. The antibacterial activity 
seemed to depend on the specific bacteria tested rather than on whether they were Gram 
positive or Gram negative. Both ROS generation and membrane damage were found to effect 
the toxicity observed. Also cytotoxicity of AgNWs against mammalian cells ((human foreskin 
fibroblasts (Hs27), human colon adenocarcinoma (Caco-2) and human osteoblasts (hFOB 
1.19)) was found to be dependent on cell type, dose and incubation time with ROS formation 
playing a major role. Preliminary studies on osteoblasts also showed that AgNWs were 
efficiently internalized by the cells. 
 
In the second part of the work, we formulated a thermosensitive chitosan-based hydrogel 
enriched with HACS and AgNWs to promote both remineralization of the implant and to 
prevent biofilm formation. The inclusion of AgNWs showed to improve the hydrogel strength 
without interfering with gelation time and Ca/P deposition. Further antibacterial in vitro 
studies showed that the composite formulation was capable of inhibiting bacterial growth in 
suspension and preventing biofilm formation on the scaffold against E. coli, S. aureus, MRSA 
and S. saprophyticus. Finally, in vitro studies showed the scaffold’s ability to promote MC3T3 
cells proliferation. 
 
In the third part, AgNWs were added in commercial PMMA bone cements containing 
different weight ratios of CS/CSMCC, ranging from 10 to 30 % wt/wt. Initially, CSMCC was 
successfully synthesised with a degree of substitution of ca. 25.7%. Increasing the 
concentration of additives in cements significantly reduced the polymerization 
temperature, possibly decreasing the risk of tissue necrosis in vivo. Furthermore, the elastic 
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modulus was reduced with increasing concentrations of chitosan, with potential effect in 
decreasing the mechanical mismatch between the cement and the trabecular bone. AgNWs 
(1% wt/wt) significantly reduced the number of viable S. aureus cells on the scaffold, while 
not affecting the mechanical properties of the composite materials. AgNWs loaded 
cements  demonstrated  a  long  term  release  of  Ag+     ions  in  water,  suggesting  potential 
antimicrobial activity over an extended period of time. Cytotoxicity studies showed the 
higher the concentrations of CS/CSMCC included in the cements, the higher the cytotoxicity 
of the cements’ extracts and the lower the proliferation on the cements, probably due to 
an increased amount of unreacted reagents, such as MMA. This study suggests that the 
inclusion of CS/CSMCC (between 10 and 20%) and AgNWs (1%) in the existing commercial 
materials can provide bone cements with good results in terms of cytocompatibility 
combined with appropriate thermal, mechanical, and antibacterial properties. No 
statistical differences were recorded between CS and CSMCC. 
 
Overall, this project shows that the inclusion of AgNWs, at appropriate concentrations, 
could be beneficial for preventing biofilm formation in soft and hard scaffolds for bone 
regeneration, without significantly affecting cell viability. 
 
6.2 Future work 
 
1) Evaluation of antibacterial and cytotoxicity properties of silvernanowires and their 
composites with carbon nanotubes for biomedical applications. 
 
Future work will focus on more in depth exploration of AgNWs mechanism of action in 
bacteria and mammalian cell assessing: 1) the contribution of Ag+    ions release; 2) possible 
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DNA damage; 3) AgNWs internalization through TEM and fluorescence microscopy; 4) 
alteration of mitochondrial membrane potential (ΔΨm) in eukaryotic cells and 5) activation 
of apoptosis pathways. 
 
2) Injectable composite gels containing silver nanowires as bone scaffold material 
 
 
Future work will focus on confirming osteoblasts differentiation through the observation 
of expression of other markers which are up-regulated during later stages of bone formation, 
such as RUNX2 (Runt-related transcription factor 2), osteocalcin and osteopontin [313]. 
RUNX2 should show an increase at about 14 days, whereas osteocalcin and osteopontin 
should increase through 14-21 days in culture. Further in vitro studies should be carried out, 
implanting the scaffold into rat calvarial bone tissue defects. New bone formation can be 
evaluated over two months via micro-CT and histology. Hydrogels can also be loaded with 
growth factors (e.g. BMP-2) to improve their osteogenic properties, as it has been 
demonstrated that chitosan-based hydrogels are able to release macromolecules in a 
controlled manner [254]. 
 
 
3) Novel antibacterial PMMA composites as alternative bone cements with tunable 
thermal and mechanical properties 
 
 
Future work should focus on testing in vitro biocompatibility of the cement in an animal 
model infected with S. aureus. X rays, microbiological and histopathological analyses should 
be carried out after two months to evaluate bone formation and efficacy of the antimicrobial 
effect. 
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Abstract 
 
Age related bone diseases such as osteoporosis are considered among the main causes of 
reduced bone mechanical stability and bone fractures. In order to restore both biological and 
mechanical function of diseased/fractured bones, novel bioactive scaffolds that mimic the 
bone structure are constantly under development in tissue engineering applications. Among 
the possible candidates, chitosan-based thermosensitive hydrogel scaffolds represent ideal 
systems due to their biocompatibility, biodegradability, enhanced antibacterial properties, 
promotion of osteoblast formation and ease of injection, which makes them suitable for less 
invasive surgical procedures. As a main drawback, these chitosan systems present poor 
mechanical performance that could not support load-bearing applications. In order to 
produce more mechanically-competent biomaterials, the combined addition of 
hydroxyapatite and carbon nanotubes (CNTs) is proposed in this study. Specifically, the aim 
of this work is to develop thermosensitive chitosan hydrogels containing 
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stabilised single-walled and multi-walled CNTs, where their effect on the 
mechanical/physiochemical properties, calcium deposition patterns and ability to provide a 
plat- form for the controlled release of protein drugs was investigated. It was found that the 
addition of CNTs had a significant effect on the sol–gel transition time and significantly 
increased the resistance to compression for the hydrogels. Moreover, in vitro calcification 
studies revealed that CNTs played a major role in maintaining a stable 3D-structure, allowing 
a more homogeneous deposition of salts essential for the correct repair of fragile or 
fractured bones. 
 
 
 
 
8.1 Introduction 
 
Bone is a dynamic, mineralised and highly vascularised tissue whose major functions are 
body support, motion and organ protection. Major alterations in its structure, due to injuries 
or metabolic diseases, can cause long-term pain, infection, inflammation and loss of mobility 
that can lead to a general decrease in functionality and quality of life [1]. Current therapies 
for complex bone fractures are mainly based on auto- and allo- bone grafts, or on the use of 
inert materials such as metals and ceramics that replace bone. These invasive strategies 
have, however, many serious limitations such as an inadequate revascularisation and 
mineralization of the bone grafts, risk of infection, rejection and immunoreaction [2]. 
Bone tissue engineering (BTE) provides an interdisciplinary approach to promote the 
physiological regeneration of bone tissues, overcoming the downfalls of current methods. 
BTE research focuses on developing bioactive scaffolds that, mimicking the bone structure, 
work as temporary matrices for cell proliferation, extracellular matrix deposition and 
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vascularization of newly formed tissue [3, 4]. In order to reach these targets, an ideal scaffold 
for BTE applications should possess the following properties: have a porous structure; be 
biocompatible; have good mechanical properties to support tissue ingrowth; be fully 
biodegradable; resorb while bone formation occurs, eliminating the need for a revision 
surgery; not form toxic products; and finally deliver bioactive molecules or drugs in a 
controlled manner where needed [5]. 
Among the possible scaffolds for tissue engineering, hydrogels represent ideal systems due 
to their biocompatibility and biodegradability [6, 7]. These gels can be formulated from 
different natural polymers such as collagen, chitosan, fibrin, hyaluronic acid and alginate. 
Chitosan is a linear polysaccharide derived from N-deacetylation of chitin, which is commonly 
found in the exoskeletons of crustaceans and insects [10]; its biocompatibility, antibacterial 
properties and structure amenable to simple chemical modifications, make chitosan a very 
interesting polymer for biomedical applications [11]. Chitosan only hydrogels present poor 
bioactive and mechanical properties; however, we have previously demonstrated that the 
combined addition of hydroxyapatite (HA) and carbon nanotubes (CNTs) can improve gels 
properties [12]. HA is a natural, nontoxic and bioactive ceramic, shown to enhance 
osteoconduction, bone bonding and stiffness in scaffolds. Moreover, HA favours deposition 
of calcium phosphate, improving the bone-matrix interface strength [13, 14]. 
Carbon nanotubes are cylindrical molecules of carbon atoms in sp2 conformation with 
outstanding chemical, electrical, mechanical and thermal properties [15]. They have recently 
been shown to have a role in the differentiation of osteoblasts suggesting that they might 
have a double function in scaffolds for BTE as structural reinforcement and osteinductive 
materials [16]. However, their application is dependent on their successful dispersion in 
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physiological conditions. In fact, CNTs have a tendency to form large bundles in aqueous 
media, resulting from Van der Waals interaction and π-π stacking [17-19]. Such bundles may 
cause slippage between nanotubes, become stress concentrators or initiate cracks under 
applied forces. Many covalent and non-covalent modifications of CNTs have been proposed 
in order to increase their water dispersability and hence their biocompatibility. Non-covalent 
modifications, in particular, are based on the absorption or the wrapping of various 
functional molecules, such as biomolecules, polymers, surfactants and phospholipids around 
the carbon nanotubes [20]. In a previous study, we have demonstrated the possibility of 
efficiently stabilising SWCNTs with the amphiphilic and self-assembling chitosan derivative 
N-octyl-O-sulfate chitosan (NOSC) [21]. 
In the present study, we developed thermosensitive chitosan hydrogels containing NOSC 
stabilised CNTs (SWNTs or MWNTs). Our aim was to develop a more flexible formulation 
strategy by using non-covalent CNTs stabilisation instead of chemical grafting and studying 
the effects of this strategy on the mechanical and physicochemical properties of the 
formulations. Image analysis was used to qualitatively and quantitatively assess the effect of 
CNTs on salts deposition within the formulated hydrogels. The ability of the gel to provide a 
platform for the controlled release of protein drugs was also evaluated. 
 
 
8.2 Materials and methods 
 
8.2.1 Materials 
 
All salts and solvents, unless otherwise stated, were obtained from Fisher Scientific (UK). 
Sodium phosphate monobasic monohydrate, low viscosity chitosan from shrimp, glycerol 
phosphate disodium salt hydrate, tris(hydroxymethyl)amino-methane ((HOCH 2 ) 3 CNH 2 ), 
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albumin from bovine serum (BSA), albumin from chicken egg white (OVA) and QuantiPro™ 
Bicinchoninic Acid Assay Kit were obtained from Sigma-Aldrich (UK). L (+) –lactic acid 90% 
solution in water was obtained from Acros Organics (USA). Dialysis membranes (size 10, 
MWCO 12-14 KDa) were obtained from Medicell International Ltd (UK). MWCTs and SWCTs 
were purchased from Cheap Tubes Inc. (USA). The MWCTs used in the study were 8-15nm in 
diameter and 10-50µm in length. The SWCTs used were 1-4nm in diameter and 5-30µm in 
length. Di-potassium hydrogen orthophosphate anhydrous (K2HPO4 ) was acquired from 
British Drug Houses (UK) and troclosene sodium dehydrate from Guest Medical (UK). Water 
used in all experiments was purified water. N-octyl-O-sulfate chitosan and chitosan modified 
hydroxyapatite (HACS) were prepared as described previously [12, 21]. 
 
 
 
8.2.2 Formulation of hydrogels 
 
Clear solutions of chitosan were prepared by dissolving chitosan (200 mg) in lactic acid (0.1 
M, 7 ml), 86 mg of HACS were then added and dispersed by vigorous mixing and sonication. 
CNTs loaded formulations were prepared by addition of stable CNTs suspensions in NOSC (2 
ml), water was added to the control. NOSC suspensions of CNTs were obtained by adding 
CNTs (2.5 mg) to a solution of NOSC (1.25 mg/ml) sonicating for 2 hours, followed by 
overnight rest and further sonication for 1 h. A glycerol phosphate solution (1 ml, 1.12 g/ml) 
was then added to the vials and stirred for 10 min. Gelation was obtained by incubating the 
formulations at 37°C. The gels prepared were labelled CS (chitosan control gel), CS-HACS- 
SWNTs and CS-HACS-MWNTs (gels containing HACS and SWNTs or MWNTs, respectively). All 
gels were prepared in triplicate; gelation time was evaluated visually by the inversion 
method [22]. 
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8.2.3 Texture analysis of the gels 
 
A Texture Analyzer (XT plus, Stable Micro Systems Ltd, UK) was used to determine 
syringeability of the suspensions before gelation as well as the texture profile of the formed 
gels. The methods employed have been described previously by Yasmeen et al. [12]. Briefly, 
 
 
 
 
 
 
 
 
 
 (N∙mm). All measurements were performed at room temperature. 
 
 
 
8.2.4 Characterisation of the freeze dried hydrogels 
 
Freeze dried hydrogels were prepared from the suspension described above and then 
transferred into 24 well-plates (2 ml per well), before incubation at 37°C. Once formed, the 
gels were flash-freezed and freeze-dried (Edwards Micro Modulyo RV3, UK). The samples 
were characterized by FT-IR (Varian Spectrometer 640, UK), DVS (Surface Measurement 
Systems DVS Advantage, UK) and SEM (JEOL JSM-6060 LV Scanning Electron Microscope, 
UK). In the DVS analysis the mass change of the gels subjected to a changing water vapour 
partial pressure at 25°C was recorded. The partial pressure was increased from 0% to 90 % 
at incremental steps of 10%, where the next step was reached either after equilibrium or 
for syringeability the liquid formulations were loaded onto 5 ml plastic syringes fitted with 
19 G, 25 mm long needles. The vertically clamped syringe was actioned by the instrument 
probe (10 mm diameter) that compressed the barrel (1 mm/s) to a distance of 40 mm and 
the initial glide force, dynamic glide force and maximum force were measured. 
Compressibility tests were performed by depressing a polycarbonate probe (10 mm dia) 
into the gels at 1 mm/s up to a depth of 5 mm, six measurements were taken before and 
after the sol–gel transition took place. Gels were formed and tested in 14 ml glass vials. 
Force/displacement curves were obtained and used to calculate the gel compressibility 
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after a maximum time of 360 min. A full adsorption/desorption cycle was performed and the 
data collected were used to calculate the adsorption/desorption isotherms. 
 
 
8.2.5 In vitro calcification assay 
 
 
Calcification studies were performed to investigate the ability of the composite hydrogels 
to induce calcium salts deposition. Simulated body fluid (SBF), prepared according to Kokubo 
and Takadama [23], was used to mimic the in vivo environment, as it contains ions at very 
similar concentrations to those of human blood plasma. The freeze dried samples were 
inserted in a 50 ml tube to which 15 ml of SBF were added. Samples were incubated at 37°C 
for 7 or 14 days. The SBF was changed every 4 days. Finally, samples were dried under 
vacuum at 40°C overnight. Controls were hydrated in deionised water for 5 hours and dried 
as above. All samples were gold-coated with sputter coater (Polaron e500, Quoram 
Technologies, UK) and analysed by SEM, coupled with EDS (Silicon Drift Detector (SDD)−X- 
MaxN, Oxford Instruments, UK) and microCT (XTH225, Nikon Systems, UK). The microCT 
scanner was set to a voltage of 55 kV and a current of 75 μA. With an isotropic voxel size of 
10.6 μm and exposure of 2 s, the image acquisition was performed at a rotational step of 
0.23° over 360° for 90 min approximately. The images were then analysed using ImageJ 
(1.48v, NIH, USA) as described below. To quantify calcium deposition, image thresholding 
(global) based on the grey scale histogram was carried out to distinguish between the 
different material densities (different attenuation). Total volume of the sample and total 
volume of the denser material in the sample (i.e. the deposits of calcium salts) were obtained 
and the percentage of calcium deposition was calculated for each sample (n=5). EDS images 
for calcium (Ca) and phosphorus (P) were also analysed after being overlaid to corresponding 
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SEM images. The total area of overlapping for Ca and P onto the total sample surface area 
was used to calculate percentage of calcium and phosphorus salt deposition (n=3). 
 
 
8.2.6 Release of model drugs 
 
Release studies were performed including bovine serum albumin (BSA, 1mg/ml) in the 
hydrogels (5 ml). After the gelation of the samples, prepared in a 15 ml tubes (n=4), PBS (5ml) 
was added. The samples were then incubated at 37°C and at set time points 2 ml of PBS were 
sampled and replaced with 2 ml of fresh buffer. Release studies were also performed 
including ovalbumin (OVA, 1mg/ml) in the hydrogels. The suspensions were transferred (1g 
per sample) into a Flot-A-Lyzer G2 dialysis device (cut off 50 KDa ) and PBS (15 ml) was added 
to them. The samples were subsequently incubated at 37°C and at set time points the 
sampled buffer was replaced with fresh buffer. Determination of both BSA and OVA 
concentrations was carried out with a QuantiPro™ Bicinchoninic Acid Assay Kit (Sigma, UK) 
and samples prepared according to manufacturer’s instructions, reading the UV absorbance 
at 570 nm. Unloaded gels were used as a control to eliminate any false response due to 
chitosan interaction with the assay kit. The two drugs were tested with slightly different 
methods due to limitations imposed by their molecular weight. In order to compare the 
release profiles, these were calculated as percentage of drug release per unit of surface area 
of the gel in contact with the release medium. 
 
 
 
 
8.3 Results 
 
8.3.1 Texture analysis of the thermosentive hydrogels 
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A chitosan only formulation was used as a control to evaluate the effect of the addition of 
HACS and CNTs suspensions on the physical properties of gels before and after formation. 
The chitosan only formulation underwent sol/gel transition at 37°C in 60 min, whereas the 
addition of HACS and NOSC suspensions of SWNTs and MWNTs reduced this time to 7 and 9 
min, respectively. The syringeability of the suspensions was also studied. A force of 30 N was 
considered as the maximum acceptable force for an injection to be performed without 
particular patient discomfort [24]; none of the samples tested presented values above 10 N 
(Table 8.1) [25]. Furthermore, texture analysis was performed to determine gel 
compressibility 
(Fig. 8.1A). All suspensions tested showed significant difference in strength before and after 
gelation at 37 °C (at least p = 0.0004, two tailed, t-test with Welch’s correction) apart from 
the chitosan control. In particular, after gelation the formulation containing SWNTs showed 
significantly higher values compared to all other formulations (0.273 ± 0.001 N·mm). 
 
 
 
Table 8.1 Syringeability of composite formulations 
 
 
 Stiction (N) Plateau Force (N) End capture (N) 
Chitosan 8.36 ± 0.33 8.56 ± 0.29 8.92 ± 0.13 
Chitosan-HACS 8.86 ± 0.39 8.56 ± 0.34 9.09 ± 0.34 
Chitosan-HACS-(NOSC- 
 
SWNTs) 
6.69 ± 0.25*** 6.40 ± 0.24*** 6.56 ± 0.21*** 
Chitosan-HACS-(NOSC- 
 
MWNTs) 
7.03 ± 0.15*** 6.92 ± 0.15*** 7.51 ± 0.22*** 
 
Stiction, plateau force and end capture are expressed as mean ± SD (n = 3). One way ANOVA, P < 0.001; Tukey–Kramer 
multiple comparison test *** P< 0.001, compared to the chitosan control. 
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Fig. 8.1a Compressibility of the different formulations before (grey) and after (black) sol-gel transition. Results 
are reported as a mean ± SD (n=3). One way ANOVA (a = 0.05) on the values after gelation returned p= 0.0131; 
Tukey’s multiple comparison test: *p <0.05, compared to chitosan, # p<0.05 compared to CS-HACS. Water 
sorption and desorption isotherms of the freeze dried hydrogels; b chitosan; c CS-HACS-(NOSC-SWNTs); d CS- 
HACS-(NOSC-MWNTs). Data are reported as a mean ± SD (n=3). 
 
 
8.3.2 Characterisation of the freeze dried hydrogels 
 
The morphology of the freeze-dried hydrogels was evaluated by SEM (Fig. 8.2). The 
chitosan only gel appeared to be scaly and rough while the gels containing CNTs showed a 
more defined porous structure with evidence of coated CNTs filaments bridging the 
structure; this was previously observed by Ormsby et al. who observed CNTs bridging sub- 
micron voids and preventing pore coalescence [26]. 
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Fig. 8.2 SEM of chitosan, CS-HACS-(NOSC-SWNTs) and CS-HACS-(NOSC-MWNTs) freeze dried hydrogels. 
 
Arrows indicate coated carbon nanotubes within the hydrogel matrix. 
 
 
 
 
Table 8.2 Kinetic parameter values for water penetration in freeze-dried hydrogels. 
 np Kp R2 
CS control 1.67 ± 0.15 0.000369 ± 0.000314 0.968 ± 0.015 
CS-HACS-(NOSC-SWNTs) 1.79 ± 0.23 0.000260 ± 0.000335 0.973 ± 0.016 
CS-HACS-(NOSC-MWNTs) 1.65 ± 0.16 0.000461 ± 0.000298 0.983 ± 0.007 
Data are reported as mean ± SD (n = 3) 
 
 
 
 
8.3.3 Dynamic vapour sorption 
231  
DVS analysis was performed to evaluate the amount and kinetics of water sorption of the 
hydrogels. Previous work showed that the addition of chitosan grafted carbon nanotubes to 
chitosan hydrogel significantly decreased the hydrophilicity of the formulation [12]; this was 
not the case when the added CNTs were non-covalently coated with NOSC (Fig. 8.1 B-D). 
Applying Korsmeyer-Peppas model to the absorption vs. time curves, the mechanism of 
water penetration described by the value of np > 0.89 was determined to be super case-II 
transport (Table 8.2). Hence, it seems that the dynamic swelling behaviour of hydrogels is 
dependent on the contribution of both the penetrant (water) diffusion and polymer 
relaxation. 
 
 
8.3.4 In vitro calcification studies 
 
Bioactivity of a scaffold proposed for bone regeneration can be evaluated by studying the 
calcium salts deposition on its surface and internal structure [28, 23]. Samples were soaked 
in SBF for 7 and 14 days, at 37 °C, and superficial Ca/P co-deposition was evaluated by EDS 
coupled SEM (Fig 8.3) while deposition, in the whole volume, of a denser material was also 
visualised and quantified by microCT. The quantitative analysis of the EDS data (Fig. 8.4 A) 
revealed that no calcium-phosphate deposits were found in the chitosan control samples, 
both at 7 and 14 days. Samples containing CNTs also contained HACS and similar values of 
co-localised Ca and P at time zero were expected. This was indeed confirmed by the 
quantitative analysis. However, the SEM images showed that HACS is more homogeneously 
distributed in the samples containing SWNTs. In both samples an increase in the 
concentration of co- localised Ca and P was observed, with significantly higher values for the 
gel containing SWNTs (7.8 ± 0.1%). Salts deposition was also observed by micro CT (Fig. 8.4 
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B), were volumes of denser material were identified and quantified, these may represent the 
deposition of other salts as well as calcium phosphate salts that possess similar x-ray 
attenuations. The microCT analysis evidenced differences in the microarchitecture of the 
hydrogel, were chitosan alone gels presented a less homogenous and more porous structure 
(Fig. 8.5). This may be attributed to the drying process, during which the migration of water 
from the core to the periphery of the gel might have dragged the chitosan to condense on 
the edge leaving a porous structure in the core. This phenomenon is much less noticeable in 
the gels containing CNTs, confirming how CNTs have an important role in the formation and 
preservation of the 3D gel structure. As a consequence, a marked difference in the 
distribution of the salts deposition was observed and resulted in a much more homogeneous 
distribution in gels containing CNTs. Quantitative analysis (Fig. 8.4 B) also revealed a higher 
deposition of salts in CNTs containing gels, with no significant difference between SWNTs 
and MWNTs (34.6 ± 2.6 and 36.0 ± 1.1% salt deposition over total sample volume, 
respectively) [29]. These data are in good agreement with the EDS/SEM data and confirm 
that calcification is notably more pronounced in samples containing HACS and CNTs. 
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Fig. 8.3 Overlay images of SEM pictures with EDS data: Ca (green), P (red) and co-localisation of Ca/P (yellow). 
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Fig. 8.4 a Quantitative analysis of surface calcium deposition presenting % of surface covered by co-localised 
Ca and P (from SEM). Data are reported as a mean ± SD (n=3. One-way ANOVA (a = 0.05) p<0.0001 for both 
gels containing CNTs; Tukey’s multicomparison test, ***p<0.001 compared to control at time zero, ###p<0.001 
compared to a specific sample as indicated in figure. b Average % salt deposition on different types of hydrogel 
samples (from microCT). Data are reported as a mean ± SD (n=5). One-way ANOVA (a = 0.05) p< 0.0001 for both 
gels containing CNTs, Tukey’s multicomparison test, all samples presented p<0.001 compared to control, and 
P<0.001 was obtained for all comparisons between 7 and 14 days. Release profile of c BSA d OVA from (black 
closed circle) chitosan; (red closed square) CS-HACS-(NOSC-SWNTs); (blue closed triangle) CS-HACS- (NOSC-
MWNTs) gels. Data are reported as a mean ± SD (n = 3). 
 
 
 
Table 8.3 Ca/P ratio of salt deposits on hydrogels incubated with SBF for 7 and 14 days, t-test (paired, two- 
tailed). 
 
 7 days 14 days 
CS-HACS-(NOSC-SWNTs) 1.45 ± 0.54 1.32 ± 0.04 
CS-HACS-(NOSC-SWNTs) 1.55 ± 0.30 1.55 ± 0.15* 
 
 
* P < 0.05, comparedtothe HACSincludedinthegelswhichhada Ca/P ratio of 1.34 ± 0.06. 
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8.3.5 Release of model drugs 
 
The release of two macromolecular model drugs, albumin form chicken egg (OVA, Mw 45 
kDa, Fig. 8.4c) and bovine serum albumin (BSA, Mw 66 kDa, Fig. 8.4d), were studied for 14 
days. All the hydrogels tested showed the potential to provide controlled release within the 
2 weeks of the experiment. Analysis of the release during the first 5 h revealed very similar 
release profiles for all gels, indicating that the initial release is governed by the behavior of 
the chitosan component of the gel. The addition of HACS and CNTs decreased the amount of 
BSA release over 14 days, but this did not have a significant effect on the release of OVA. This 
suggests that the mechanism of release for OVA is mainly dependent on the interaction of 
the protein with the chitosan network. Also gel degradation has an effect, indeed a marked 
change in the gel structure was noticed after 14 days of BSA release study. Hydrogels before 
the release study presented a typical porous structure, with well-defined pores of different 
size; while hydrogels after the release presented a scaly appearance. 
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Fig. 8.5 Representative micro CT slices of different gel samples incubated in SBF for 0, 7 and 14 days 
 
 
 
 
 
8.4 Discussion 
 
Composite thermosensitive chitosan hydrogels were formulated. The addition of CNTs was 
confirmed to have a significant effect on the sol–gel transition time; these results are in 
accordance to those obtained by addition of chitosan grafted CNTs [12], indicating that both 
covalently and non-covalently coated CNTs present similar thermal behaviour and lead to 
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similar effects on the gelation time of the formulations [30, 31]. Unexpectedly, the 
formulations containing NOSC suspensions of CNTs had better syringeability performance 
than chitosan only or chitosan with HACS formulation, while previous studies showed that 
the addition of chitosan grafted CNTs increased the force needed to expel the suspension 
from the syringe [12]. These data show that covalent and non-covalent coating of CNTs can 
have very different effect on the viscosity of the suspensions and their syringeability. In our 
previous work, we demonstrated that NOSC tends to stretch and align along the surface of 
CNTs [32], reducing the opportunity for formation of physical entanglements between NOSC 
and the free chitosan chains present in the gel. It is postulated that under the shear stress 
applied during injection non-covalently coated CNTs are able to align within the flowing 
liquid formulation therefore present a reduced resistance compared to a crosslinked system. 
Conversely, CNTs afforded a significant increase in resistance to compression for the 
composite hydrogels. In comparison with published data, where chitosan grafted CNTs were 
added instead of non-covalently coated ones, no statistical difference was noticed in the 
hydrogels containing MWNTs, while SWNTs produced statistically stronger gels (P <0.05) 
when suspended in NOSC solutions [12]. The use of NOSC for the stabilisation of CNTs 
reduced the hydrophobicity of the nanotubes when compared to chitosan grafted CNTs. This 
phenomenon can be explained by considering the shielding effect that NOSC has on the 
surface of the nanotubes. In fact, five chains of NOSC arrange themselves along the entire 
surface of CNTs, thus resulting in a net decrease of surface hydrophobicity [21]. Reduced 
hydrophobicity has been linked with better in vivo outcomes [26, 33, 34]; furthermore, 
previous studies demonstrated the cytocompatibility of CNTs stabilised in NOSC (data not 
shown). The in vitro calcification studies revealed that CNTs played a major role in the spatial 
arrangements of newly formed calcium deposits in the composite materials studied, 
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suggesting that they may have a role in the way the repair of fragile and/or fractured bones 
occurs in vivo. Finally, in model drug delivery studies, the composite gels demonstrated 
potential as delivery platforms for macromolecular drugs with mini- mum interference by 
CNTs in the determination of the mechanism of drug release. 
In conclusion the present study reports of a simple non- covalent method for the inclusion 
of CNTs into hydrophilic chitosan hydrogels. The non-covalent stabilisation of the nanotubes 
is advantageous as it facilitates the injectability of the formulation while affording gels with 
higher compressibility. CNTs also proved to be key in guaranteeing a homogeneous 
deposition of salts suggesting that they can be used for guided mineralisation of scaffold for 
bone regeneration. Finally the gels have potential also as plat- forms for prolonged drug 
delivery. 
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Abstract 
 
Injuries of bone and cartilage constitute important health issues costing the National 
Health Service billions of pounds annually, in the UK only. Moreover, these damages can 
become cause of disability and loss of function for the patients with associated social costs 
and diminished quality of life. The biomechanical properties of these two tissues are 
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massively different from each other and they are not uniform within the same tissue due to 
the specific anatomic location and function. In this perspective, tissue engineering (TE) has 
emerged as a promising approach to address the complexities associated with bone and 
cartilage regeneration. Tissue engineering aims at developing temporary three- dimensional 
multicomponent constructs to promote the natural healing process. Biomaterials, such as 
hydrogels, are currently extensively studied for their ability to reproduce both the ideal 3D 
extracellular environment for tissue growth and to have adequate mechanical properties 
for load bearing. This review will focus on the use of two manufacturing techniques, namely 
electrospinning and 3D printing that present promise in the fabrication of complex 
composite gels for cartilage and bone tissue engineering applications. 
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9.1 Tissue Engineering 
 
Defects that affect tissues such as cartilage or bone can be irreversible and become a 
clinical challenge. This is particularly true when these lesions are associated with conditions 
such as osteoarthritis and osteoporosis. Currently, it is estimated that  75 million people 
suffer of osteoporosis in Europe, USA and Japan [1], while 27 million are 
affected by osteoarthritis in USA only [2]. These numbers are certainly due to  increase, as 
 
the population is aging, leading to higher healthcare costs. Current treatments for bone 
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(i.e., autografts and allografts) present drawbacks such as limited availability of donor 
tissue, risk of infection and unsatisfactory lesion repair [3], whilst the use of bone graft 
substitutes are not as reliable as gold standard autograft. For small cartilage defects 
autologous chondrocyte implantation, mosaic pasty and autologous matrix-induced 
chondrogenesis can be used with variable success but for larger cartilage defects, often joint 
replacement is the only solution. 
Therefore, new strategies are needed to repair damaged cartilage and bone tissue [ 4]. 
 
Tissue engineering is a promising interdisciplinary approach in this field: it aims at 
developing temporary 3D multicomponent scaffolds that mimic the natural  tissue, working 
as a porous framework for the migration, adhesion and growth of cells to replace the 
damaged biological material. Ideally, a scaffold for tissue regeneration should have a highly 
interconnected porous network for the diffusion of nutrients and gases, have good 
mechanical properties in loadbearing conditions and degrade without producing toxic 
products with increasing formation of new tissue [3]. 
 
 
 
9.2 Challenges in Tissue Engineering of Soft and Hard Tissues 
 
Tissue engineering has become one of the most commonly used approaches for cartilage 
and bone tissue repair [5,6,7,8]. Even though these two tissues are important constituents 
of the skeletal system, their structure and mechanics differ considerably. Bone is a hard and 
rigid tissue, whereas cartilage is soft, viscoelastic and flexible and these two tissues are  
different in  several aspects [9]. In  addition, according to  the  anatomic  location  and 
function, the same type of tissue can be heterogeneous displaying different anisotropic 
properties,  biochemistry and  cellular  activity  [10]. These  characteristics complicate the 
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fabrication of scaffolds that successfully mimic the structural and mechanical 
characteristics of the target tissue. 
 
 
 
9.2.1 Cartilage 
 
Cartilage is a strong and elastic connective tissue that covers the articulating surface of the 
bone in diarthrodial joints (articular cartilage) and is a structural component of the rib cage, 
ear, nose and other body components [11]. Three types of cartilage exist, according 
to the extracellular matrix (ECM) composition: elastic cartilage (if elastic fibres are present 
in the ECM), fibrous cartilage (if the matrix is rich in collagenous fibres) and hyaline cartilage 
if the matrix is predominantly composed of glycosaminoglycans, (GAGs). The latter, also 
known as articular cartilage, if found at the interface between the gliding bony surfaces in 
the articular synovial joints, provides a deformable low-friction surface that facilitates the 
movement of articulating bones and supports high dynamic compressive loads   [12].   
Mechanically,    human    cartilage    presents   the    following  characteristics: 
compressive modulus of 0.7–0.8 MPa, shear modulus of 0.7 MPa and tensile modulus of 
0.3–10 MPa [13]. At the microscopic scale, human cartilage consists of an ECM, which can 
be mineralized and is produced and maintained by chondrocytes embedded within it. The 
hydrated ECM is composed of proteoglycans consisting of a core protein with covalently 
attached  GAGs,  mainly chondroitin sulphates,  and  collagen  type  II [ 14]. The  GAGs   are 
responsible for the cartilages’ ability to support high compressive loads, whereas the 
collagen II fibrils contribute to its high tensile strength and ability to tolerate shear stresses. 
Cartilage composition includes 80% of water, drawn into the collagen II fibrils by the 
hydrophilic proteoglycan complexes; this plays an important role in defining the tissue 
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load-bearing  function  [12].  As   cartilage   is   compressed,   the   extracellular   matrix   is 
 
compacted causing the efflux of water. As the cartilage is compacted more, the flow of water 
is reduced due to increasing drag increasing the hydrostatic pressure, which withstands the 
load. It is important to note that cartilage is avascular, which means that nutrients and cells 
infiltration is poor and wound healing, after injury or trauma, is hindered. In particular, 
fibrocartilage is formed to replace the native cartilage and this   new tissue is functionally 
and biomechanically inferior to the native one. Current  therapies to facilitate cartilage 
regeneration include autografting, microfractures and autologous chondrocyte 
implantation (ACI); however, they all present drawbacks and are unable to fully restore the 
functional hyaline cartilage, making long-term prognosis uncertain [15]. For  instance,  
autografting causes  donor  site  morbidity and  is  limited by 
donor tissue availability. Microfracture treatments can extend the damage to the 
surrounding tissue and stem cells implantation can still induce the formation of 
fibrocartilage. In this scenario, cartilage tissue engineered (CTE) scaffolds could be a turning 
point. 
 
 
 
9.2.2 Bone 
 
Bone is the main constituent of the musculoskeletal system [16] and differs from other 
 
connective tissues (i.e., cartilage, ligaments and tendons) in rigidity and hardness [ 17] due 
 
to high mineralization of its ECM [18]. Bone provides stiffness to the skeleton allowing for 
 
the shape of the body to be maintained, plays a role in the transmission of muscular forces 
for movement, affords protection to soft tissues within the cranial, thoracic and pelvic 
cavities as well as the bone marrow [19,20]. At the microscopic scale, bone is arranged in 
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two architectural forms: trabecular and cortical bone. Trabecular bone represents 20% of 
the skeletal mass and forms the inner part of the bone, it presents high porosity (50–90%) 
and contributes to mechanical support in bones such as the vertebrae. Cortical bone, the 
dense outer layer of bone, comprises 80% of the weight of the human skeleton, and its 
function is  to  provide  mechanical  strength  and protection  [16]. Mechanically, the bone 
presents the following characteristics: the compressive strength for cortical bone ranges 
from 170 to 193 MPa and its elastic modulus is found to be in the range of 7 –20 GPa. 
Trabecular bone, however, has a compressive strength ranging from 2 to 12 MPa and its 
modulus is in the range of 0.1–5 GPa [21,22]. Bone tissue presents a highly complex and 
hierarchical  structure  [23]  which   can   be   defined  as   a   nanocomposite  consisting of 
 
inorganic nanocrystalline hydroxyapatite (HAp), organic components (mainly type-I 
collagen) and water [24]. The nanocomposite structure is essential to provide the required 
compressive strength and high toughness of the bone [25]. Collagen fibres reinforced by 
 
HAp crystals form a tough and flexible nanostructured extracellular matrix,  which  supports 
adhesion, proliferation, and differentiation of bone cells (osteoblasts,  bone  lining    cells,    
osteocytes,   and    osteoclasts)    [19,26,27].   Bone    constantly undergoes 
remodelling during life to help it adapt to loading conditions; remove old, microdamaged 
bone replacing it with new, mechanically stronger bone; and help to preserve bone strength    
[28].   This    remarkably    dynamic   structure    of    bone    displays exceptional 
regenerative properties [29]; however, non-union fractures, tumour resections and some 
 
musculoskeletal  diseases  can  lead  to  critical  size  bone  defects  [30]   that  cannot  heal 
 
spontaneously and require additional treatment before they can regenerate [31]. Bone is 
 
the most commonly transplanted tissue after blood [32]. Several therapeutic approaches 
 
including bone  grafting procedures [33], implantation of  different  biomaterials [34]  and 
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application of hormones or growth factors have been investigated [35]. However, there is 
 
still  no  effective  treatment  for  most  cases  [36,37]. The  limitations of  autografting and 
 
allografting   were   previously   addressed   [38,39].   Metal   implants   provide immediate 
 
mechanical support, but present limitations due to poor integration with the tissue, 
infection   and   fatigue   fracture   [40,41].  Furthermore,  ceramic  bone   graft  substitute 
materials present very low tensile strength and are brittle, restricting their use in locations 
of  significant  torsion,  bending  or  shear  stress  [42].  In  this  perspective,  bone  tissue 
engineering (BTE) has emerged as a promising approach for bone reconstitution, 
overcoming the limitations of traditional implants [43,44,45]. 
 
9.2.3 Osteochondral Tissue 
 
Osteochondral (OC) tissue is located at the interface between the osseous and the 
chondral tissue and it promotes their interplay; its role and location require a complex 
composition that includes cartilage, calcified cartilage and subchondral bone. The 
mechanical, structural and biochemical characteristics of the osteochondral tissue vary 
throughout. For instance, from a biochemical point of view, mineral content increases from 
cartilage to bone, while collagen and water concentration diminishes. Structurally, pore size, 
porosity and vascularization increase from cartilage to bone face. Mechanically, compressive  
modulus  increases  from  cartilage   to  osseous  tissue   [46].  Osteochondral 
defects (OCDs) seem to play an important role in the genesis of joint diseases, such as 
osteoarthritis or osteochondritis dissecans. Moreover, subchondral bone includes 
unmyelinated free nerve endings which may cause pain in case of OC degeneration, due  to 
the applied forces from surrounding tissues [47]. This said, it is fundamental to repair 
osteochondral defects to prevent joint destruction. However, OCDs are extremely difficult 
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to treat due to the widely different features between articular cartilage, calcified cartilage 
and subchondral bone [48]. Osteochondral scaffolds should be designed to concurrently 
rehabilitate these three tissues all together. Several approaches have been studied to 
promote OC regeneration, such as debridement, bone marrow stimulation techniques, and 
the use of osteochondral allografts. However, these  present  strategies are  affected by 
many drawbacks. For instance, microfractures may lead to degeneration of the  repaired 
tissue and formation of the non-functional fibrocartilage. In the case of grafting techniques, 
there is lack of donor tissue or immunoreactions. Considering the complexity of this tissue, 
more research into osteochondral engineering is required [ 46,49]. 
 
9.3 Hydrogels as Tissue Engineering Scaffolds 
 
Hydrogels have been widely investigated not only for tissue engineering applications,  
but also for drug delivery and wound dressing [4,50,51]. They are insoluble hydrophilic 
polymeric networks that can swell without disintegrating and absorb a high degree of 
water,  up  to  several  times  their  dry  weight  [52].  Their  fully  hydrated  3D  structure 
resembles the extracellular matrix of native tissues, both physico-chemically and 
biologically. Moreover, their porous structure enables the transfer of nutrients and 
metabolites that are fundamental for cell growth. Hydrogels can be formulated from 
different natural and synthetic polymers such as alginate, chitosan, fibrin, hyaluronic acid 
(HA), poly(ethylene glycol) (PEG) and poly(ethylene oxide) (PEO). However, hydrogels often 
show inadequate mechanical performance, due to the interstitial liquid and its plasticizing 
effect, which make them too weak for applications in the musculoskeletal system [53]. For 
instance, most hydrogels have an elastic modulus ranging from kPa to 
MPa,  whereas  native  bone  has  a  modulus of  ~1–20 GPa.  Matching these  properties is 
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fundamental for two main reasons: (1) scaffolds must support loads and movements; and 
 
(2) cells respond differently to different stresses, such as compression, tension and shear 
[54].   Luckily,   hydrogels   are   tuneable   materials;   their   chemical   modification   and 
differential crosslinking allow achieving the desired properties for the proposed application. 
For example, it is possible to increase the hydrogel elastic modulus increasing crosslinks 
density inside the gel or combining two or more independent networks, known as 
interpenetrating networks. Numerous researchers have worked on finding ways to 
formulate  hydrogel  constructs  with  optimized  mechanical  properties  [ 55,56,57],  and 
several techniques have been employed in order to fabricate them [58]. Microfabrication 
 
techniques such as electrospinning and 3D printing have emerged as promising strategies 
for manufacturing complex hydrogel structures for tissue engineering applications. 
 
 
 
9.4 Electrospinning 
 
Electrospinning is a versatile, efficient, cheap and reproducible technique that can be used 
to produce 1D fibrous materials or composites with a wide range of diameters (from nm to 
mm), by applying an electrostatic force to a solution. Applications in tissue/organ repair  and  
regeneration  [59], drug delivery  [59], medical  diagnostic,  protective fabrics 
against  environmental  [60]  and  infectious  agents,  and  dental  materials  have  all been 
 
studied  [61]. A  general electrospinning apparatus (Figure  9.1) consists  of  three  parts: a 
 
high voltage power supply device; a syringe/capillary tube with a metallic needle; and a 
grounded metallic collector. 
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Figure 9.1. Schematic illustration of the basic setup for electrospinning. Reproduced from [62] with 
 
permission. Copyright (2015) Elsevier. 
 
 
 
 
In a typical electrospinning process, a polymeric solution (or melt) is loaded into a syringe 
and ejected at a controlled rate, forming a drop (Figure 9.2a). Simultaneously, a high voltage 
(up to 2–30 kV, depending on the solution used) is applied, and a charged jet of  the 
polymeric solution or melt is formed (Figure 9.2b–c). When the electrostatic repulsion starts 
to overcome the surface tension of the fluid, the hemispherical surface of the liquid will 
deform into a conical shape, called Taylor cone, at the tip of the needle ( Figure 9.2d). Finally, 
the solution jet starts to evaporate, and the polymer solidifies creating a thin fibre jet that 
deposits on the grounded collector. 
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Figure 9.2. Effect of increasing applied voltage on the shape of the solution drop ejected by the needle: (a) 
normal dripping; (b) micro dripping; (c) intermittent Taylor cone; and (d) Taylor cone jet. 
 
 
 
The electrospinning of fibres is relatively complex, as the product characteristics can be 
influenced by several parameters classed into three categories: 
1. Solution characteristics (viscosity, surface tension and conductivity): the 
electrospinning technique relies on the uniaxial stretching of a charged jet, which, in turn, 
is significantly affected by changing the concentration of the polymeric  solution. Generally, 
by reducing the polymer concentration, the fibre diameter is decreased. However, when the 
concentration of the polymeric solution is lowered to a critical value, known as 
entanglement concentration (Ce), beaded fibres are produced. If the concentration  is  too  
high  no  fibres  are  produced  due  to  the  excessive  viscosity [63]. 
Solution conductivity is fundamental to optimize both fibre diameter and stability of the 
Taylor cone. If the solution has a low conductivity the fluid surface  cannot be charged,  and 
no Taylor cone can be formed. By increasing the charge on the surface of the droplet   a  
Taylor  cone  is  formed  and the fibre  diameter is  decreased  [64]. The conductivity of a 
polymeric solution can be controlled by the addition of salts. Moreover, the solvent has a 
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crucial role in determining the characteristics of the solution; an ideal solve nt must to be 
able to solubilize the polymer at the required  concentrations and be sufficiently volatile  to 
evaporate in the space between the needle and the collector. However, if the boiling point 
is too low, the solvent will evaporate too quickly causing the drying of the jet at the needle 
tip [65]. 
2. Process parameters (applied voltage, flow rate and tip to collector distance): these 
parameters influence the diameter and morphology of the fibres. As the feed rate increases, 
the charge density will decrease. Thus, by increasing the flow rate the diameter of fibres is 
increased and beaded morphology can be observed [64]. Fibres are formed just 
when the applied voltage is higher than the threshold voltage (the value depends on the 
solution). Generally, by increasing the voltage there is an increase of the electrostatic  force 
on the solution and thus, a reduction of the fibre diameter. A critical distance between tip 
and collector is needed for the solvent evaporation and for the preparation  of smooth and 
uniform electrospun fibres. Generally, the longer the distance, the thinner the fibres will be. 
3. Environment conditions (humidity and temperature) [66,67]. Ideal environmental 
 
conditions must be found for better and improved fibre production. Ambient humidity  and 
temperature can affect both the morphology and diameter of the fibres. Depending on the 
chemistry of the polymer [68], the fibre diameter can increase or decrease and no 
definitive comparisons with experimental data can be currently made. 
 
To date, many electrospun scaffolds made of polymers and inorganic nanoparticles have 
been produced for tissue engineering applications. However, these electrospun scaffolds are 
in the form of 2D mats (Figure 9.3b) with tightly packed fibres that negatively impact cell 
infiltration and growth throughout the scaffold. Alternatively, scaffolds obtained by 
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the amalgamation of fibres and hydrogels can be used to achieve better properties, such 
as a well-interconnected porous structures [69]. Different composite structures have been 
employed to fabricate fibrous hydrogels: laminated composites (Figure 9.3c), encapsulating 
fibres into the hydrogels (Figure 9.3d), injectable hydrogels, composite coatings and dual 
electrospun/electrospray composites [70]. 
 
 
Figure 9.3. (a) Architectural framework of a native extracellular matrix (ECM); (b) electrospun 2D mat; (c) 
laminated hydrogel; and (d) fibres encapsulated into a hydrogel. Reproduced from [ 71] with permission. 
Copyright (2011) PMC. 
 
 
 
 
9.4.1 Fibrous Hydrogels for Cartilage Tissue Engineering via Electrospinning 
255  
Articular cartilage plays an important role in load-bearing joints during dynamic loading. 
When damaged, it cannot heal naturally, and clinical treatments are necessary. Tissue 
engineering aims at temporarily replacing damaged articular cartilage with 3D scaffolds. 
Hydrogels are promising materials for cartilage regeneration when strategies to reinforce 
their structure are applied, for example combining them with electrospun fibres. Indeed, 
these scaffolds can emulate the natural ECM (for its porosity and water content) and possess 
improved mechanical properties due to the fibres ability to reorient under deformation, 
stiffening, strengthening and toughening the system. Thus, researchers have tried to 
optimize the mechanical properties of the hydrogels, studying different parameters such as 
the polymers used, fibre diameter and alignment, porosity and mono or multi layered 
scaffolds. 
Many synthetic and natural polymers have been used for electrospun fibres for cartilage 
regeneration, such as polycaprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA), poly(L- 
lactic acid) (PLLA), poly(vinyl alcohol) (PVA), Bombyx mori silk fibroin and chitosan. Chitosan, 
an amino saccharide that is biodegradable and cytocompatible, with antibacterial and 
wound healing activities as well as tissue-adhesive features has been one the most studied 
polymers. This polymer can be easily obtained by alkaline treatment of chitin, a naturally 
occurring polysaccharide obtained from the exoskeleton of crustaceans.  To  overcome 
chitosan  poor  mechanical  properties,  Mirahmadi et  al.  [ 72] 
developed a chitosan hydrogel enriched with electrospun silk fibroin fibres. They  fabricated 
two gels, one with homogeneously dispersed chopped degummed silk fibres (SC/GP-D) and 
one as a three-layered composite with a layer of electrospun fibres sandwiched between 
two layers of chitosan gel (SC/GP-L). Results showed that the mechanical  properties  were  
generally  enhanced  by  silk  and  that  the  laminated  gel 
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presented both better compressive and Young’s moduli compared to chitosan only (3.1 
times stiffer) even though the mechanical performances were not as good as the natural 
cartilage. On the other hand, the SC/GP-D scaffold was the best scaffold for cartilage 
formation (as shown by proteoglycan and collagen II content) among the studied hydrogels 
[72]. For future studies, a combination of both degummed fibres and nanofiber 
sheets could be examined to obtain improved mechanical properties. A second possibility to 
improve the mechanical characteristics of the gel is to incorporate individual and short 
electrospun nanofibers in hydrogel scaffolds, positioning them in a random way to favour 
an irregular orientation of the chondrocytes. Mohabatbour and his group [ 73] fabricated 
PLA fibres fragmented through aminolysis reaction to improve their hydrophobicity and cell-
interaction abilities. They fabricated an alginate grafted hyaluronic acid (Alg-HA) 
incorporating fragmented PLA nanofibers. The nanofiber incorporated hydrogels had higher 
compressive modulus and lower swelling ratio than Alg-HA hydrogel alone. In this case, the 
composite was cytocompatible and the chondrocytes were able to maintain their functional 
properties producing GAGs and other extracellular molecules. This research highlighted 
that, to control gel fracture and strength, fibres can be differently oriented into a hydrogel. 
Other studies have focused on introducing biological signals such as chondroitin  sulphate 
(CS), hyaluronic acid, and collagen, into tissue-engineered scaffolds to encourage tissue   
specificity.   Coburn   et   al.   [74],   for   instance,   fabricated   poly(vinyl  alcohol)- 
methacrylate (PVA-MA) fibrous scaffolds with or without chondroitin sulphate, a signal that 
has been shown to enhance chondrogenesis of mesenchymal stem cells. These hydrogels 
allowed for immediate cell infiltration, cartilaginous tissue formation and chondrogenic 
differentiation (as indicated by a higher cartilage specific gene expression). 
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Finally, the addition of CS increased type II collagen deposition compared to PVA fibres 
alone [74]. 
 
More recently, solution electrospinning has been further developed into Melt 
Electrospinning Writing (MEW), this exploits a layer-by-layer process similar to other 3D 
printing technologies affording highly organised fibrous 3D structures in the micron scale. 
This process eliminates the need for organic solvents that can induce cell toxicity and avoids 
mechanical and electrical coiling of the fibres simplifying the manufacturing process. Using 
this technique, Bas et al. [75] produced a negatively charged proteoglycan 
matrix with a star-shaped poly(ethylenglycol)/heparin hydrogel combined with wet  melted 
PCL fibres and deposited a 0°–90° crosshatch architecture with different network spacing. 
The best electrospun matrix had 600 μm spacing; its negative charge density and strong 
water retention capacity, provided by PEG crosslinked heparin,  accurately mimicked the 
natural cartilage tissue in terms of electrochemical, mechanical and viscoelastic properties. 
The constructs presented high chondrocyte viability and allowed for cell differentiation 
under physiologically relevant loading. 
Even though the most common strategy is to form fibrous scaffolds with embedded fibres 
within hydrogels, multilayer scaffolds constructed with fibres in different orientations have 
been investigated. For instance, Tonsomboon et al. [ 76] studied how 
different designs of laminated and non-laminated electrospun gelatin nanofibers in an 
alginate hydrogel could mimic the mechanical characteristics of the collagenous ECM. In 
particular they have fabricated single layer composites (a) with or (b) without a random 
orientation or multilayer composites with (c) unidirectional (where fibres had the same 
orientation), (d) cross-ply (where alternating layers were perpendicular) or (e) angle-ply 
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orientation (where there were four different fibres orientations). Firstly, this work showed 
that nanocomposite hydrogels were stronger and tougher than single polymer hydrogels. 
Secondly, aligned fibres increased tensile strength without improving toughness. Thirdly, 
multilayer arranged nanofibers increased the toughness by two orders of magnitude when 
compared to the controls [76]. Therefore, this paper demonstrated that, by tuning 
different architectures of fibre reinforced and laminated composite hydrogels, it is  possible 
to resemble the mechanical properties of the native tissue. Literature on hydrogels 
reinforced with electrospun  fibres  for  cartilage  regeneration  is  summarised in Table 9.1. 
 
Table 9.1. Publications on electrospun fibres reinforced hydrogels for cartilage regeneration. 
Fibre(s) Hydrogel Fabrication 
 
method 
Mechanical 
 
properties 
Cytocompatibility Reference 
PCL or 
CSMA/PVAMA 
PEG-diacrylate Fibres mixed 
with the 
hydrogel 
Not reported Chondrogenic 
differentiation 
[71] 
Polyacrylonitrile Alginate- 
polyacrylamide 
Sandwich-like 
structure 
Young 
modulus: 3.4 
MPa 
Not reported [77] 
PDLA/PLLA or 
PDLA/PCL 
Chitosan Fibres 
infiltrated 
with 
hydrogels 
Compressive 
modulus: 2-12 
MPa 
Cartilage ECM 
deposition 
[78] 
PCL GelMA and 
GelMA/HAMA 
Fibres 
infiltrated 
with 
hydrogels 
Compressive 
modulus: 20- 
1500 kPa 
Not reported [79] 
PCL PEG-heparin Fibres 
infiltrated 
with 
hydrogels 
Compressive 
modulus: 20- 
1500 kPa 
Cell viability > 80% 
Chondrogenic 
differentiation 
[75] 
PLA Alginate-graft- 
hyaluronate 
Hydrogel 
mized fibres 
and gelled 
Compressive 
modulus: 3-5.4 
kPa 
Cell viability > 85% 
Chondrogenic 
differentiation 
[73] 
Silk Chitosan Sandwich-like 
structure 
Compressive 
modulus:0.5- 
0.6 kPa 
Cell viability > 90% 
Chondrogenic 
differentiation 
[72] 
PCL Alginate or 
alginatesulphate 
Hydrogel 
pipetted onto 
the scaffold 
Shear modulus: 
0.5-5 kPa 
Cartilage ECM 
deposition 
[80] 
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9.4.2 Fibrous Hydrogels for Bone Tissue Engineering via Electrospinning 
 
Hydrogels have been suggested as possible scaffolds for bone regeneration, but their poor 
mechanical properties and low bioactivity make them inappropriate for hard tissue. One 
strategy is to reinforce the gel with electrospun fibres, but only a few studies have been 
reported on fibrous scaffolds for application in bone tissue engineering. Mehdi- Sahad et al. 
fabricated a 3D cell-laden three-layered hybrid scaffold (Figure 9.4), incorporating a 2D mat 
layer of poly(hydroxybutyrate) (PHB) and nano-hydroxyapatite fibres (diameter 2.0 ± 0.2 
μm) between two layers of methacrylated gelatin/HAp. As expected, the introduction of 
PHB/HAp fibres enhanced the mechanical strength (tensile modulus 7.0 ± 1.2 MPa, tensile 
strength 329 ± 18 kPa for the hybrid scaffold) and matrix mineralisation while the hydrogel 
provided a biocompatible scaffold for cell penetration and proliferation. Even though the 
mechanical properties were improved in comparison  to the hydrogel only, they were still 
inferior to the natural tissue. Thus, Sadat-Shojai and his group [69] suggested increasing the 
thickness of the electrospun mat located at the 
centre of the scaffold, however this approach would lead to a denser electrospun mat, with 
decreased porosity that would potentially hindered cell penetration into the electrospun 
centre. 
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Figure 9.4. Schematic overview of the method to fabricate 3D cell-laden laminated hydrogels. Reproduced 
from [69] with permission. Copyright (2016) Elsevier. 
 
 
 
A further problem encountered in bone grafting procedures is the development of 
infection, inflammation and pain, intrinsically linked to any invasive procedure. However, 
due to poor vascularity of the bone tissue, osteomyelitis is often difficult and costly to treat. 
For this reason. injectable systems for minimally invasive procedure (MIP)  have been 
developed. Calcium phosphate cements are among the most used cements (e.g., Hydroset 
Accell 100™) for bone regeneration as they are bioactive, and they have the ability of self-
hardening. However, they are brittle, difficult to inject and present limited porosity, 
therefore research has been focusing on replacing the cements with injectable hydrogels. 
Liu  et  al. [81] have produced  a biomimetic bone substitute made  of  chopped 
poly(L-lactide-co-ε-caprolactone) nanoyarns manually incorporated in a collagen hydrogel 
before gelation. Interestingly, to obtain well aligned nanoyarns, a water vortex was used  as 
collector, instead of more traditional systems as rotating drums or dual metal collection 
rings (Figure 9.5). As a result, they obtained massive continuous nanoyarns with 
homogenous diameters (16 ± 4 μm). Furthermore, the cut nanoyarns were short enough 
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to avoid the formation of entanglements when they were mixed with collagen solution. 
Results showed again that the incorporation of nanoyarns improved the mechanical 
properties of the hydrogel, without interfering with the cell proliferative ability of collagen. 
 
 
Figure 9.5. Schematic of the steps for the formation of nanoyarns using a water vortex. Reproduced from 
 
[82] with permission. Copyright (2007) Elsevier. 
 
 
 
 
Another approach for promoting osteogenesis in comparison to just polymeric hydrogels 
is to include growth factors inside the matrix. The scaffold needs to work as a delivery system 
promoting a sustained release and improved local retention. Kolambkar et al. [ 83] 
introduced electrospun nanofiber mesh tubes as a guide for rat bone regeneration in a 
segmental bone defect to deliver recombinant bone morphogenetic protein-2 (rhBMP-2) 
(Figure 9.6G). The PCL nanofibers (Figure 9.6A) had diameters ranging from 51 to 974 nm, 
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with high porous meshes (80–90%). The thick nanofiber meshes were able to be wrapped 
tightly around a steel mandrel and glued to form a tube (of 5 and 13 mm length) that was 
finally put in a mouse bone defect (Figure 9.6D,E), as they were (Figure 9.6B) or after being 
perforated (1 mm diameter perforations) (Figure 9.6C). Then, 125 μL pre-gelled 2% alginate 
with or without 5 μg rhBMP-2 were injected in the tube lumen. As control groups, they 
examined the nanofiber mesh alone and in combination with alginate hydrogel. Results 
showed that the systems containing meshes + hydrogel + rhBMP-2 produced substantial 
bone formation and complete defect bridging, while the controls did not exhibit any 
significant bone repair response. Indeed, defects were bridged by 12 weeks with densely 
packed, cellular mineralized tissue for both perforated and not perforated meshes 
containing alginate loaded with rhBMP-2. However, micro-computed tomography (μCT) 
revealed that perforations in mesh tubes enhanced bone formation at earlier stages in 
comparison to the scaffolds without perforations. Moreover, samples implanted with both 
perforated mesh tube and rhBMP-2 containing alginate were the only one presenting 
mechanical performances, in extracted femora at 12 weeks, statistically similar to the ones 
of natural bone. They attributed this phenomenon to the fact that the perforations allow 
sufficient vascularization to develop, while limiting soft tissue ingrowth [ 83]. 
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Figure 9.6. (A) SEM images of electrospun nanofiber mesh; (B) tubular implant without perforations; (C) 
tubular implant with perforations; (D) stabilized femur defect with implant; (E) bone defect, after placement 
of a perforated mesh tube; (F) alginate hydrogel was still present after 1 week, in vivo; and (G) release of 
rhBMP-2 from alginate hydrogel. Reproduced from [83] with permission. Copyright (2010) Elsevier. 
 
 
 
9.4.3 Fibrous Hydrogels for Osteochondral Engineering via Electrospinning 
 
The challenge in the development of OC scaffolds is that they should be able to replicate 
the complexity of this tissue, and therefore restore cartilage, intermediate calcified cartilage 
and bone tissues, all together. To achieve this result, composites scaffolds should be able to 
recruit mesenchymal cells from the bone marrow. Moreover, they must present a stratified 
structure in order to mimic the three different functional layers of OC tissue [46].  
Hydrogel/fibre  3D  composites  have  a  great  potential  to  mimic  this  complexity; 
however, to  date, literature on  graded  or  non-graded hydrogels  with  electrospun fibres 
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for osteochondral regeneration is scarce. Single-phase composites have been used for 
instance by Coburn et al.; they fabricated poly(vinyl alcohol)-methacrylate (PVA-MA) fibrous 
scaffolds with or without chondroitin sulphate, a signal that has been shown to enhance 
chondrogenesis of mesenchymal stem cells. These hydrogels, implanted into rat 
osteochondral bone defects, allowed for immediate cell infiltration, cartilaginous ti ssue 
formation and chondrogenic differentiation, as indicated by a higher cartilage specific gene 
expression. Furthermore, the addition of chondroitin sulphate increased type II collagen 
deposition compared to PVA fibres alone [74]. Filovà et al. prepared a 
PVA/liposomes blend that was electrospun and finally incorporated into a fibrin/type I 
collagen/fibrin composite hydrogel. Compressive tests showed the addition of nanofibers 
improved the mechanical properties of the composite gel as predicted. Moreover, once 
implanted into osteochondral defects of miniature pigs, the composite scaffold had better 
osteochondral regeneration towards hyaline cartilage and/or fibrocartilage compared with 
the controls that were mainly filled with fibrous tissue [84]. 
 
 
 
9.5 3D Printing 
 
Three-dimensional (3D) printing refers to manufacturing techniques in which 3D models 
are built in a computer-controlled layer-by-layer process [85]. It should be clarified that it 
is common to use the term “3D printing” in literature and mainstream media when referring 
to all Rapid Prototyping (RP) techniques; however, 3D printing also refers to a particular RP 
inkjet-based technology. The main advantage of 3D printing techniques in tissue 
engineering relies on the possibility of generating 3D scaffolds with a precise  control over  
the  internal  architecture [86,87]. Furthermore, fabrication  of scaffolds with 
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a complex, subject-specific geometry by modelling data acquired using different imaging 
techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans 
can be achieved [88]. Around 20 different 3D printing techniques have been applied 
to the biomedical field [86]; however, not all of them are compatible for the processing 
 
of hydrogels. For an extensive review in the hydrogel-rapid prototyping for tissue 
engineering the reader can refer to a recent publication by Billiet et al. [ 89]. 
 
Briefly, 3D printing of hydrogels can be divided in three main methods: laser-based, nozzle-
based, and inkjet printer-based systems, depending on the stimuli employed to assist the 
printing process and deposition of the material. Despite the differences in material 
deposition mechanism employed in the different techniques, the typical apparatus includes 
a hydrogel reservoir from which the material is transferred in a controlled manner to an 
ejection system and a collection platform. Nozzle- and inkjet printers sequentially deposit 
material, while laser-based or laser-assisted systems are based on photopolymerization of 
the pre-deposited material irradiated by light energy in specific predefined patterns 
[90,91,92]. Nozzle-based or extrusion systems rely on a 3D 
dispensing process in which the hydrogel is extruded through a nozzle driven by 
compressed air or a piston/rotating screw [93,94,95]. Electrical signals are used to  control 
the ejection of individual droplets and/or direction of a sequence of droplets [96,97]. 
 
These conventional 3D printing techniques are used to print cell-free 3D scaffolds for  
use  in  surgery  [98].  In  recent  years,  3D  bioprinting  has  gained  popularity  in  tissue 
engineering to allow the direct one-step fabrication of 3D scaffolds containing biomaterials, 
cells and  other biochemicals in  the same structure. The working principles  of 3D bioprinting 
are similar to conventional 3D printing techniques (Figure 9.7). The main 
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difference lies on the deposition of the hydrogels together with small units of cells. For a 
thorough review on the basic principles of bioprinting, readers can refer to Mandrycky et al. 
[99]. 
 
 
 
Figure 9.7. Illustration of 3D bioprinting technologies based on the mechanism used to assist the deposition 
of the bioinks and its main components; (Left) Inkjet bioprinters eject small droplets of cells and hydrogel 
sequentially to build up the  scaffold; (Middle) Laser bioprinters use a laser to generate the local ejection  of 
small droplets from a donor ribbon coated with the bioink; (Right) Extrusion bioprinters uses pneumatic of 
mechanical forces to continuously extrude the bioink through a nozzle. Reproduced from [ 100] with 
permission. Copyright (2015) Wiley-VCH. 
 
 
 
 
Hydrogel inks used in 3D printing fabrication methods can be formulated from injectable, 
shear-thinning  hydrogels  [101], as  they  are  required  to  flow  under  low  pressures, gel 
quickly, and maintain their shape after build up [102]. When the hydrogel inks contain 
 
cells and/or biochemicals for the use in bioprinting, they are referred as bioinks [ 103]. The 
 
design of hydrogel inks for 3D printing starts with the formulation of a polymer solution that 
forms a connected network soon after printing. The printed network can be physically or 
chemically cross-linked as a response to external stimuli (e.g., temperature, light, and ion 
concentration) [104]. The development of hydrogel inks suitable for bioprinting (both 
fabrication and cell culture), remains a challenge [105]. Whereas stiff hydrogels containing 
 
high concentration of polymer are needed for optimal shape fidelity, these highly dense 
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networks limit cell migration, growth and differentiation [106,107]. Conversely, cells grow 
 
better in soft hydrogels, which are too watery to maintain the desired shape (Figure 9.8). 
Maintaining shape conformity may compromise the biological competence and  the  clinical 
outcomes of the printed structures. Therefore, despite the advances in 3D printing 
technologies that allow researchers to design and fabricate complex structures, the lack  of 
suitable bioinks for tissue engineering is restricting the progress in the field and its 
translation to clinical practice. Initially, 3D printing technologies focused on the use of pure 
polymers; however, as the technology advances, the development of novel composite-
hydrogels for 3D printing are becoming increasingly popular, aiming at enhancing 
properties such as printability, mechanics and bioactivity [108,109,110,111]. 
 
 
 
Figure 9.8. Schematic of the challenges for engineering bioinks suitable for 3D printing. Optimal shape fidelity 
can be typically achieved with stiff hydrogels (top right), however, this dense network limits cell viability. 
Contrarily, cell survive best in soft hydrogels, but shape fidelity cannot be achieved ( bottom left). Therefore, a 
compromise between biological and fabrication properties must be done ( middle). Novel strategies aimed at 
obtaining high shape fidelity with cytocompatible hydrogels. Reproduced from [ 105] 
with permission. Copyright (2009) Wiley-VCH. 
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9.5.1 3D Printing of Hydrogels for Cartilage Tissue Engineering 
 
Current scaffolds of 3D printing of hydrogels for CTE are mainly based on two different 
approaches: direct printing from hydrogels and hybrid printing from composite-hydrogels 
[112]. The advantage of using bioinks composed of a unique hydrogel is based on their 
simpler printability process compared to hybrid bioprinting and their physiological 
crosslinking conditions. Once again, when a high-level of printability is needed from the 
bioink, the mechanical  properties of  the 3D  scaffolds are commonly weak [ 113], but  the 
use of composite-hydrogels or the combination of a polymer network with bioinks can offer 
enough mechanical performance to support the 3D structure, although it may  reduce the 
bioactivity. 
Both natural and synthetic hydrogels have been used for CTE applications using 3D 
printing, where stem cells and chondrocytes are among the most common cell sources used 
in cartilage bioprinting [114]. Alginate has been extensively used as a bioink due to 
its  rapid  crosslinking. You  et  al.  [113] successfully  printed  a porous cell-laden hydrogel 
 
scaffold using sodium alginate impregnated with ATDC5 chondrogenic cell lines or primary 
chick chondrocytes as a bioink. The resulting scaffolds supported cell survival (85% cell 
viability), proliferation and ECM deposition of chondrogenic cells in vitro, however the 
compressive modulus was considerably low (20–70 kPa) compared to human cartilage 
(700–800 kPa). The compressive modulus was enhanced (75–250 kPa) in Markstedt et al. 
[115] by combining cellulose nanofibers with alginate. As a result, the printed complex 
 
scaffolds supported the culture of human chondrocytes (73–86% viability after one and 
seven days) as shown in Figure 9.9. The same bioink formulation (nanofibrillated 
cellulose/alginate)  in  combination  with  human  chondrocytes  and  MSCs  was  found to 
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promote in vivo chondrogenesis after subcutaneous implantation of the printed 
constructs in mice [116,117], suggesting the potential of 3D bioprinting of human cartilage 
for clinical applications. On the other hand, cell viability (80–96%) and cartilage ECM 
deposition  was  improved by  Kesti  et  al. [118] by  developing  a  cartilage-specific bioink 
based on a blend of gellan and alginate and incorporating cartilage ECM particles and seeded 
with bovine articular chondrocytes. 3D scaffolds were successfully printed with good 
mechanical properties (tensile modulus: 116–230 kPa) and complex shapes (i.e., meniscus, 
intervertebral disks and nose). 
 
 
Figure 9.9. 3D printed constructs made of a composite hydrogel (alginate + nanofibrillated cellulose) seeded 
with human chondrocytes. (A) 3D printed small grids (7.2 × 7.2 mm2). Deformed grid during (B), and after 
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(C) squeezing. (D) 3D printed human ear. (E, F) 3D printed sheep meniscus. Reproduced from [115] with 
 
permission Copyright (2015) American Chemical Society. 
 
 
 
 
Hyaluronic acid (HA) is gaining popularity as a bioink for CTE because of its viscoelastic 
and bioactive properties [119]. However, HA on its own has poor mechanical properties 
and it is therefore necessary to add other materials to improve printability and 
performance.,  Muller et  al.  [120] and  Pescosolido  et  al.  [121] demonstrated  increased 
viability of chondrocyte cells by adding acrylated Pluronic and a dextran derivate to HA. 
 
Gelatin has also shown excellent biocompatibility, but due to its low viscosity it is hard     
to  print  [122]. Therefore,  gelatin  is  usually modified with  an  acrylate  or  methacrylate 
agent  [123,124]. Gelatin-methacrylamide hydrogels (GelMA) have  been  extensively used 
 
to  produce  bioinks  for  CTE  [125,126,127].  Schuurman  et  al.  [127]  demonstrated that 
 
introducing HA increased the printability and bioactivity of the 3D printed scaffolds, with 
high  chondrocyte  cells  viability  (82% after  3  days).  Costantini et  al. [ 126] showed  that 
incorporating HA-methacrylate also enhanced the mechanical properties (compressive 
modulus ranging from 48 kPa for GelMA to 100 kPa for the composite bioink). On the  other  
hand,  Levato  et  al.  [125]  investigated  different  cell-sources  to  impregnate  the 
GelMA-based hydrogels. They concluded that the use of articular cartilage-resident 
chondroprogenitor cells (ACPCs) as an alternative or in combination with chondrocytes and 
mesenchymal stromal cells (MSCs) supported the formation of 3D cartilage scaffolds  in 
vitro. 
Poly(ethylene-glycol) (PEG) is one of the most common synthetic hydrogels used for 3D 
printing in CTE, showing higher mechanical properties compared to natural hydrogels. Cui 
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et    al.    [128]   successfully    3D    printed   PEG-dimethacrylate   (PEGDMA)    with human 
 
chondrocytes reaching a compressive modulus of 396 kPa and high cell viability (89%). In 
addition, Gao  et  al. [129] combined  PEG with  GelMA  and  both  hydrogels  were printed 
together with human MSCs, demonstrating an improvement of the mechanical properties 
after chondrogenic differentiation. 
The relative weak mechanical properties of all the above-mentioned hydrogel constructs 
considerably limit their application. To overcome this problem, alternating the printing of 
bioinks  and  thermoplastic polymers fibres  is  becoming  more popular  in  CTE  [130]. 3D 
printed scaffolds have been created by combining the deposition of a stiff polymer 
(polycaprolactone, PCL) and cell-laden hydrogel (alginate) [130,131,132], with 
chondrocyte cell viability varying from 70% to 85%. In vivo studies by Kundu et al. [131] 
 
showed enhanced cartilage ECM deposition by addition of transforming growth factor-β 
(TGFβ). Furthermore, Schuurman et al. [130] reported a compressive modulus of 6000 kPa 
of the printed hydrogels constructs. 
 
 
 
 
9.5.2 3D Printing of Hydrogels for Bone Tissue Engineering 
 
Natural biopolymer hydrogels are excellent bioinks for 3D printing, due to their easily 
adjustable materials characteristics such as viscosity or gelation kinetics as well as their 
capacity to provide biocompatibility resulting in a consistency similar to the soft tissue 
matrix [133], however their weak mechanical properties limits the support of osteogenic 
differentiation   and   therefore   their   use   for   BTE   [134,135].   Adjusting   the  scaffold 
 
composition is essential for the fabrication of bone tissue constructs. Composite hydrogel- 
based materials consisting of an hydrogel phase mimicking the organic part of the bone 
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(mainly collagen type I) and a mineral phase representing the mineral content of bone 
(mainly hydroxyapatite) [136,137,138] can  enhance the  mechanical properties of  the 3D 
scaffolds  and  their  regenerative  potential  [139,140].  Natural  (e.g.,  collagen,  alginate, 
 
chitosan, HA, gelatin, and agarose) and synthetic (PEG) hydrogels have been used as 
bioinks for BTE applications, with the addition or not of inorganic particles (e.g., HAp). 
HA is abundantly present in bone ECM, where it gives mechanical support. When it is 
modified with methacrylate groups, resulting in methacrylated HA (MeHA), printability and 
rigidity improve while maintaining good biocompatibility [141]. Poldevaart et al. [141] 
showed that human bone marrow derived MSCs survival (64% after 21 days) and osteogenic 
differentiation, measured by quantification of calcium deposition, were successfully 
achieved in 3D printed MeHA scaffolds; however, the elastic modulus of the hydrogel was 
very low (10.6 kPa) compared to bone tissue. MSC osteogenic differentiation and  
mechanical  properties  were  enhanced  [142] by  combining  agarose  hydrogels with 
collagen type I. Different combinations of agarose-collagen were tested showing high cell 
viability (over 98%) and a compressive modulus ranging from 18 to 89 kPa. The less stiff 
hydrogel exhibited a higher MSC osteogenic differentiation in vitro. In vivo bone matrix 
formation was observed [143] after implantation of 3D printed alginate-gelatin scaffolds 
seeded with human adipose-derived stem cells (hASCs). Despite the good biocompatibility 
and osteogenic differentiation, using 3D printed hydrogel scaffolds without the addition of 
any inorganic particle notably affects the mechanical properties. 
Early attempts to enhance the performance of the printed hydrogels by incorporating 
HAp  particles  by  Ang  et  al.  [144]  used  a  chitosan-HAp  composite  and  showing  cell 
biocompatibility.  However,  osteogenesis  and  mechanics  were  not  evaluated,  and cells 
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were not printed together with the hydrogels. More recently, 3D printed cell-laden scaffolds 
using different hydrogel formulations (e.g., chitosan, alginate, and gelatin) with HAp   
particles   have   been   studied   [145,146].   The   incorporation   of   HAp   particles 
significantly improved the mechanical strength of the hydrogels and promoted osteogenic 
differentiation in vivo [140,145,146,147], making them suitable for repairing bone tissue 
defects (Figure 9.10). 
 
 
 
Figure 9.10. 3D bio-printed constructs made of alginate/gelatin (AG) and alginate/gelatin/nano-HAp (AGH) 
mixed with human adipose-derived stem cells (hASCs) before and after implantation showing osteoinduction. 
Constructs were implanted into the back sub-cutaneous area of nude mice and harvested eight weeks after 
surgery. Larger bone formation was observed in the constructs containing HAp. Reproduced from [ 140] 
with permission, Copyright (2016) Royal Society of Chemistry. 
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Although hydrogels and composite-hydrogels have shown to be suitable for application in 
low load-bearing bone defects, adequate mechanical properties are still needed. In this 
perspective, hybrid scaffolds combining synthetic polymer scaffolds and cell-laden 
hydrogels are a promising area to explore. PCL is commonly used for bone scaffolds due  to  
its high mechanical strength  [98], but it presents limited  cell affinity [148]. To improve 
cell  proliferation and  enhance  the  osteogenesis of  PCL 3D printed scaffolds,  Dong et al. 
 
[149]  integrated  them  with  bone  marrow  MSCs-laden  chitosan  hydrogel,  achieving  a 
 
compressive strength of the hybrid scaffolds of about 6.7 MPa (similar to  trabecular  bone). 
Osteogenesis was enhanced by incorporating chitosan  into the PCL scaffolds and  in vivo 
bone formation was found after implantation of the seeded scaffolds in a mice model  [149]. 
Vascularization of  3D  printed bone  constructs  was  studied  by  Kang  et al. 
[150] and  Kuss et al. [151]. Cell laden  hydrogels were  hybrid  bioprinted together  with a 
 
PCL frame. Bone and vessel formation was observed in vitro and in vivo, resulting in 
promising results for the regeneration of bone defects. 
Works involving the use of 3D printing in the fabrication of scaffolds for bone and cartilage 
regeneration are summarised in Table 9.2 and Table 9.3. Even if these are not exhaustive 
lists of publications, they highlight the progress done on the front of providing viable cells 
for implantation. However, in vivo work is so far limited and needs to be explored more 
widely to bring these strategies closer to clinical translation. 
 
 
 
Table 9.2 Overview of publication on 3D printing of hydrogels for cartilage tissue engineering. 
 
 
Materials Cell source(s) Printing 
method 
Mechanical 
properties 
Cytocompatibilit 
y 
Referenc 
e 
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Sodium 
alginate 
ATDC5 chondrogenic cell 
line 
Inkjet 
bioprintin 
g 
Compressive 
modulus: 20 – 
70 kPa 
~ 85%  cell 
viability  
Cartilage ECM 
deposition 
[113] 
Alginate with 
cellulose 
nanofibers 
Human nasoseptal 
chondrocyte 
Inkjet 
bioprintin 
g 
Compressive 
modulus: 75 – 
250 kP 
73-86% cell 
viability 
[115] 
Alginate with 
cellulose 
nanofibers 
Human nasoseptal 
chondrocyte 
Extrusion 
bioprintin 
g 
 
Compressiv 
e modulus: 
15 – 88 kP 
Cartilage ECM 
deposition 
[116] 
Alginate with 
cellulose 
nanofibers 
Human nasoseptal 
chondrocytes and MSCs 
Extrusion 
bioprintin 
g 
Not reported Chondrogenic 
differentiation 
Chondrocytes 
proliferation 
[117] 
Alginate with 
gellan 
Bovine articular 
chondrocytes 
Extrusion 
bioprintin 
g 
Tensile 
modulus: 116- 
230 kPa 
80-96%  cell 
viability  
Cartilage ECM 
deposition 
Chondrocytes 
proliferation 
[118] 
Methacrylate 
d HA with 
diacrylated 
Pluronic 
Bovine articular 
chondrocytes 
Inkjet 
bioprintin 
g 
Compressive 
modulus: 1.5 – 
6.5 kPa 
62-86% cell 
viability 
[120] 
HA with 
dextran 
derived 
Equine articular 
chondrocytes 
Extrusion 
bioprintin 
g 
Ultimate 
compressive 
stress: 100- 
160 kPa 
>75% cell 
viability 
[121] 
GelMA with 
HA 
Equine articular 
chondrocytes 
Inkjet 
bioprintin 
g 
Compressive 
modulus: 5 – 
180 kPa 
>73% cell 
viability 
[127] 
GelMA with 
HA- 
methacrylate 
Human bone marrow 
MSCs 
Extrusion 
bioprintin 
g 
Compressive 
modulus: 48 – 
100 kPa 
85-95% cell 
viability 
[126] 
GelMA Equine     
ACPCs/Chondrocytes/MS 
Cs 
Inkjet 
bioprintin 
g 
Compressive 
modulus: 100 
– 187 kPa 
>75% cell 
viability 
[125] 
PEGDMA Human articular 
chondrocytes 
Inkjet 
bioprintin 
g 
Compressive 
modulus: ~ 
400 kPa 
89% cell viability 
Cartilage ECM 
deposition 
[128] 
PEG-GelMA Human MSCs Inkjet 
bioprintin 
g 
Compressive 
modulus: 1 
MPa 
~ 80%  cell 
viability  
Cartilage ECM 
deposition 
Chondrogenic 
differentiation 
[129] 
 Embryonic chick 
chondrocytes 
Inkjet Not reported 77-85% cell 
viability 
[132] 
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Alginate 
reinforced 
with PCL 
 bioprintin 
g 
 Cartilage ECM 
deposition 
 
Alginate 
reinforced 
with PCL + 
TGFβ 
Human nososeptal 
chondrocytes 
Extrusion 
bioprintin 
g 
Not reported 85% cell viability 
Cartilage ECM 
deposition 
[131] 
Alginate 
reinforced 
with PCL 
C20A4 human 
chondrocyte cell line 
Extrusion 
bioprintin 
g 
Compressive 
modulus: 6 
MPa 
~70 % cell 
viability 
[130] 
 
 
 
 
 
 
Table 9.3 Overview of publications on 3D printing of hydrogels for bone tissue engineering. 
 
 
Materials Cell source(s) Printing 
 
method 
Mechanical 
 
properties 
Cytocompatibility Reference 
MeHA Human BM MSCs Inkjet 
bioprinting 
Elastic 
modulus: ~ 11 
kPa 
~ 65% cell viability 
Osteogenic 
differentiation 
[141] 
Agarose with 
collagen type I 
Human BM MSCs Inkjet 
bioprinting 
Compressive 
modulus: 18- 
90 kPa 
~ 95% cell viability 
Osteogenic 
differentiation 
[142] 
Alginate-gelatin hASCs Inkjet 
bioprinting 
Not reported Osteogenic 
differentiation 
Bone matrix 
formation 
[143] 
Chitosan-HAp Human osteoblasts Extrusion 
bioprinting 
Not reported Good cell 
attachment and 
proliferation 
[144] 
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Chitosan- 
Hap/Alginate- 
Hap 
MC3T3-E1 cells Inkjet 
bioprinting 
Elastic 
modulus: 4.6- 
15 kPa/3.5-19 
 
kPa 
> 90% cell viability 
Cell proliferation 
Bone matrix 
formation 
[145] 
MeHA with Hap 
or GelMA with 
Hap 
hASCs Extrusion 
bioprinting 
Not reported Osteogenic 
differentiation 
Bone matrix 
formation 
[146] 
Alginate- 
gelatin/alginate- 
gelatin with 
nano-Hap 
hASCs Extrusion 
bioprinting 
Not reported > 88% cell viability 
Osteogenic 
differentiation 
[140] 
Alginate-PVA 
with Hap 
MC3T3-E1 cells Extrusion 
bioprinting 
Compressive 
modulus: 2.4- 
10.3 kPa 
77-95% cell 
viability 
[147] 
Chitosan 
reinforced with 
PCL 
Rabbit BM MSCs Extrusion 
bioprinting 
Compressive 
strength: 6.7 
MPa 
Osteogenic 
differentiation 
Bone matrix 
formation 
[149] 
HA and Gelatin 
reinforced with 
PCL/TCP 
Human amniotic 
fluid-SCs 
Extrusion 
bioprinting 
Not reported 91% cell viability 
Osteogenic 
differentiation 
Bone matrix 
formation 
[150] 
MeHA and 
GelMA 
reinforced with 
PCL/HAp 
Stromal vascular 
 
fraction derived 
cells 
Extrusion 
bioprinting 
Not reported Osteogenic 
differentiation 
[151] 
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9.5.3 3D Printing of Hydrogels for Osteochondral Tissue Engineering 
 
3D printing of hydrogels has shown great potential for the production of customized 
scaffolds in cartilage and bone tissue engineering, as previously described. Because of its 
ability to fabricate 3D constructs with complex shapes by depositing cell laden hydrogels  at 
desired locations, 3D printing also results in a promising technique for the fabrication  of 
gradient scaffolds with hydrogels stacked in a multilayer manner [ 152]. This unique 
capability enables to expand the use of 3D printing to the efficient regeneration of 
osteochondral tissue, providing a scaffold that favours integration between the chondral 
and the osseous phases for osteochondral defects repair. 3D printed constructs for 
osteochondral tissue regeneration are usually built in a bilayer fashion, by employing 
different bioink formulations for the subchondral bone and the cartilage zone. Early 
attempts were  done  by  Fedorovick et  al.  [153] encapsulating human  chondrocytes and 
osteogenic progenitors in alginate hydrogel, biofabricating 3D scaffolds with different parts 
for both cell types. Distinctive tissue formation at defined locations was observed both in 
vitro and in vivo, however, the scaffolds presented low mechanical strength (Young’s 
modulus < 7.6 kPa) and a limited height of the construct could be achieved. Anatomically  
relevant  size  bilayered  scaffolds  were  fabricated  by  Levato  et  al.  [ 154] 
combining two different bioinks: GelMA-Gellan Gum with PLA microcarriers (MCs) seeded 
with MSCs for the bone and without MCs for the cartilage layer. The MC laden region 
improved the compressive modulus (25–50 kPa) of the hydrogel constructs and supported 
osteogenic differentiation and bone matrix deposition by MSCs, suggesting the  potential of 
the use of MCs-based biofabrication for osteochondral tissue engineering. An efficient 
osteochondral gradient scaffolds was fabricated using a novel laser-based 3D printer by 
Castro  et  al.  [155] and human  MSCs  osteogenic and  chondrogenic differentiation  was 
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enhanced through the incorporation of tissue specific nano-HAp with different 
concentrations of PEG-diacrylate (PEG-Da) for the porous osseous layer and the transitional 
calcified cartilage layer, and TGF-β1 added to the PEG-Da for the solid  cartilage layer. It is 
known that hydrogels derived from natural ECM can enhance tissue regeneration by 
providing biochemical signals inducing cellular differentiation and migration  [156,157]. In  
this  sense,  HA  and  collagen type  I  (Col-I), which  are the  major 
organic ECM components of cartilage and bone, respectively, were combined in a 3D 
printed  scaffold  fabricated  by  Park  et  al.  [158].  A  bilayer  construct   was   3D   printed 
encapsulating chondrocytes in a HA hydrogel for the cartilage zone and osteoblast in a Col-
I hydrogel for the bone area within a PCL printed framework. Viability and function of each 
cell type were well maintained up to 14 days in vitro. A validation of the potential of a 3D 
printed bilayer construct for osteochondral tissue regeneration using an in  vivo animal 
model was reported by Shim et al. [159]. A subchondral bone layer was fabricated 
by dispensing a solution of atelocollagen with human turbinate-derived MSCs onto a PCL 
framework, whereas a solution of cucurbit [6] uril-HA and 1,6-diaminohexane-conjugated 
HA was dispensed into the PCL matrix for the superficial cartilage layer. 3D printed scaffolds 
were implanted in the knee joints of rabbits. Neo-cartilage was observed in the cartilage 
region and new bone formation in the subchondral bone region at eight weeks post 
implantation. 
 
 
 
9.6 Future Trends 
 
Electrospinning and 3D printing both have a great potential in the fabrication of complex 
structures such as those required for tissue engineering of bone, cartilage and 
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osteochondral tissue. Combining the two could also overcome some of the limitations of 
the individual methods such as the tight intertwining of electrospun fibres that limits cell 
migration and the limited resolution of some 3D prototyping methods. The first reports    of 
materials obtained by combining these two fabrication methods have only emerged in 
recent years [160]. More specific reports on their combined use in the manufacturing of 
tissue engineering scaffolds for bone, cartilage and osteochondral tissues are still limited. 
Yu et al. prepared PCL printed meshes that were infused with homogenised electrospun 
PCL/gelatine   fibres   crosslinked   with   glutarhaldehyde   [161].  The   work   showed that 
combination of the mechanically competent 3D printed mesh with the biocompatible 
nanofibers can be exploited to obtain the ratio of porosity and the pore size that is most 
advantageous for cell migration and proliferation. Naghieh et al. fabricated scaffolds with 
alternating layers of 3D printed PLA mesh and gelatin/forsterite electrospun fibres [ 162]. 
These hierarchical structures presented appropriate mechanical behaviour for applications 
in bone tissue engineering with additional bioactive properties. These first reports 
demonstrate the potential of using a combinatorial approach, where 3D printing and 
electrospinning can afford additive advantages to the use of a single technique. The 
translational potential of this strategy must be now explored. 
 
 
 
9.7 Conclusions 
 
Hydrogels and their combination with other biomaterials are very attractive in tissue 
engineering applications targeting both soft and hard tissue replacement, with specific 
relevance to orthopaedics. To achieve complex hydrogel constructs with the necessary 
requirements to substitute the specific tissue and help regeneration, two manufacturing 
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techniques are currently considered the most promising in the field: electrospinning and 3D 
printing. This review considers the most recent advances of hydrogel-based scaffold 
production using such techniques applied to cartilage and bone tissue engineering. As a 
result, a variety of materials can be used to fine-tune composite implants to achieve the 
desired mechanical and biological properties. However, as it stands, both electrospinning 
and 3D printing of hydrogel composites is still limited by the inability of selectively assign 
materials to reproduce tissue geometry and properties with required resolution and further 
work is needed in this sense, particularly to target tissue transition at the interface between 
bone and cartilage. 
 
 
 
Acknowledgments 
The authors thank the University of Portsmouth Research and Innovation Development 
Fund, the Institute of Biology and Biomedical Science (IBBS) and the Faculty of Technology 
at University of Portsmouth for financial support. 
 
 
 
Conflicts of Interest 
The authors declare that there is no conflict of interest. 
 
 
 
 
9.8 References 
 
1. Pisani, P.; Renna, M.D.; Conversano, F.; Casciaro, E.; Di Paola, M.; Quarta, E.;  Muratore,  M.; 
Casciaro,  S.  Major  osteoporotic  fragility  fractures:  Risk  factor  updates  and  societal  impact. 
World J. Orthop. 2016, 7, 171–181. [Google Scholar] [CrossRef] [PubMed] 
282  
2. Murphy, L.; Helmick, C.G. The Impact of Osteoarthritis in  the  United  States.  Orthop.  Nurs. 
2012, 31, 85–91. [Google Scholar] [CrossRef] [PubMed] 
3. Tozzi, G.; De Mori, A.; Oliveira, A.; Roldo, M.  Composite  hydrogels  for  bone  regeneration. 
Materials (Basel) 2016, 9, 267. [Google Scholar] [CrossRef] [PubMed] 
4. Liu, M.; Zeng, X.; Ma, C.; Yi, H.; Ali, Z.; Mou, X.; Li, S.; Deng, Y.; He, N. Injectable hydrogels for 
cartilage and bone tissue engineering. Bone Res.2017, 5, 17014. [Google Scholar] [CrossRef]  
[PubMed] 
5. Kim, T.G.; Shin, H.; Lim, D.W. Biomimetic Scaffolds for Tissue Engineering. Adv. Funct. Mater. 
2012, 22, 2446–2468. [Google Scholar] [CrossRef] 
6. Khan, W.S.; Malik, A. Stem Cell Therapy and Tissue Engineering Applications for Cartilage 
Regeneration. Curr. Stem Cell Res. Ther. 2012, 7, 241–242. [Google Scholar] [CrossRef] [PubMed] 
7. Grottkau, B.E.; Lin, Y. Osteogenesis of Adipose-Derived Stem Cells. Bone Res.2013, 1, 133– 
145. [Google Scholar] [CrossRef] [PubMed] 
8. Bush, J.R.; Liang, H.; Dickinson, M.; Botchwey, E.A. Xylan hemicellulose improves chitosan 
hydrogel for bone tissue regeneration. Polym. Adv. Technol.2016, 27,  1050–1055.  [Google Scholar] 
[CrossRef] [PubMed] 
9. Trickey, W.R.; Lee, G.M.; Guilak, F. Viscoelastic properties of chondrocytes from normal  and 
osteoarthritic human cartilage. J. Orthop. Res. 2000, 18, 891–898. [Google Scholar] [CrossRef] 
[PubMed] 
10. Pal, S. Design of Artificial Human Joints & Organs; Springer: New York, NY, USA, 2014; pp. 1–
419. [Google Scholar] 
11. Mobasheri, A.; Csaki, C.; Clutterbuck, A.L.; Rahmanzadeh, M.; Shakibaei, M. Mesenchymal 
stem cells in connective tissue engineering and regenerative medicine: Applications in cartilage repair 
and osteoarthritis therapy. Histol. Histopathol. 2009, 24, 347–366. [Google Scholar] [CrossRef] 
[PubMed] 
12. Izadifar, Z.; Chen, X.; Kulyk, W. Strategic Design  and Fabrication of Engineered  Scaffolds for 
Articular Cartilage Repair. J. Funct. Biomater. 2012, 3, 799–838. [Google Scholar] [CrossRef] 
[PubMed] 
13. Reddi, A.H.; Becerra, J.; Andrades, J.A. Nanomaterials and hydrogel scaffolds for articular 
cartilage regeneration. Tissue Eng. B 2011, 17, 301–305. [Google Scholar] [CrossRef] [PubMed] 
14. Hall, B.K. Bones and Cartilage, 2nd ed.; Academic Press: San Diego, CA, USA, 2015; ISBN 978-
0-12-416678-3. [Google Scholar] 
283  
15. Benders, K.E.M.; van Weeren, P.R.; Badylak, S.F.; Saris, D.B.F.; Dhert, W.J.A.; Malda, J. 
Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol. 2013, 31, 169–
176. [Google Scholar] [CrossRef] [PubMed] 
16. Hadjidakis, D.J.; Androulakis, I.I. Bone Remodeling. Ann. N. Y. Acad. Sci.2006, 1092, 385– 
396. [Google Scholar] [CrossRef] [PubMed] 
17. Kini, U.; Nandeesh,  B.N.  Physiology  of  Bone  Formation,  Remodeling,  and  Metabolism. In 
Radionuclide and Hybrid Bone Imaging; Fogelman, I., Gnanasegaran, G., van der Wall, H., Eds.; 
Springer: Berlin/Heidelberg, Germany, 2012; pp. 29–57. ISBN  978-3-642-02400-9.  [Google Scholar] 
18. Athanasiou, K.A.; Zhu, C.; Lanctot, D.R.; Agrawal, C.M.; Wang, X. Fundamentals of 
biomechanics in tissue engineering of bone. Tissue Eng.2000, 6, 361–381. [Google Scholar] [CrossRef] 
[PubMed] 
19. Florencio-Silva, R.; Rodrigues da Silva Sasso, G.; Sasso-Cerri, E.; Simoes, M.J.; Cerri, P.S. 
Biology of Bone Tissue: Structure, Function, and Factors that Influence Bone Cells.  BioMed Res.  Int. 
2015. [Google Scholar] [CrossRef] [PubMed] 
20. Adler, C.-P. Bones and Bone Tissue. In Bone Diseases: Macroscopic, Histological, and 
Radiological Diagnosis of Structural Changes in the Skeleton; Adler, C.-P., Ed.; Springer: 
Berlin/Heidelberg, Germany, 2000; pp. 1–11. ISBN 978-3-662-04088-1. [Google Scholar] 
21. Rho, J.Y.; Ashman, R.B.; Turner, C.H. Young’s modulus of trabecular and cortical bone 
material: Ultrasonic and microtensile measurements. J. Biomech.2018, 26, 111–119. [Google 
Scholar] [CrossRef] 
22. Wu, S.; Liu, X.; Yeung, K.W.K.; Liu, C.; Yang, X. Biomimetic porous scaffolds for bone tissue 
engineering. Mater. Sci. Eng. R Rep. 2014, 80, 1–36. [Google Scholar] [CrossRef] 
23. Fratzl, P.; Weinkamer, R. Nature’s hierarchical materials. Prog. Mater. Sci.2007, 52, 1263– 
1334. [Google Scholar] [CrossRef] 
24. Kane, R.; Ma, P.X. Mimicking the nanostructure of bone matrix to regenerate bone. Mater. 
Today 2013, 16, 418–423. [Google Scholar] [CrossRef] [PubMed] 
25. Rho, J.Y.; Kuhn-Spearing, L.; Zioupos, P. Mechanical properties and the hierarchical structure 
of bone. Med. Eng. Phys. 1998, 20, 92–102. [Google Scholar] [CrossRef] 
26. Zhang, W.; Zhu, Y.; Li, J.; Guo, Q.; Peng, J.; Liu, S.; Yang, J.; Wang, Y. Cell-Derived Extracellular 
Matrix: Basic Characteristics and Current Applications in Orthopedic Tissue Engineering. Tissue Eng. 
B 2015, 22, 193–207. [Google Scholar] [CrossRef] [PubMed] 
284  
27. Blair, H.C.; Sun, L.; Kohanski, R.A. Balanced Regulation of Proliferation, Growth, 
Differentiation, and Degradation in Skeletal Cells. Ann. N. Y. Acad. Sci.2007, 1116, 165–173. [Google 
Scholar] [CrossRef] [PubMed] 
28. Sims, N.A.; Gooi, J.H. Bone remodeling: Multiple cellular interactions required for coupling of 
bone formation and resorption. Semin. Cell Dev. Biol. 2008, 19, 444–451. [Google Scholar] [CrossRef] 
[PubMed] 
29. Oryan,  A.;  Monazzah,  S.;  Bigham-Sadegh,  A.  Bone  injury  and   fracture   healing biology. 
Biomed. Environ. Sci. 2015, 28, 57–71. [Google Scholar] [CrossRef] [PubMed] 
30. Schubert, T.; Lafont, S.; Beaurin, G.; Grisay, G.; Behets, C.; Gianello, P.; Dufrane, D. Critical 
size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from 
differentiated adipose MSCs. Biomaterials2013, 34, 4428–4438. [Google Scholar] [CrossRef] 
[PubMed] 
31. Giannoudis,   P.V.;   Einhorn,   T.A.;   Marsh,   D.   Fracture   healing:   The    diamond concept. 
Injury 2018, 38, S3–S6. [Google Scholar] [CrossRef] 
32. Campana, V.; Milano, G.; Pagano, E.; Barba, M.; Cicione, C.; Salonna, G.; Lattanzi, W.; 
Logroscino, G. Bone substitutes in orthopaedic surgery: From basic science to clinical practice. J. 
Mater. Sci. Mater. Med. 2014, 25, 2445–2461. [Google Scholar] [CrossRef] [PubMed] 
33. Wang, W.; Yeung, K.W.K. Bone grafts and biomaterials substitutes for bone defect repair:   A 
review. Bioact. Mater. 2017, 2, 224–247. [Google Scholar] [CrossRef] 
34. Stevens, M.M. Biomaterials for bone tissue engineering. Mater. Today 2008, 11, 18–25. 
[Google Scholar] [CrossRef] 
35. Nauth, A.; Ristevski, B.; Li, R.; Schemitsch, E.H. Growth factors and bone  regeneration: How 
much bone can we expect? Injury 2011, 42, 574–579. [Google Scholar] [CrossRef] [PubMed] 
36. Agarwal, R.; Garcia, A.J. Biomaterial strategies for engineering implants for enhanced 
osseointegration and bone repair. Adv. Drug Deliv. Rev. 2015, 94, 53–62. [Google Scholar] [CrossRef] 
[PubMed] 
37. Roseti, L.; Parisi, V.; Petretta, M.; Cavallo, C.; Desando, G.; Bartolotti, I.; Grigolo, B.  Scaffolds  
for  Bone  Tissue  Engineering:  State  of the  art  and new  perspectives. Mater. Sci. Eng.  C 2017, 78, 
1246–1262. [Google Scholar] [CrossRef] [PubMed] 
38. Younger, E.M.; Chapman,  M.W.  Morbidity  at  bone  graft  donor  sites.  J.  Orthop.  Trauma 
1989, 3, 192–195. [Google Scholar] [CrossRef] [PubMed] 
39. García-Gareta, E.; Coathup, M.J.; Blunn, G.W. Osteoinduction of bone grafting materials   for 
bone repair and regeneration. Bone 2015, 81, 112–121. [Google Scholar] [CrossRef] [PubMed] 
285  
40. Yunus Basha, R.; Sampath Kumar, T.S.; Doble, M. Design of biocomposite materials for  bone 
tissue regeneration. Mater. Sci. Eng. C 2015, 57, 452–463. [Google Scholar] [CrossRef] [PubMed] 
41. Dabrowski, B.; Swieszkowski, W.; Godlinski, D.; Kurzydlowski, K.J. Highly porous titanium 
scaffolds for orthopaedic applications. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 95, 53–61. 
[Google Scholar] [CrossRef] [PubMed] 
42. Sarkar, S.K.; Lee, B.T. Hard tissue regeneration using bone substitutes: An update on 
innovations in materials. Korean J. Intern. Med. 2015, 30, 279–293. [Google Scholar] [CrossRef] 
[PubMed] 
43. Atala, A.; Kasper, F.K.; Mikos, A.G. Engineering complex tissues. Sci. Transl. Med. 2012, 4, 
160rv12. [Google Scholar] [CrossRef] [PubMed] 
44. Amini, A.R.; Laurencin, C.T.; Nukavarapu, S.P. Bone Tissue Engineering: Recent Advances and 
Challenges. Crit. Rev. Biomed. Eng. 2012, 40, 363–408. [Google Scholar] [CrossRef] [PubMed] 
45. Henkel, J.; Woodruff, M.A.; Epari, D.R.; Steck, R.; Glatt, V.; Dickinson, I.C.; Choong, P.F.M.; 
Schuetz, M.A.; Hutmacher, D.W. Bone  Regeneration  Based on Tissue  Engineering Conceptions— A 
21st Century Perspective. Bone Res.2013, 1, 216–248. [Google Scholar] [CrossRef] [PubMed] 
46. Khorshidi, S.; Karkhaneh, A. A review on gradient hydrogel/fiber scaffolds for  osteochondral 
regeneration. J. Tissue Eng. Regen. Med. 2017. [Google Scholar] [CrossRef] [PubMed] 
47. Nukavarapu, S.P.; Dorcemus, D.L. Osteochondral tissue engineering:  Current  strategies and 
challenges. Biotechnol. Adv. 2013, 31, 706–721. [Google Scholar] [CrossRef] [PubMed] 
48. Nooeaid, P.; Salih, V.; Beier, J.P.; Boccaccini, A.R. Osteochondral tissue engineering: Scaffolds, 
stem cells and applications. J. Cell. Mol. Med. 2012, 16, 2247–2270. [Google Scholar] [CrossRef] 
[PubMed] 
49. Gomoll, A.H.; Madry, H.; Knutsen, G.; van Dijk, N.; Seil, R.; Brittberg, M.; Kon, E. The 
subchondral  bone  in  articular  cartilage  repair:  Current  problems   in   the   surgical management. 
Knee Surg. Sports Traumatol. Arthrosc. 2010, 18, 434–447. [Google Scholar] [CrossRef] [PubMed] 
50. Seliktar,     D.     Designing     cell-compatible     hydrogels      for      biomedical   applications. 
Science 2012, 336, 1124–1128. [Google Scholar] [CrossRef] [PubMed] 
51. Zhang, L.; Xia, K.; Lu, Z.; Li, G.; Chen, J.; Deng, Y.; Li, S.; Zhou, F.; He, N. Efficient and Facile 
Synthesis of Gold Nanorods with Finely  Tunable  Plasmonic  Peaks  from  Visible  to  Near-IR  Range. 
Chem. Mater. 2014, 26, 1794–1798. [Google Scholar] [CrossRef] 
286  
52. Peppas, N.A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical 
formulations. Eur. J. Pharm. Biopharm. 2000, 50, 27–46. [Google Scholar] [CrossRef] 
53. Vega, S.; Kwon, M.; Burdick, J. Recent advances in hydrogels for cartilage tissue engineering. 
Eur. Cells Mater. 2017, 33, 59–75. [Google Scholar] [CrossRef] [PubMed] 
54. Visser, J.; Melchels, F.P.W.; Jeon, J.E.; van Bussel, E.M.; Kimpton, L.S.; Byrne, H.M.; Dhert, 
W.J.A.; Dalton, P.D.; Hutmacher, D.W.; Malda, J. Reinforcement of hydrogels using three- 
dimensionally printed microfibres. Nat. Commun. 2015, 6, 6933. [Google Scholar] [CrossRef] 
[PubMed] 
55. Vedadghavami, A.; Minooei, F.; Mohammadi, M.H.; Khetani, S.; Rezaei Kolahchi, A.; 
Mashayekhan, S.; Sanati-Nezhad, A. Manufacturing of hydrogel biomaterials with controlled 
mechanical properties for tissue engineering applications. Acta Biomater.  2017, 62,  42–63. [Google 
Scholar] [CrossRef] [PubMed] 
56. Snyder, T.N.; Madhavan, K.; Intrator, M.; Dregalla, R.C.; Park, D. A fibrin/hyaluronic acid 
hydrogel for the delivery of mesenchymal stem cells and potential for articular cartilage repair. J. Biol. 
Eng. 2014, 8, 10. [Google Scholar] [CrossRef] [PubMed] 
57. Guo, Y.; Yuan, T.; Xiao, Z.; Tang, P.; Xiao, Y.; Fan, Y.; Zhang, X. Hydrogels of 
collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue 
engineering. J. Mater. Sci. Mater. Med. 2012, 23, 2267–2279. [Google Scholar] [CrossRef]  [PubMed] 
58. Yanagawa, F.; Sugiura, S.; Kanamori, T. Hydrogel microfabrication  technology  toward three 
dimensional tissue engineering. Regen. Ther. 2016, 3, 45–57. [Google Scholar] [CrossRef] 
59. Da Costa, F.F.P.; Araujo, E.S.; Nascimineto, M.L.F.; de Oliveira, H.P. Electrospun Fibers of 
Enteric Polymer for Controlled Drug Delivery. Int. J. Polym. Sci. 2015. [Google Scholar] [CrossRef] 
60. Scholten, E.; Bromberg, L.; Rutledge, G.C.; Hatton,  T.A. Electrospun Polyurethane Fibers  for 
Absorption of Volatile Organic Compounds from Air. ACS Appl. Mater. Interfaces 2011, 3, 3902–3909. 
[Google Scholar] [CrossRef] [PubMed] 
61. Li, G.; Zhang, T.; Li, M.; Fu, N.; Fu, Y.; Ba, K.; Deng, S.; Jiang, Y.; Hu, J.; Peng, Q.; et al. 
Electrospun fibers for dental and craniofacial applications. Curr. Stem Cell Res. Ther. 2014, 9, 187– 
195. [Google Scholar] [CrossRef] [PubMed] 
62. Hu, X.; Liu, S.; Zhou, G.; Huang, Y.; Xie, Z.; Jing, X. Electrospinning of polymeric nanofibers for 
drug delivery applications. J. Control. Release 2014, 185, 12–21. [Google Scholar] [CrossRef] 
[PubMed] 
287  
63. Shi, X.; Zhou, W.; Ma, D.; Ma, Q.; Bridges, D.; Ma, Y.; Hu, A. Electrospinning of Nanofibers and 
Their Applications for Energy Devices. J. Nanomater. 2015, 2015, 140716. [Google Scholar] [CrossRef] 
64. Zhu, P.; Lin, A.; Tang, X.; Lu, X.; Zheng, J.; Zheng, G.; Lei, T. Fabrication of three-dimensional 
nanofibrous macrostructures by electrospinning. AIP Adv.2016, 6, 55304. [Google Scholar] 
[CrossRef] 
65. Haider, A.; Haider, S.; Kang, I.-K. A comprehensive review summarizing the effect of 
electrospinning parameters and potential applications of nanofibers in biomedical and 
biotechnology. Arab. J. Chem. 2015. [Google Scholar] [CrossRef] 
66. Ray, S.S.; Chen, S.-S.; Li, C.-W.; Nguyen, N.C.; Nguyen, H.T. A comprehensive review: 
Electrospinning technique for fabrication and surface modification of membranes for water 
treatment application. RSC Adv. 2016, 6, 85495–85514. [Google Scholar] [CrossRef] 
67. Erdem-Kuruca, S.; Kayaman-Apohan, N.; Oktay, B. Fabrication of nanofiber mats from 
electrospinning of functionalized polymers. IOP Conf. Ser. Mater. Sci. Eng. 2014, 64,  12011.  [Google 
Scholar] 
68. Thompson, C.J.; Chase, G.G.; Yarin, A.L.; Reneker, D.H. Effects of parameters on nanofiber 
diameter determined from electrospinning model. Polymer (Guildford) 2007, 48, 6913–6922. 
[Google Scholar] [CrossRef] 
69. Sadat-Shojai, M.; Khorasani, M.-T.; Jamshidi, A. A new strategy for fabrication of bone 
scaffolds using electrospun nano-HAp/PHB fibers and protein hydrogels. Chem. Eng. J. 2016, 289, 
38–47. [Google Scholar] [CrossRef] 
70. Bosworth, L.A.; Turner, L.-A.; Cartmell, S.H. State of the art composites comprising 
electrospun fibres coupled with hydrogels: A review. Nanomedicine2013, 9, 322–335. [Google 
Scholar] [CrossRef] [PubMed] 
71. Coburn, J.; Gibson, M.; Bandalini, P.A.; Laird, C.; Mao, H.-Q.; Moroni, L.; Seliktar, D.; Elisseeff, 
J. Biomimetics of the Extracellular Matrix: An Integrated Three-Dimensional Fiber- Hydrogel 
Composite for Cartilage Tissue Engineering. Smart Struct.  Syst. 2011, 7,  213–222. [Google Scholar] 
[CrossRef] [PubMed] 
72. Mirahmadi, F.; Tafazzoli-Shadpour, M.; Shokrgozar, M.A.; Bonakdar, S. Enhanced mechanical 
properties of thermosensitive chitosan hydrogel by silk fibers for cartilage tissue engineering. Mater. 
Sci. Eng. C 2013, 33, 4786–4794. [Google Scholar] [CrossRef] [PubMed] 
73. Mohabatpour, F.; Karkhaneh, A.; Sharifi, A.M. A hydrogel/fiber composite scaffold for 
chondrocyte encapsulation in cartilage tissue regeneration. RSC Adv. 2016, 6, 83135–83145. [Google 
Scholar] [CrossRef] 
288  
74. Coburn, J.M.; Gibson, M.; Monagle, S.; Patterson, Z.; Elisseeff, J.H. Bioinspired nanofibers 
support chondrogenesis for articular cartilage repair. Proc. Natl. Acad. Sci. USA 2012, 109, 10012– 
10017. [Google Scholar] [CrossRef] [PubMed] 
75. Bas, O.; De-Juan-Pardo, E.M.; Meinert, C.; D’Angella, D.; Baldwin, J.G.; Bray, L.J.; Wellard, 
R.M.; Kollmannsberger, S.; Rank, E.; Werner, C.; et al. Biofabricated soft network composites for 
cartilage tissue engineering. Biofabrication 2017, 9, 25014. [Google Scholar] [CrossRef] [PubMed] 
76. Tonsomboon, K.; Butcher, A.L.; Oyen, M.L. Strong and tough nanofibrous hydrogel 
composites based on biomimetic principles. Mater. Sci. Eng. C 2017, 72,  220–227.  [Google Scholar] 
[CrossRef] [PubMed] 
77. He, Q.; Wang, Z.; Yan, Y.; Zheng,  J.; Cai, S. Polymer nanofiber reinforced double network  gel 
composite: Strong, tough and transparent. Extrem. Mech. Lett. 2016, 9, 165–170. [Google Scholar] 
[CrossRef] 
78. Wright, L.D.; McKeon-Fischer, K.D.; Cui, Z.; Nair, L.S.; Freeman, J.W. PDLA/PLLA and 
PDLA/PCL nanofibers with a chitosan-based hydrogel in composite scaffolds for tissue engineered 
cartilage. J. Tissue Eng. Regen. Med. 2014, 8, 946–954. [Google Scholar] [CrossRef] [PubMed] 
79. Bas, O.; De-Juan-Pardo, E.M.; Chhaya, M.P.; Wunner, F.M.; Jeon, J.E.; Klein, T.J.; Hutmacher, 
D.W. Enhancing structural integrity of hydrogels by using highly organised melt electrospun fibre 
constructs. Eur. Polym. J. 2015, 72, 451–463. [Google Scholar] [CrossRef] 
80. Formica, F.A.; Öztürk, E.; Hess, S.C.; Stark, W.J.; Maniura-Weber, K.; Rottmar, M.; Zenobi- 
Wong, M. A Bioinspired Ultraporous Nanofiber-Hydrogel Mimic of the Cartilage Extracellular Matrix. 
Adv. Healthc. Mater. 2016, 5, 3129–3138. [Google Scholar] [CrossRef] [PubMed] 
81. Liu, W.; Zhan, J.; Su, Y.; Wu, T.; Ramakrishna, S.; Liao, S.; Mo, X. Injectable hydrogel 
incorporating with nanoyarn for bone regeneration. J. Biomater. Sci. Polym. Ed. 2014, 25, 168– 
180. [Google Scholar] [CrossRef] [PubMed] 
82. Teo, W.-E.; Gopal, R.; Ramaseshan, R.; Fujihara, K.; Ramakrishna, S. A dynamic liquid support 
system for continuous electrospun yarn fabrication. Polymer (Guildford) 2007, 48, 3400– 3405. 
[Google Scholar] [CrossRef] 
83. Kolambkar, Y.M.; Dupont, K.M.; Boerckel, J.D.; Huebsch, N.; Mooney, D.J.; Hutmacher, D.W.; 
Guldberg, R.E. An alginate-based hybrid system for growth factor delivery in the functional repair of 
large bone defects. Biomaterials 2011, 32, 65–74. [Google Scholar] [CrossRef] [PubMed] 
84. Filova, E.; Rampichova, M.; Litvinec, A.; Drzik, M.; Mickova, A.; Buzgo, M.; Kostakova, E.; 
Martinova, L.; Usvald, D.; Prosecka, E.; et al. A cell-free nanofiber composite scaffold regenerated 
osteochondral defects in miniature pigs. Int. J. Pharm. 2013, 447, 139–149. [Google Scholar] 
[CrossRef] [PubMed] 
289  
85. Chua, C.K.; Leong, K.F.; Lim, C.S. Rapid Prototyping. Principles and Applications, 3rd ed.; 
World Scientific: Singapore, 2010; ISBN 978-981-277-897-0. [Google Scholar] 
86. Peltola, S.M.; Melchels, F.P.W.; Grijpma, D.W.; Kellomaki, M. A review  of  rapid prototyping 
techniques for tissue engineering purposes. Ann. Med. 2008, 40, 268–280. [Google Scholar] 
[CrossRef] [PubMed] 
87. Sachlos, E.; Czernuszka, J.T. Making tissue engineering scaffolds work. Review: The 
application of solid freeform fabrication technology to the production of tissue engineering scaffolds. 
Eur. Cell Mater. 2003, 5, 29–40. [Google Scholar] [CrossRef] [PubMed] 
88. Do, A.-V.; Khorsand, B.; Geary, S.M.; Salem, A.K. 3D Printing of Scaffolds for Tissue 
Regeneration Applications. Adv. Healthc. Mater. 2015, 26, 1742–1762.  [Google  Scholar]  [CrossRef] 
[PubMed] 
89. Billiet, T.; Vandenhaute, M.; Schelfhout, J.; Van Vlierberghe, S.; Dubruel, P. A review of trends       
and       limitations       in       hydrogel-rapid      prototyping       for        tissue  engineering. Biomaterials 
2012, 33, 6020–6041. [Google Scholar] [CrossRef] [PubMed] 
90. Melchels, F.P.W.; Feijen, J.; Grijpma, D.W. A review on stereolithography and its applications 
in biomedical engineering. Biomaterials 2010, 31, 6121–6130. [Google Scholar] [CrossRef] [PubMed] 
91. Liska, R.; Schuster, M.; Inführ, R.; Turecek, C.; Fritscher, C.; Seidl, B.; Schmidt, V.; Kuna, L.; 
Haase, A.; Varga, F.; et al. Photopolymers for rapid prototyping. J. Coat. Technol. Res. 2007, 4, 505–
510. [Google Scholar] [CrossRef] 
92. Dhariwala, B.; Hunt, E.; Boland, T. Rapid prototyping of tissue-engineering  constructs, using 
photopolymerizable hydrogels and stereolithography. Tissue Eng. 2004, 10, 1316–1322. [Google 
Scholar] [CrossRef] [PubMed] 
93. Khalil, S.; Nam, J.; Sun, W. Multi-nozzle deposition for construction of  3D  biopolymer tissue 
scaffolds. Rapid Prototyp. J. 2005, 11, 9–17. [Google Scholar] [CrossRef] 
94. Liu, L.; Xiong, Z.; Yan, Y.; Zhang, R.; Wang, X.; Jin, L. Multinozzle low-temperature deposition 
system for construction of gradient tissue engineering scaffolds. J. Biomed. Mater. Res. B Appl. 
Biomater. 2009, 88, 254–263. [Google Scholar] [CrossRef] [PubMed] 
95. Vozzi, G.; Ahluwalia, A. Microfabrication for tissue engineering: Rethinking the cells-on-a 
scaffold approach. J. Mater. Chem. 2007, 17, 1248. [Google Scholar] [CrossRef] 
96. Sachs, E.; Cima, M.; Cornie, J. Three-Dimensional Printing: Rapid Tooling and Prototypes 
Directly from a CAD Model. CIRP Ann. 1990, 39, 201–204. [Google Scholar] [CrossRef] 
290  
97. Nakamura, M.; Kobayashi, A.; Takagi, F.; Watanabe, A.; Hiruma, Y.; Ohuchi, K.; Iwasaki, Y.; 
Horie, M.; Morita, I.; Takatani, S. Biocompatible inkjet printing technique for designed seeding of 
individual living cells. Tissue Eng. 2005, 11, 1658–1666. [Google Scholar] [CrossRef] [PubMed] 
98. Chia, H.N.; Wu, B.M. Recent advances in 3D printing of biomaterials. J. Biol. Eng. 2015, 9, 
4. [Google Scholar] [CrossRef] [PubMed] 
99. Mandrycky, C.; Wang, Z.; Kim, K.; Kim, D.  3D  bioprinting  for  engineering  complex  tissues. 
Biotechnol. Adv. 2016, 34, 422–434. [Google Scholar] [CrossRef] [PubMed] 
100. Pereira, R.F.; Bartolo, P.J. 3D bioprinting of photocrosslinkable hydrogel  constructs.  J.  Appl. 
Polym. Sci. 2015. [Google Scholar] [CrossRef] 
101. Guvendiren, M.; Lu, H.D.; Burdick, J.A. Shear-thinning hydrogels for biomedical applications. 
Soft Matter 2012, 8, 260–272. [Google Scholar] [CrossRef] 
102. Stanton, M.M.; Samitier, J.; Sanchez, S. Bioprinting of 3D hydrogels. Lab Chip2015, 15, 3111–
3115. [Google Scholar] [CrossRef] [PubMed] 
103. Holzl, K.; Lin, S.; Tytgat, L.; Van Vlierberghe, S.; Gu, L.; Ovsianikov, A. Bioink properties before, 
during and after 3D bioprinting. Biofabrication 2016, 8, 32002. [Google  Scholar]  [CrossRef] 
[PubMed] 
104. Zhang, X.; Zhang, Y. Tissue Engineering Applications of Three-Dimensional Bioprinting. Cell 
Biochem. Biophys. 2015, 72, 777–782. [Google Scholar] [CrossRef] [PubMed] 
105. Malda, J.; Visser, J.; Melchels, F.P.; Jüngst, T.; Hennink, W.E.; Dhert, W.J.A.; Groll, J.; 
Hutmacher, D.W. 25th Anniversary Article:  Engineering  Hydrogels  for  Biofabrication.  Adv.  Mater. 
2013, 25, 5011–5028. [Google Scholar] [CrossRef] [PubMed] 
106. Khalil, S.; Sun, W. Bioprinting endothelial cells with alginate for 3D tissue constructs. J. 
Biomech. Eng. 2009, 131, 111002. [Google Scholar] [CrossRef] [PubMed] 
107. Tirella, A.; Orsini, A.; Vozzi, G.; Ahluwalia, A. A phase diagram for microfabrication of 
geometrically controlled hydrogel scaffolds. Biofabrication2009, 1, 45002. [Google Scholar] 
[CrossRef] [PubMed] 
108. Luo, Y.; Zhai, D.; Huan, Z.; Zhu, H.; Xia, L.; Chang, J.; Wu, C. Three-Dimensional Printing of 
Hollow-Struts-Packed  Bioceramic  Scaffolds  for  Bone   Regeneration. ACS   Appl.   Mater. Interfaces 
2015, 7, 24377–24383. [Google Scholar] [CrossRef] [PubMed] 
109. Osterbur, L.W. 3D Printing of Hyaluronic Acid Scaffolds for  Tissue  Engineering  Applications; 
University of Illinois at Urbana-Champaign: Champaign, IL, USA, 2013. [Google Scholar] 
291  
110. Zhao, S.; Zhang, J.; Zhu, M.; Zhang, Y.; Liu, Z.; Tao, C.; Zhu, Y.; Zhang, C. Three-dimensional 
printed strontium-containing mesoporous bioactive glass scaffolds for repairing rat critical-sized 
calvarial defects. Acta Biomater. 2015, 12, 270–280. [Google Scholar] [CrossRef] [PubMed] 
111. Jakus, A.E.; Taylor, S.L.; Geisendorfer, N.R.; Dunand, D.C.; Shah,  R.N.  Metallic  Architectures 
from 3D-Printed Powder-Based Liquid Inks. Adv. Funct. Mater.2015, 25, 6985–6995. [Google 
Scholar] [CrossRef] 
112. You, F.; Eames, B.F.; Chen, X. Application of Extrusion-Based Hydrogel Bioprinting for 
Cartilage Tissue Engineering. Int. J. Mol. Sci. 2017, 18, 1597. [Google Scholar] [CrossRef] [PubMed] 
113. You, F.; Wu, X.; Zhu, N.; Lei, M.; Eames, B.F.; Chen, X. 3D Printing of Porous Cell-Laden 
Hydrogel Constructs for Potential Applications in Cartilage Tissue Engineering. ACS Biomater. Sci. Eng. 
2016, 2, 1200–1210. [Google Scholar] [CrossRef] 
114. Klein, T.J.; Rizzi, S.C.; Reichert, J.C.; Georgi, N.; Malda, J.; Schuurman, W.; Crawford, R.W.; 
Hutmacher, D.W. Strategies for Zonal Cartilage Repair using Hydrogels. Macromol. Biosci. 2009, 9, 
1049–1058. [Google Scholar] [CrossRef] [PubMed] 
115. Markstedt, K.; Mantas, A.; Tournier, I.; Martínez Ávila, H.; Hägg, D.; Gatenholm, P. 3D 
Bioprinting Human Chondrocytes with Nanocellulose–Alginate Bioink for Cartilage Tissue 
Engineering Applications. Biomacromolecules 2015, 16, 1489–1496. [Google Scholar] [CrossRef] 
[PubMed] 
116. Möller, T.; Amoroso, M.; Hägg, D.; Brantsing, C.; Rotter, N.; Apelgren, P.; Lindahl, A.; Kölby, 
L.; Gatenholm, P. In Vivo Chondrogenesis in 3D Bioprinted  Human  Cell-laden Hydrogel  Constructs. 
Plast. Reconstr. Surg. Glob. Open2017, 5, e1227. [Google Scholar]  [CrossRef]  [PubMed] 
117. Apelgren, P.; Amoroso, M.; Lindahl, A.; Brantsing, C.; Rotter, N.; Gatenholm, P.; Kölby, L. 
Chondrocytes and stem cells in 3D-bioprinted structures create human  cartilage  in  vivo.  PLoS ONE 
2017, 12, e0189428. [Google Scholar] [CrossRef] [PubMed] 
118. Kesti, M.; Eberhardt, C.; Pagliccia, G.; Kenkel, D.; Grande, D.; Boss, A.; Zenobi-Wong, M. 
Bioprinting Complex Cartilaginous Structures with Clinically Compliant Biomaterials. Adv. Funct. 
Mater. 2015, 25, 7406–7417. [Google Scholar] [CrossRef] 
119. Burdick, J.A.; Prestwich, G.D. Hyaluronic Acid Hydrogels for Biomedical Applications. Adv. 
Mater. 2011, 23, H41–H56. [Google Scholar] [CrossRef] [PubMed] 
120. Müller, M.; Becher, J.; Schnabelrauch, M.; Zenobi-Wong, M. Nanostructured Pluronic 
hydrogels as bioinks for 3D bioprinting. Biofabrication 2015, 7, 35006. [Google Scholar] [CrossRef] 
[PubMed] 
292  
121. Pescosolido, L.; Schuurman, W.; Malda, J.; Matricardi, P.; Alhaique, F.; Coviello, T.; van 
Weeren, P.R.; Dhert, W.J.A.; Hennink, W.E.; Vermonden, T. Hyaluronic Acid and Dextran-Based Semi-
IPN Hydrogels as Biomaterials for Bioprinting. Biomacromolecules 2011, 12, 1831–1838. [Google 
Scholar] [CrossRef] [PubMed] 
122. Wang, X.; Tuomi, J.; Mäkitie, A.A.; Paloheimo, K.-S.; Partanen, J.; Yliperttula, M. The 
Integrations of Biomaterials and Rapid Prototyping Techniques for Intelligent Manufacturing of 
Complex Organs; Pignatello, R., Ed.; InTech: Rijeka, Croatia, 2013; p. 17. [Google Scholar] 
123. Ifkovits, J.L.; Burdick, J.A. Review: Photopolymerizable and degradable biomaterials for tissue 
engineering applications. Tissue Eng. 2007, 13, 2369–2385. [Google Scholar] [CrossRef] [PubMed] 
124. Billiet, T.; Gevaert, E.; De Schryver, T.; Cornelissen, M.; Dubruel, P. The 3D printing of gelatin    
methacrylamide    cell-laden    tissue-engineered    constructs    with    high     cell   viability. 
Biomaterials 2014, 35, 49–62. [Google Scholar] [CrossRef] [PubMed] 
125. Levato, R.; Webb, W.R.; Otto, I.A.; Mensinga, A.; Zhang, Y.; van Rijen, M.; van Weeren, R.; 
Khan, I.M.; Malda, J. The bio in the ink: Cartilage regeneration with bioprintable hydrogels and 
articular cartilage-derived progenitor cells. Acta Biomater. 2017, 61, 41–53. [Google Scholar] 
[CrossRef] [PubMed] 
126. Costantini, M.; Idaszek, J.; Szöke, K.; Jaroszewicz, J.; Dentini, M.; Barbetta, A.; Brinchmann, 
J.E.; Święszkowski, W. 3D bioprinting of BM-MSCs-loaded ECM biomimetic hydrogels for in vitro 
neocartilage formation. Biofabrication 2016, 8, 35002. [Google Scholar] [CrossRef] [PubMed] 
127. Schuurman, W.; Levett, P.A.; Pot, M.W.; van Weeren, P.R.; Dhert,  W.J.A.;  Hutmacher, D.W.; 
Melchels, F.P.W.; Klein, T.J.; Malda, J. Gelatin-Methacrylamide Hydrogels as Potential Biomaterials    
for    Fabrication    of    Tissue-Engineered    Cartilage     Constructs.  Macromol. Biosci. 2013, 13, 551–
561. [Google Scholar] [CrossRef] [PubMed] 
128. Cui, X.; Breitenkamp, K.; Finn, M.G.; Lotz, M.; D’Lima, D.D. Direct Human Cartilage Repair 
Using Three-Dimensional Bioprinting Technology. Tissue Eng. Part A 2012, 18,  1304–1312.  [Google 
Scholar] [CrossRef] [PubMed] 
129. Gao, G.; Schilling, A.F.; Hubbell, K.; Yonezawa, T.; Truong, D.; Hong, Y.; Dai, G.; Cui, X. 
Improved properties of bone and cartilage tissue from 3D inkjet-bioprinted human mesenchymal 
stem  cells  by  simultaneous  deposition  and   photocrosslinking   in   PEG-GelMA. Biotechnol.   Lett. 
2015, 37, 2349–2355. [Google Scholar] [CrossRef] [PubMed] 
130. Schuurman, W.; Khristov, V.; Pot, M.W.; van Weeren, P.R.; Dhert, W.J.; Malda, J.  Bioprinting      
of      hybrid      tissue      constructs      with       tailorable       mechanical    properties. Biofabrication 
2011, 3, 21001. [Google Scholar] [CrossRef] [PubMed] 
293  
131. Kundu, J.; Shim, J.-H.; Jang, J.; Kim, S.-W.; Cho, D.-W. An additive manufacturing-based PCL-
alginate-chondrocyte bioprinted scaffold for cartilage tissue  engineering. J.  Tissue  Eng. Regen. Med. 
2015, 9, 1286–1297. [Google Scholar] [CrossRef] [PubMed] 
132. Izadifar, Z.; Chang, T.; Kulyk, W.; Chen, X.; Eames, B.F. Analyzing Biological Performance    of 
3D-Printed, Cell-Impregnated Hybrid Constructs for Cartilage Tissue Engineering. Tissue  Eng. Part C 
Methods 2016, 22, 173–188. [Google Scholar] [CrossRef] [PubMed] 
133. Murphy, S.V.; Skardal, A.; Atala, A. Evaluation of hydrogels for bio-printing applications. J. 
Biomed. Mater. Res. A 2013, 101, 272–284. [Google Scholar] [CrossRef] [PubMed] 
134. Zhu, J.; Marchant, R.E. Design properties of hydrogel tissue-engineering scaffolds. Expert 
Rev. Med. Devices 2011, 8, 607–626. [Google Scholar] [CrossRef] [PubMed] 
135. Maas, M.; Hess, U.; Rezwan, K. The contribution of rheology for designing hydroxyapatite 
biomaterials. Curr. Opin. Colloid Interface Sci. 2014, 19, 585–593. [Google Scholar] [CrossRef] 
136. Hayrapetyan, A.; Bongio, M.; Leeuwenburgh, S.C.G.; Jansen, J.A.; van den Beucken, J.J.J.P. 
Effect of Nano-HA/Collagen Composite Hydrogels on Osteogenic Behavior of Mesenchymal  Stromal 
Cells. Stem Cell Rev. Rep.2016, 12, 352–364. [Google Scholar] [CrossRef] [PubMed] 
137. Wust, S.; Godla, M.E.; Muller, R.; Hofmann, S. Tunable hydrogel composite with two-step 
processing in combination with innovative hardware upgrade for cell-based three-dimensional 
bioprinting. Acta Biomater. 2014, 10, 630–640. [Google Scholar] [CrossRef] [PubMed] 
138. Sadat-Shojai, M.; Khorasani, M.-T.; Jamshidi, A. 3-Dimensional cell-laden nano- 
hydroxyapatite/protein hydrogels for bone regeneration applications. Mater. Sci. Eng. C Mater. Biol. 
Appl. 2015, 49, 835–843. [Google Scholar] [CrossRef] [PubMed] 
139. Thakur, T.; Xavier, J.R.; Cross, L.; Jaiswal, M.K.; Mondragon, E.; Kaunas, R.; Gaharwar, A.K. 
Photocrosslinkable  and  elastomeric  hydrogels  for  bone  regeneration.  J.  Biomed.  Mater.  Res.  A 
2016, 104, 879–888. [Google Scholar] [CrossRef] [PubMed] 
140. Wang, X.-F.; Lu, P.-J.; Song, Y.; Sun, Y.-C.; Wang, Y.-G.; Wang, Y. Nano hydroxyapatite 
particles promote osteogenesis in a three-dimensional bio-printing construct consisting of 
alginate/gelatin/hASCs. RSC Adv. 2016, 6, 6832–6842. [Google Scholar] [CrossRef] 
141. Poldervaart, M.T.; Goversen, B.; de Ruijter, M.; Abbadessa, A.; Melchels, F.P.W.; Öner,   F.C.; 
Dhert, W.J.A.; Vermonden, T.; Alblas, J. 3D bioprinting of methacrylated hyaluronic acid (MeHA) 
hydrogel with intrinsic osteogenicity. PLoS ONE 2017, 12, e0177628. [Google Scholar] [CrossRef] 
[PubMed] 
142. Duarte Campos, D.F.; Blaeser, A.; Buellesbach, K.; Sen, K.S.; Xun, W.; Tillmann, W.; Fischer, 
H. Bioprinting Organotypic Hydrogels with Improved Mesenchymal Stem Cell Remodeling and 
294  
Mineralization Properties for Bone Tissue Engineering. Adv. Healthc. Mater. 2016, 5, 1336–1345. 
[Google Scholar] [CrossRef] [PubMed] 
143. Wang, X.-F.; Song, Y.; Liu, Y.-S.; Sun, Y.; Wang, Y.; Wang, Y.; Lyu, P.-J. Osteogenic 
Differentiation of Three-Dimensional Bioprinted Constructs Consisting of Human Adipose-Derived 
Stem Cells In Vitro and In Vivo. PLoS ONE 2016, 11, e0157214. [Google Scholar] [CrossRef] [PubMed] 
144. Ang, T.H.; Sultana, F.S.A.; Hutmacher, D.W.; Wong, Y.S.; Fuh, J.Y.H.; Mo, X.M.; Loh, H.T.; 
Burdet, E.; Teoh, S.H. Fabrication of 3D chitosan-hydroxyapatite scaffolds using a robotic dispensing 
system. Mater. Sci. Eng. C 2002, 20, 35–42. [Google Scholar] [CrossRef] 
145. Demirtaş, T.T.; Irmak, G.; Gümüşderelioğlu, M. A bioprintable form of chitosan hydrogel 
for bone tissue engineering. Biofabrication 2017, 9, 35003. [Google Scholar] [CrossRef] [PubMed] 
146. Wenz, A.; Borchers, K.; Tovar, G.E.M.; Kluger, P.J. Bone matrix production in hydroxyapatite-
modified hydrogels suitable for bone bioprinting. Biofabrication2017, 9, 44103. [Google Scholar] 
[CrossRef] [PubMed] 
147. Bendtsen, S.T.; Quinnell, S.P.; Wei, M. Development of a novel alginate-polyvinyl alcohol- 
hydroxyapatite hydrogel for 3D bioprinting bone tissue engineered scaffolds. J. Biomed. Mater.  Res. 
Part A 2017, 105, 1457–1468. [Google Scholar] [CrossRef] [PubMed] 
148. Ciardelli, G.; Chiono, V.; Vozzi, G.; Pracella, M.; Ahluwalia, A.; Barbani, N.; Cristallini, C.; Giusti, 
P. Blends of poly-(epsilon-caprolactone) and polysaccharides in tissue engineering applications. 
Biomacromolecules 2005, 6, 1961–1976. [Google Scholar] [CrossRef] [PubMed] 
149. Dong, L.; Wang, S.-J.; Zhao, X.-R.; Zhu, Y.-F.; Yu, J.-K. 3D-Printed Poly(ε-caprolactone) Scaffold  
Integrated  with  Cell-laden  Chitosan  Hydrogels  for  Bone   Tissue   Engineering.  Sci.   Rep. 2017, 7, 
13412. [Google Scholar] [CrossRef] [PubMed] 
150. Kang, H.-W.; Lee, S.J.; Ko, I.K.; Kengla, C.; Yoo, J.J.; Atala, A. A 3D bioprinting system to 
produce human-scale tissue constructs with structural integrity. Nat. Biotechnol. 2016, 34, 312– 
319. [Google Scholar] [CrossRef] [PubMed] 
151. Kuss, M.A.; Harms, R.; Wu, S.; Wang, Y.; Untrauer, J.B.; Carlson, M.A.; Duan, B. Short-term 
hypoxic preconditioning promotes prevascularization in 3D bioprinted bone constructs with  stromal 
vascular fraction derived cells. Rsc Adv. 2017, 7, 29312–29320. [Google  Scholar]  [CrossRef] 
[PubMed] 
152. Bracaglia, L.G.; Messina, M.J.; Winston, S.; Kuo, C.-Y.; Lerman, M.; Fisher, J.P. 3D Printed 
Pericardium       Hydrogels       to       Promote       Wound       Healing       in       Vascular  Applications. 
Biomacromolecules 2017. [Google Scholar] [CrossRef] [PubMed] 
295  
153. Fedorovich, N.E.; Schuurman, W.; Wijnberg, H.M.;  Prins, H.-J.; van Weeren, P.R.; Malda,   J.; 
Alblas, J.; Dhert, W.J.A. Biofabrication of Osteochondral Tissue Equivalents by Printing Topologically 
Defined, Cell-Laden Hydrogel Scaffolds. Tissue Eng. C 2012, 18, 33–44. [Google Scholar] [CrossRef] 
[PubMed] 
154. Levato, R.; Visser, J.; Planell, J.A.; Engel, E.; Malda, J.; Mateos-Timoneda, M.A. Biofabrication     
of     tissue     constructs     by     3D     bioprinting     of      cell-laden     microcarriers. Biofabrication 
2014, 6, 35020. [Google Scholar] [CrossRef] [PubMed] 
155. Castro, N.J.; O’Brien, J.; Zhang, L.G. Integrating Biologically Inspired Nanomaterials and Table-
top      Stereolithography      for      3D       Printed       Biomimetic       Osteochondral    Scaffolds. 
Nanoscale 2015, 7, 14010–14022. [Google Scholar] [CrossRef] [PubMed] 
156. Gillette, B.M.; Jensen, J.A.; Tang, B.; Yang, G.J.; Bazargan-Lari, A.; Zhong, M.;  Sia, S.K. In  situ  
collagen  assembly  for  integrating   microfabricated   three-dimensional   cell-seeded matrices. Nat. 
Mater. 2008, 7, 636–640. [Google Scholar] [CrossRef] [PubMed] 
157. Sahoo, S.; Chung, C.; Khetan, S.; Burdick, J.A. Hydrolytically Degradable Hyaluronic Acid 
Hydrogels with Controlled Temporal Structures. Biomacromolecules 2008, 9, 1088–1092. [Google 
Scholar] [CrossRef] [PubMed] 
158. Park, J.Y.; Choi, J.-C.; Shim, J.-H.; Lee, J.-S.; Park, H.; Kim, S.W.; Doh, J.; Cho, D.-W. A 
comparative study on collagen type I and hyaluronic acid dependent cell behavior for osteochondral 
tissue bioprinting. Biofabrication2014, 6, 35004. [Google Scholar] [CrossRef] [PubMed] 
159. Shim, J.-H.; Jang, K.-M.; Hahn, S.K.; Park, J.Y.; Jung, H.; Oh, K.; Park, K.M.; Yeom, J.; Park, S.H.; 
Kim, S.W.; et al. Three-dimensional bioprinting of multilayered constructs containing human 
mesenchymal  stromal  cells  for   osteochondral   tissue   regeneration   in   the   rabbit   knee   joint. 
Biofabrication 2016, 8, 14102. [Google Scholar] [CrossRef] [PubMed] 
160. Lee, S.J.; Heo, D.N.; Park, J.S.; Kwon, S.K.; Lee, J.H.; Lee, J.H.; Kim, W.D.; Kwon, I.K.; Park, 
S.A. Characterization and preparation of bio-tubular scaffolds for fabricating artificial  vascular grafts 
by combining electrospinning and a 3D printing system. Phys. Chem. Chem. Phys. 2015, 17, 2996–
2999. [Google Scholar] [CrossRef] [PubMed] 
161. Yu, Y.; Hua, S.; Yang, M.; Fu, Z.; Teng, S.; Niu, K.; Zhao, Q.; Yi, C. Fabrication and 
characterization   of   electrospinning/3D   printing   bone   tissue    engineering    scaffold. RSC    Adv. 
2016, 6, 110557–110565. [Google Scholar] [CrossRef] 
162. Naghieh, S.; Foroozmehr, E.;  Badrossamay, M.;  Kharaziha, M. Combinational  processing  of 
3D printing and electrospinning of hierarchical poly(lactic acid)/gelatin-forsterite scaffolds as a 
296  
biocomposite: Mechanical and biological assessment. Mater. Des. 2017, 133, 128–135. [Google Scholar] 
[CrossRef] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
297  
 
Appendix III: UPR16 
 
 
